The present disclosure generally relates to ultrasonic surgical systems and, more particularly, to ultrasonic and electrosurgical systems that allows surgeons to perform cutting and coagulation.
Ultrasonic surgical instruments are finding increasingly widespread applications in surgical procedures by virtue of the unique performance characteristics of such instruments. Depending upon specific instrument configurations and operational parameters, ultrasonic surgical instruments can provide substantially simultaneous cutting of tissue and hemostasis by coagulation, desirably minimizing patient trauma. The cutting action is typically realized by an-end effector, or blade tip, at the distal end of the instrument, which transmits ultrasonic energy to tissue brought into contact with the end effector. Ultrasonic instruments of this nature can be configured for open surgical use, laparoscopic, or endoscopic surgical procedures including robotic-assisted procedures.
Some surgical instruments utilize ultrasonic energy for both precise cutting and controlled coagulation. Ultrasonic energy cuts and coagulates by using lower temperatures than those used by electrosurgery. Vibrating at high frequencies (e.g., 55,500 times per second), the ultrasonic blade denatures protein in the tissue to form a sticky coagulum. Pressure exerted on tissue with the blade surface collapses blood vessels and allows the coagulum to form a hemostatic seal. The precision of cutting and coagulation is controlled by the surgeon's technique and adjusting the power level, blade edge, tissue traction, and blade pressure.
A primary challenge of ultrasonic technology for medical devices, however, continues to be sealing of blood vessels. Work done by the applicant and others has shown that optimum vessel sealing occurs when the inner muscle layer of a vessel is separated and moved away from the adventitia layer prior to the application of standard ultrasonic energy. Current efforts to achieve this separation have involved increasing the clamp force applied to the vessel.
Furthermore, the user does not always have visual feedback of the tissue being cut. Accordingly, it would be desirable to provide some form of feedback to indicate to the user that the cut is complete when visual feedback is unavailable. Moreover, without some form of feedback indicator to indicate that the cut is complete, the user may continue to activate the harmonic instrument even though the cut is complete, which cause possible damage to the harmonic instrument and surrounding tissue by the heat that is generated when activating a harmonic instrument with little to nothing between the jaws.
The ultrasonic transducer may be modeled as an equivalent circuit having first branch comprising a static capacitance and a second “motional” branch comprising a serially connected inductance, resistance and capacitance that defines the electromechanical properties of the resonator. Conventional ultrasonic generators may include a tuning inductor for tuning out the static capacitance at a resonant frequency so that substantially all of generator's current output flows into the motional branch. The motional branch current, along with the drive voltage, define the impedance and phase magnitude. Accordingly, using a tuning inductor, the generator's current output represents the motional branch current, and the generator is thus able to maintain its drive output at the ultrasonic transducer's resonant frequency. The tuning inductor also transforms the phase impedance plot of the ultrasonic transducer to improve the generator's frequency lock capabilities. However, the tuning inductor must be matched with the specific static capacitance of an ultrasonic transducer. A different ultrasonic transducer having a different static capacitance requires a different tuning inductor.
Electrosurgical devices for applying electrical energy to tissue in order to treat and/or destroy the tissue are also finding increasingly widespread applications in surgical procedures. An electrosurgical device typically includes a hand piece, an instrument having a distally-mounted end effector (e.g., one or more electrodes). The end effector can be positioned against the tissue such that electrical current is introduced into the tissue. Electrosurgical devices can be configured for bipolar or monopolar operation. During bipolar operation, current is introduced into and returned from the tissue by active and return electrodes, respectively, of the end effector. During monopolar operation, current is introduced into the tissue by an active electrode of the end effector and returned through a return electrode (e.g., a grounding pad) separately located on a patient's body. Heat generated by the current flowing through the tissue may form hemostatic seals within the tissue and/or between tissues and thus may be particularly useful for sealing blood vessels, for example. The end effector of an electrosurgical device may also include a cutting member that is movable relative to the tissue and the electrodes to transect the tissue.
Electrical energy applied by an electrosurgical device can be transmitted to the instrument by a generator in communication with the hand piece. The electrical energy may be in the form of radio frequency (“RF”) energy. RF energy is a form of electrical energy that may be in the frequency range of 300 kilohertz (kHz) to 1 megahertz (MHz). In application, an electrosurgical device can transmit low frequency RF energy through tissue, which causes ionic agitation, or friction, in effect resistive heating, thereby increasing the temperature of the tissue. Because a sharp boundary is created between the affected tissue and the surrounding tissue, surgeons can operate with a high level of precision and control, without sacrificing un-targeted adjacent tissue. The low operating temperatures of RF energy is useful for removing, shrinking, or sculpting soft tissue while simultaneously sealing blood vessels. RF energy works particularly well on connective tissue, which is primarily comprised of collagen and shrinks when contacted by heat.
It would be desirable to provide a surgical instrument that overcomes some of the deficiencies of current instruments. The surgical system described herein overcomes those deficiencies.
The novel features of the described forms are set forth with particularity in the appended claims. The described forms, however, both as to organization and methods of operation, may be best understood by reference to the following description, taken in conjunction with the accompanying drawings in which:
Applicant of the present application also owns the following patent applications that were filed on Mar. 15, 2013 and which are each herein incorporated by reference in their respective entireties:
U.S. patent application Ser. No. 13/839,014, entitled “DEVICES AND TECHNIQUES FOR CUTTING AND COAGULATING TISSUE,” now U.S. Pat. No. 9,237,921;
U.S. patent application Ser. No. 13/839,242, entitled “ROTATABLE ELECTRICAL CONNECTION FOR ULTRASONIC SURGICAL INSTRUMENTS,” now U.S. Pat. No. 9,241,731;
U.S. patent application Ser. No. 13/839,351, entitled “SERIAL COMMUNICATION PROTOCOL FOR MEDICAL DEVICE,” now U.S. Pat. No. 9,226,766; and
U.S. patent application Ser. No. 13/839,470, entitled “TECHNIQUES FOR CUTTING AND COAGULATING TISSUE FOR ULTRASONIC SURGICAL INSTRUMENTS,” now U.S. Patent Application Publication No. 2013/0296908.
Before explaining various forms of ultrasonic surgical instruments in detail, it should be noted that the illustrative forms are not limited in application or use to the details of construction and arrangement of parts illustrated in the accompanying drawings and description. The illustrative forms may be implemented or incorporated in other forms, variations and modifications, and may be practiced or carried out in various ways. Further, unless otherwise indicated, the terms and expressions employed herein have been chosen for the purpose of describing the illustrative forms for the convenience of the reader and are not for the purpose of limitation thereof.
Further, it is understood that any one or more of the following-described forms, expressions of forms, examples, can be combined with any one or more of the other following-described forms, expressions of forms, and examples.
Various forms are directed to improved ultrasonic surgical instruments configured for effecting tissue dissecting, cutting, and/or coagulation during surgical procedures. In one form, an ultrasonic surgical instrument apparatus is configured for use in open surgical procedures, but has applications in other types of surgery, such as laparoscopic, endoscopic, and robotic-assisted procedures. Versatile use is facilitated by selective use of ultrasonic energy.
The various forms will be described in combination with an ultrasonic instrument as described herein. Such description is provided by way of example, and not limitation, and is not intended to limit the scope and applications thereof. For example, any one of the described forms is useful in combination with a multitude of ultrasonic instruments including those described in, for example, U.S. Pat. Nos. 5,938,633; 5,935,144; 5,944,737; 5,322,055; 5,630,420; and 5,449,370.
As will become apparent from the following description, it is contemplated that forms of the surgical instrument described herein may be used in association with an oscillator unit of a surgical system, whereby ultrasonic energy from the oscillator unit provides the desired ultrasonic actuation for the present surgical instrument. It is also contemplated that forms of the surgical instrument described herein may be used in association with a signal generator unit of a surgical system, whereby electrical energy in the form of radio frequencies (RF), for example, is used to provide feedback to the user regarding the surgical instrument. The ultrasonic oscillator and/or the signal generator unit may be non-detachably integrated with the surgical instrument or may be provided as separate components, which can be electrically attachable to the surgical instrument.
One form of the present surgical apparatus is particularly configured for disposable use by virtue of its straightforward construction. However, it is also contemplated that other forms of the present surgical instrument can be configured for non-disposable or multiple uses. Detachable connection of the present surgical instrument with an associated oscillator and signal generator unit is presently disclosed for single-patient use for illustrative purposes only. However, non-detachable integrated connection of the present surgical instrument with an associated oscillator and/or signal generator unit is also contemplated. Accordingly, various forms of the presently described surgical instruments may be configured for single use and/or multiple use with either detachable and/or non-detachable integral oscillator and/or signal generator unit, without limitation, and all combinations of such configurations are contemplated to be within the scope of the present disclosure.
With reference to
In accordance with the described forms, the ultrasonic generator 30 produces an electrical signal or drive signal of a particular voltage, current, and frequency, e.g., 55,500 cycles per second (Hz). The generator is 30 connected by the cable 22 to the handle assembly 68, which contains piezoceramic elements forming the ultrasonic transducer 50. In response to a switch 312a on the handle assembly 68 or a foot switch 434 connected to the generator 30 by another cable the generator signal is applied to the transducer 50, which causes a longitudinal vibration of its elements. The transducer 50 is secured to the handle assembly 68 via a connector 300. When installed, the transducer 50 is acoustically coupled to the surgical blade 79 via a structure or waveguide 80 (
Referring to
Referring to
With reference now back to
The transmission assembly 71 may include an outer tubular member or an outer sheath 72, an inner tubular actuating member 76, a waveguide 80, and an end effector 81 comprising, for example, the blade 79, a clamp arm 56, and one or more clamp pads 58. The transducer 50 and transmission assembly 71 (including or excluding the end effector 81) may be referred to as an ultrasonic drive system. As subsequently described, the outer sheath 72, the actuating member 76, and the waveguide 80 or transmission rod may be joined together for rotation as a unit (together with the ultrasonic transducer 50) relative to the handle assembly 68. The waveguide 80, which is adapted to transmit ultrasonic energy from the ultrasonic transducer 50 to the blade 79 may be flexible, semi-flexible, or rigid. The waveguide 80 also may be configured to amplify the mechanical vibrations transmitted through the waveguide 80 to the blade 79 as is well known in the art. The waveguide 80 may further have features to control the gain of the longitudinal vibration along the waveguide 80 and features to tune the waveguide 80 to the resonant frequency of the system. In particular, the waveguide 80 may have any suitable cross-sectional dimension. For example, the waveguide 80 may have a substantially uniform cross-section or the waveguide 80 may be tapered at various sections or may be tapered along its entire length. In one expression of the current form, the waveguide diameter is about 0.113 inches nominal to minimize the amount of deflection at the blade 79 so that gapping in the proximal portion of the end effector 81 is minimized.
The blade 79 may be integral with the waveguide 80 and formed as a single unit. In an alternate expression of the current form, the blade 79 may be connected by a threaded connection, a welded joint, or other coupling mechanisms. The distal end of the blade 79 is disposed near an anti-node in order to tune the acoustic assembly to a preferred resonant frequency fo when the acoustic assembly is not loaded by tissue. When the ultrasonic transducer 50 is energized, the distal end of the blade 79 is configured to move longitudinally in the range of, for example, approximately 10 to 500 microns peak-to-peak, and preferably in the range of about 20 to about 200 microns at a predetermined vibration frequency fo of, for example, 55,500 Hz.
With particular reference to
In one expression of the form, the clamp pad 58 is formed from TEFLON® a trademark name of E. I. Du Pont de Nemours and Company, a low coefficient of friction polymer material, or any other suitable low-friction material. The clamp pad 58 mounts on the clamp arm 56 for cooperation with the blade 79, with pivotal movement of the clamp arm 56 positioning the clamp pad 58 in substantially parallel relationship to, and in contact with, the blade 79, thereby defining a tissue treatment region. By this construction, tissue is grasped between the clamp pad 58 and the blade 79. As illustrated, the clamp pad 58 may be provided with a non-smooth surface, such as a saw tooth-like configuration to enhance the gripping of tissue in cooperation with the blade 79. The saw tooth-like configuration, or teeth, provide traction against the movement of the blade 79. The teeth also provide counter traction to the blade 79 and clamping movement. As would be appreciated by one skilled in the art, the saw tooth-like configuration is just one example of many tissue engaging surfaces to prevent movement of the tissue relative to the movement of the blade 79. Other illustrative examples include bumps, criss-cross patterns, tread patterns, a bead, or sand blasted surface.
Due to sinusoidal motion, the greatest displacement or amplitude of motion is located at the most distal portion of the blade 79, while the proximal portion of the tissue treatment region is on the order of 50% of the distal tip amplitude. During operation, the tissue in the proximal region of the end effector 81 will desiccate and thin, and the distal portion of the end effector 81 will transect tissue in that distal region, thereby allowing the desiccated and thinned tissue within the proximal region to slide distally into the more active region of the end effector 81 to complete the tissue transection.
FT=FA(X2/X1) (1)
Where FA equals the spring preload of a proximal spring 94 (less frictional losses), which, in one form, is about 12.5 pounds, and FT equals about 4.5 pounds.
FT is measured in the region of the clamp arm/blade interface where optimal tissue treatment occurs as defined by tissue marks 61a and 61b. The tissue marks 61a, b are etched or raised on the clamp arm 56 to provide a visible mark to the surgeon so the surgeon has a clear indication of the optimal tissue treatment area. The tissue marks 61a, b are about 7 mm apart in distance, and more preferably about 5 mm apart in distance.
In one form, the generator 30 drive system 32 may comprise one or more embedded applications implemented as firmware, software, hardware, or any combination thereof. The generator 30 drive system 32 may comprise various executable modules such as software, programs, data, drivers, application program interfaces (APIs), and so forth. The firmware may be stored in nonvolatile memory (NVM), such as in bit-masked read-only memory (ROM) or flash memory. In various implementations, storing the firmware in ROM may preserve flash memory. The NVM may comprise other types of memory including, for example, programmable ROM (PROM), erasable programmable ROM (EPROM), electrically erasable programmable ROM (EEPROM), or battery backed random-access memory (RAM) such as dynamic RAM (DRAM), Double-Data-Rate DRAM (DDRAM), and/or synchronous DRAM (SDRAM).
In one form, the generator 30 drive system 32 comprises a hardware component implemented as a processor 400 for executing program instructions for monitoring various measurable characteristics of the ultrasonic surgical instrument 100 (
In one form, under control of one or more software program routines, the processor 400 executes the methods in accordance with the described forms to generate a step function formed by a stepwise waveform of drive signals comprising current (I), voltage (V), and/or frequency (f) for various time intervals or periods (T). The stepwise waveforms of the drive signals may be generated by forming a piecewise linear combination of constant functions over a plurality of time intervals created by stepping the generator 30 drive signals, e.g., output drive current (I), voltage (V), and/or frequency (f). The time intervals or periods (T) may be predetermined (e.g., fixed and/or programmed by the user) or may be variable. Variable time intervals may be defined by setting the drive signal to a first value and maintaining the drive signal at that value until a change is detected in a monitored characteristic. Examples of monitored characteristics may comprise, for example, transducer impedance, tissue impedance, tissue heating, tissue transection, tissue coagulation, and the like. The ultrasonic drive signals generated by the generator 30 include, without limitation, ultrasonic drive signals capable of exciting the ultrasonic transducer 50 in various vibratory modes such as, for example, the primary longitudinal mode and harmonics thereof as well flexural and torsional vibratory modes.
In one form, the executable modules comprise one or more step function algorithm(s) 402 stored in memory that when executed causes the processor 400 to generate a step function formed by a stepwise waveform of drive signals comprising current (I), voltage (V), and/or frequency (f) for various time intervals or periods (T). The stepwise waveforms of the drive signals may be generated by forming a piecewise linear combination of constant functions over two or more time intervals created by stepping the generator's 30 output drive current (I), voltage (V), and/or frequency (f). The drive signals may be generated either for predetermined fixed time intervals or periods (T) of time or variable time intervals or periods of time in accordance with the one or more stepped output algorithm(s) 402. Under control of the processor 400, the generator 30 steps (e.g., increment or decrement) the current (I), voltage (V), and/or frequency (f) up or down at a particular resolution for a predetermined period (T) or until a predetermined condition is detected, such as a change in a monitored characteristic (e.g., transducer impedance, tissue impedance). The steps can change in programmed increments or decrements. If other steps are desired, the generator 30 can increase or decrease the step adaptively based on measured system characteristics.
In operation, the user can program the operation of the generator 30 using the input device 406 located on the front panel of the generator 30 console. The input device 406 may comprise any suitable device that generates signals 408 that can be applied to the processor 400 to control the operation of the generator 30. In various forms, the input device 406 includes buttons, switches, thumbwheels, keyboard, keypad, touch screen monitor, pointing device, remote connection to a general purpose or dedicated computer. In other forms, the input device 406 may comprise a suitable user interface. Accordingly, by way of the input device 406, the user can set or program the current (I), voltage (V), frequency (f), and/or period (T) for programming the step function output of the generator 30. The processor 400 then displays the selected power level by sending a signal on line 410 to an output indicator 412.
In various forms, the output indicator 412 may provide visual, audible, and/or tactile feedback to the surgeon to indicate the status of a surgical procedure, such as, for example, when tissue cutting and coagulating is complete based on a measured characteristic of the ultrasonic surgical instrument 100, e.g., transducer impedance, tissue impedance, or other measurements as subsequently described. By way of example, and not limitation, visual feedback comprises any type of visual indication device including incandescent lamps or light emitting diodes (LEDs), graphical user interface, display, analog indicator, digital indicator, bar graph display, digital alphanumeric display. By way of example, and not limitation, audible feedback comprises any type of buzzer, computer generated tone, computerized speech, voice user interface (VUI) to interact with computers through a voice/speech platform. By way of example, and not limitation, tactile feedback comprises any type of vibratory feedback provided through the instrument housing handle assembly 68.
In one form, the processor 400 may be configured or programmed to generate a digital current signal 414 and a digital frequency signal 418. These signals 414, 418 are applied to a direct digital synthesizer (DDS) circuit 420 to adjust the amplitude and the frequency (f) of the current output signal 416 to the transducer 50. The output of the DDS circuit 420 is applied to an amplifier 422 whose output is applied to a transformer 424. The output of the transformer 424 is the signal 416 applied to the ultrasonic transducer 50, which is coupled to the blade 79 by way of the waveguide 80 (
In one form, the generator 30 comprises one or more measurement modules or components that may be configured to monitor measurable characteristics of the ultrasonic instrument 100 (
To actually cause the surgical blade 79 to vibrate, e.g., actuate the blade 79, the user activates the foot switch 434 (
The programmed operation of the generator 30 can be further illustrated with reference to
It will be appreciated by those skilled in the art that the current 300 step function set points (e.g., I1, I2, I3) and the time intervals or periods (e.g., T1, T2) of duration for each of the step function set points described in
Having described operational details of various forms of the surgical system 19, operations for the above surgical system 19 may be further described in terms of a process for cutting and coagulating a blood vessel employing a surgical instrument comprising the input device 406 and the transducer impedance measurement capabilities described with reference to
Accordingly, with reference now to
In certain forms, the amplitudes of consecutive steps or pulses may increase, decrease or stay the same. For example, in certain forms, the amplitudes of consecutive pulses may be equal. Also, in certain forms, the time periods of the pulses may take any suitable value including, for example, fractions of a second, minutes, hours, etc. In one example form, the time period of the pulses may be 55 seconds.
In one form, a first ultrasonic frequency may be set initially to mechanically separate the muscle tissue layer of a vessel prior to applying a second ultrasonic frequency to cut and seal the vessel. By way of example, and not limitation, in accordance with one implementation of the program, initially, the generator 30 is programmed to output a first drive frequency f1 for a first period T1 of time (for example less than approximately 1 second), wherein the first frequency f1 is significantly off resonance, for example, fo/2, 2fo or other structural resonant frequencies, where fo is the resonant frequency (e.g., 55.5 kHz). The first frequency f1 provides a low level of mechanical vibration action to the blade 79 that, in conjunction with the clamp force, mechanically separates the muscle tissue layer (subtherapeutic) of the vessel without causing significant heating that generally occurs at resonance. After the first period T1, the generator 30 is programmed to automatically switch the drive frequency to the resonant frequency fo for a second period T2 to transect and seal the vessel. The duration of the second period T2 may be programmed or may be determined by the length of time it actually takes to cut and seal the vessel as determined by the user or may be based on measured system characteristics such as the transducer impedance Z as described in more detail below.
In one form, the tissue/vessel transection process (e.g., separating the muscle layer of the vessel from the adventitia layer and transecting/sealing the vessel) may be automated by sensing the impedance Z characteristics of the transducer 50 to detect when the transection of the tissue/vessel occurs. The impedance Z can be correlated to the transection of the muscle layer and to the transection/sealing of the vessel to provide a trigger for the processor 400 to generate the frequency and/or current step function output. As previously discussed with reference to
In one form, the ultrasonic surgical instrument 110 may be operated in accordance with a programmed step function algorithm responsive to the transducer impedance Z. In one form, a frequency step function output may be initiated based on a comparison of the transducer impedance Z and one or more predetermined thresholds that have been correlated with tissue loads against the blade 79. When the transducer impedance Z transitions above or below (e.g., crosses) a threshold, the processor 400 applies a digital frequency signal 418 to the DDS circuit 420 to change the frequency of the drive signal 416 by a predetermined step in accordance with the step function algorithm(s) 402 responsive to the transducer impedance Z. In operation, the blade 79 is first located at the tissue treatment site. The processor 400 applies a first digital frequency signal 418 to set a first drive frequency f1 that is off resonance (e.g., fo/2, 2fo or other structural resonant frequencies, where fo is the resonant frequency). The drive signal 416 is applied to the transducer 50 in response to activation of the switch 312a on the handle assembly 68 or the foot switch 434. During this period the ultrasonic transducer 50 mechanically activates the blade 79 at the first drive frequency f1. A force or load may be applied to the clamp member 60 and the blade 79 to facilitate this process. During this period, the processor 400 monitors the transducer impedance Z until the load on the blade 79 changes and the transducer impedance Z crosses a predetermined threshold to indicate that the tissue layer has been transected. The processor 400 then applies a second digital frequency signal 418 to set a second drive frequency f2, e.g., the resonant frequency fo or other suitable frequency for transecting, coagulating, and sealing tissue. Another portion of the tissue (e.g., the vessel) is then grasped between the clamp member 60 and the blade 79. The transducer 50 is now energized by the drive signal 416 at the second drive frequency f2 by actuating either the foot switch 434 or the switch 312a on the handle assembly 68. It will be appreciated by those skilled in the art that the drive current (I) output also may be stepped as described with reference to
According to one step function algorithm 402, the processor 400 initially sets a first drive frequency f1 that is significantly off resonance to separate the inner muscle layer of the vessel from the adventitia layer. During this period of operation the processor 400 monitors the transducer impedance Z to determine when the inner muscle layer is transected or separated from the adventitia layer. Because the transducer impedance Z is correlated to the load applied to the blade 79, for example, cutting more tissue decrease the load on the blade 79 and the transducer impedance Z. The transection of the inner muscle layer is detected when the transducer impedance Z drops below a predetermined threshold. When the change in transducer impedance Z indicates that the vessel has been separated from the inner muscle layer, the processor 400 sets the drive frequency to the resonant frequency fo. The vessel is then grasped between the blade 79 and the clamp member 60 and the transducer 50 is activated by actuating either the foot switch or the switch on the handle assembly 68 to transect and seal the vessel. In one form, the impedance Z change may range between about 1.5 to about 4 times a base impedance measurements from an initial point of contact with the tissue to a point just before the muscle layer is transected and sealed.
In various forms, the clamp arm assembly 451 may comprise a non-electrically conductive or insulative material, such as plastic and/or rubber, for example, positioned intermediate the conductive jacket 472 and the base 449. The electrically insulative material can prevent current from flowing, or shorting, between the conductive jacket 472 and the base 449. In various forms, the base 449 may comprise at least one aperture 478, which can be configured to receive a pivot pin (not illustrated). The pivot pin can be configured to pivotably mount the base 449 to the sheath 72 (
Having described operational details of various forms of the surgical system 190, operations for the above surgical system 190 may be further described with reference to
In one form, a first conductor or wire may be connected to the outer sheath 72 of the instrument 120 and a second conductor or wire may be connected to the blade 79/transducer 50. By nature of the design, the blade 79 and the transducer 50 are electrically isolated from the outer sheath 72 as well as other elements of the actuation mechanism for the instrument 120 including the base 449 and the inner sheath 76. The outer sheath 79 and other elements of the actuation mechanism including the base 449 and the inner sheath 76 are all electrically continuous with one another—that is, they are all metallic and touch one another. Accordingly, by connecting a first conductor to the outer sheath 72 and connecting a second conductor to the blade 79 or the transducer 50 such that the tissue resides between these two conductive pathways, the system can monitor the electrical impedance of the tissue as long as the tissue contacts both the blade 79 and the base 449. To facilitate this contact, the base 449 itself may include outwardly and possibly downwardly protruding features to assure tissue contact while, effectively integrating conductive jacket 472 into base 449.
In one form, the ultrasonic surgical instrument 120 may be operated in accordance with a programmed step function algorithm 402 responsive to the tissue impedance Zt. In one form, a frequency step function output may be initiated based on a comparison of the tissue impedance Zt and predetermined thresholds that have been correlated with various tissue states (e.g., desiccation, transection, sealing). When the tissue impedance Zt transitions above or below (e.g., crosses) a threshold, the processor 400 applies a digital frequency signal 418 to the DDS circuit 420 to change the frequency of an ultrasonic oscillator by a predetermined step in accordance with the step function algorithm 402 responsive to the tissue impedance Zt.
In operation, the blade 79 is located at the tissue treatment site. The tissue 514 is grasped between the blade 79 and the clamp arm assembly 451 such that the blade 79 and the conductive jacket 472 make electrical contact with the tissue 514. The processor 400 applies a first digital frequency signal 418 to set a first drive frequency f1 that is off resonance (e.g., fo/2, 2fo or other structural resonant frequencies, where fo is the resonant frequency). The blade 79 is electrically energized by the low level subtherapeutic RF voltage vrf supplied by the tissue impedance module 502. The drive signal 416 is applied to the transducer 50/blade 79 in response to actuation of the switch 312a on the handle assembly 68 or the foot switch 434 until the tissue impedance Zt changes by a predetermined amount. A force or load is then applied to the clamp arm assembly 451 and the blade 79. During this period the ultrasonic transducer 50 mechanically activates the blade 79 at the first drive frequency f1 and as a result, the tissue 514 begins to desiccate from the ultrasonic action applied between the blade 79 and the one or more clamp pads 58 of the clamp arm assembly 451 causing the tissue impedance Zt to increase. Eventually, as the tissue is transected by the ultrasonic action and applied clamp force, the tissue impedance Zt becomes very high or infinite as the tissue fully transects such that no conductive path exists between the blade 79 and the conductive jacket 472. It will be appreciated by those skilled in the art that the drive current (I) output also may be stepped as described with reference to
In one form, the tissue impedance Zt may be monitored by the impedance module 502 in accordance with the following process. A measurable RF current i1 is conveyed through the first energizing conductor 504a to the blade 79, through the tissue 514, and back to the impedance module 502 through the conductive jacket 472 and the second conductor 504b. As the tissue 514 is desiccated and cut by the ultrasonic action of the blade 79 acting against the one or more clamp pads 58, the impedance of the tissue 514 increases and thus the current i1 in the return path, i.e., the second conductor 504b, decreases. The impedance module 502 measures the tissue impedance Zt and conveys a representative signal to the ADC 432 whose digital output 433 is provided to the processor 400. The processor 400 calculates the tissue impedance Zt based on these measured values of vrf and irf. The processor 400 steps the frequency by any suitable increment or decrement in response to changes in tissue impedance Zt. The processor 400 controls the drive signals 416 and can make any necessary adjustments in amplitude and frequency in response to the tissue impedance Zt. In one form, the processor 400 can cut off the drive signal 416 when the tissue impedance Zt reaches a predetermined threshold value.
Accordingly, by way of example, and not limitation, in one form, the ultrasonic surgical instrument 120 may be operated in accordance with a programmed stepped output algorithm to separate the inner muscle layer of a vessel from the adventitia layer prior to transecting and sealing the vessel. As previously discussed, according to one step function algorithm, the processor 400 initially sets a first drive frequency f1 that is significantly off resonance. The transducer 50 is activated to separate the inner muscle layer of the vessel from the adventitia layer and the tissue impedance module 502 applies a subtherapeutic RF voltage vrf signal to the blade 79. During this period T1 of operation the processor 400 monitors the tissue impedance Zt to determine when the inner muscle layer is transected or separated from the adventitia layer. The tissue impedance Zt is correlated to the load applied to the blade 79, for example, when the tissue becomes desiccated or when the tissue is transected the tissue impedance Zt becomes extremely high or infinite. The change in tissue impedance Zt indicates that the vessel has been separated or transected from the inner muscle layer and the generator 500 is deactivated for a second period of time T2. The processor 400 then sets the drive frequency to the resonant frequency fo. The vessel is then grasped between the blade 79 and the clamp arm assembly 451 and the transducer 50 is reactivated to transect and seal the vessel. Continuous monitoring of the tissue impedance Zt provides an indication of when the vessel is transected and sealed. Also, the tissue impedance Zt may be monitored to provide an indication of the completeness of the tissue cutting and/or coagulating process or to stop the activation of the ultrasonic generator 500 when the tissue impedance Zt reaches a predetermined threshold value. The threshold for the tissue impedance Zt may be selected, for example, to indicate that the vessel has been transected. In one form, the tissue impedance Zt may range between about 10 Ohms to about 1000 Ohms from an initial point to a point just before the muscle layer is transected and sealed.
The applicants have discovered that experiments that run varying current set points (both increasing and decreasing) and dwell times indicate that the described forms can be used to separate the inner muscle layer from the outer adventitia layer prior to completing the transection resulting in improved hemostasis and potentially lower total energy (heat) at the transection site. Furthermore, although the surgical instruments 100, 120 have been described in regards to threshold impedance detection schemes to determine when the muscle layer is separated from the adventitia, other forms that do not employ any detection scheme are within the scope of the present disclosure. For example, forms of the surgical instruments 100, 120 may be employed in simplified surgical systems wherein non-resonant power is applied to separate the layers for a predetermined time of approximately 1 second or less, prior to applying a resonant power to cut the tissue. The forms are not limited in this context.
Having described operational details of various forms of the surgical systems 19 (
In one form, the generator 30 generates a third ultrasonic drive signal. The ultrasonic transducer 50 is actuated with the third ultrasonic drive signal for a third period. The third drive signal is different from the first second drive signals over the first, second, and third periods. The first, second, and third drive signals define a step function waveform over the first, second, and third periods. In one form, generating the first, second, and third ultrasonic drive signals comprises generating a corresponding first, second, and third drive current and actuating the ultrasonic transducer 50 with the first drive current for the first period, actuating the ultrasonic transducer 50 with the second drive current for the second period, and actuating the ultrasonic transducer 50 with the third drive current for the third period.
In certain forms, the first, second and third drive currents may increase, decrease or stay the same relative to one another. For example, in certain forms, some or all of the first, second and third drive currents are equal. Also, in certain forms, the first, second and third periods may take any suitable value including, for example, fractions of a second, minutes, hours, etc. In one example form, some or all of the first, second and third periods may be 55 seconds.
In one form, the generator 30 generates the first ultrasonic drive signal at a first frequency, which is different from the resonant frequency. The ultrasonic transducer 50 is then actuated with the first ultrasonic drive signal at the first frequency for the first period. Actuation at the first frequency provides a first level of mechanical vibration to the end effector 81 suitable for separating a first tissue from a second tissue, for example, to separate the inner muscle layer of a vessel from the adventitia layer. The generator 30 generates the second ultrasonic drive signal at the resonant frequency, e.g., 55.5 kHz, and the actuates the ultrasonic transducer 50 with the second ultrasonic drive signal at the resonant frequency for the second period subsequent to the first period. Actuation at the second, resonant frequency, provides a second level of mechanical vibration to the end effector 81 suitable for transecting and sealing the first tissue, such as the vessel, once it separated from the inner muscle layer. In one form, the second ultrasonic drive signal at the resonant frequency is generated automatically by the generator 30 after the first period. In one form, the first frequency is substantially different from the resonant frequency and the first period is less than about one second. For example, in one form, the first frequency is defined by the following equation: f1=2*fo, wherein f1 is the first frequency and fo is the resonant frequency. In another form, the first frequency is defined by the following equation: f1=fo/2, wherein f1 is the first frequency and fo is the resonant frequency. The first, second, and third ultrasonic drive signals are also envisioned to excite be vibratory modes of the ultrasonic transducer 50 in longitudinal, flexural, and torsional modes and harmonics thereof.
In one form, the generator 30 monitors a measurable characteristic of the ultrasonic drive system and generates any one of the first and second drive signals based on the measured characteristic. For example, the generator 30 monitors the impedance Z of the ultrasonic transducer 50. The generator 30 comprises electronic circuitry suitable for measuring the impedance of the transducer 50. For example, a current sense circuit (e.g., current sense circuit 426) senses the current flowing through the transducer 50 and a voltage sense circuit (e.g., voltage sense circuit 428) senses the output voltage applied to the transducer 50. A multiplexer (e.g., multiplexer 430) routes the appropriate analog signal to an analog-to-digital converter (e.g., ADC 432), whose digital output is provided to a processor (e.g., processor 400). The processor 400 calculates the transducer impedance Z based on the measured values of current and voltage.
In one form, the generator 500 comprises an impedance module (e.g., tissue impedance module 502) to measure the impedance of a tissue portion contacting an end effector (e.g., end effector 810). The impedance module 502 includes an RF oscillator (e.g., RF oscillator 506) to generate a subtherapeutic RF signal. The subtherapeutic RF signal is applied to a blade (e.g., blade 79) portion of the end effector 810, which forms an energizing electrode. The tissue portion is grasped between the end effector 810 and a return electrode of a clamp arm assembly (e.g., clamp arm assembly 451) and the impedance of the tissue (e.g., tissue 514). The tissue impedance is then measured by a voltage sense circuit (e.g., voltage sense circuit 508) and current sense circuit (e.g., current sense circuit 510) and of the impedance module 502. These signals are applied to the ADC 432 via the multiplexer 430. The digital output of the ADC 432 is provided to the processor 400, which calculates the tissue impedance Zt based on the measured values of current through the tissue and the voltage applied to the blade 79 portion of the end effector 810.
In various forms, the feedback is provided by the output indicator 412 shown in
In one form, the logic flow diagrams 700, 800, 900 may be implemented as executable modules (e.g., algorithms) comprising computer readable instructions to be executed by the processor 400 (
The frequency inflection point analysis module and the voltage drop point analysis module determine when a change in tissue state has occurred based on correlated empirical data associated with a particular ultrasonic instrument type and the energy level at which the instrument is driven. At 714, the results 710 from the frequency inflection point analysis module and/or the results 712 from the voltage drop point analysis module are read by the processor 400. The processor 400 determines 716 whether the frequency inflection point result 710 and/or the voltage drop point result 712 indicates a change in tissue state. If the results 710, 714 do not indicate a change in tissue state, the processor 400 continues along the “No” branch to 702 and reads an additional voltage and frequency signal sample from the generator 30. In forms that utilize the generator current in the analysis, the processor 400 would now also read an additional current signal sample from the generator 30. If the results 710, 714 indicate a sufficient change in tissue state, the processor 400 continues along the “Yes” branch to 718 and activates the output indicator 412.
As previously discussed, the output indicator 412 may provide visual, audible, and/or tactile feedback to alert the user of the ultrasonic surgical instrument 100, 120 that a change in tissue state has occurred. In various forms, in response to the feedback from the output indicator 412, the operational mode of the generator 30, 500 and/or the ultrasonic instrument 100, 120 may be controlled manually, automatically, or semi-automatically. The operational modes include, without limitation, disconnecting or shutting down the output power of the generator 30, 500, reducing the output power of the generator 30, 500, cycling the output power of the generator 30, 500, pulsing the output power of the generator 30, 500, and/or outputting a high-power momentary surge from the generator 30, 500. The operational modes of the ultrasonic instrument in response to the change in tissue state can be selected, for example, to minimize heating effects of the end effector 81, 810, e.g., of the clamp pad 58 (
Stf=αYtf+(1−α)Stf−1 (2)
Where:
Stf=the current moving average of the sampled frequency signal;
Stf-1=the previous moving average of the sampled frequency signal;
α=the smoothing factor; and
Ytf=current data point of the sampled frequency signal.
The α value 808 may vary from about 0 to about 1 in accordance with a desired filtering or smoothing factor, wherein small α values 808 approaching about 0 provide a large amount of filtering or smoothing and large α values 808 approaching about 1 provide a small amount of filtering or smoothing. The α value 808 may be selected based on the ultrasonic instrument type and power level. In one form, blocks 804, 806, and 808 may be implemented as a variable digital low pass filter 810 with the α value 808 determining the cutoff point of the filter 810. Once the frequency samples are filtered, the slope of the frequency samples is calculated at 812 as:
Frequency Slope=deltaf/deltat (3)
The calculated Frequency Slope data points are provided to a “slow response” moving average filter 814 to calculate the EWMA moving average for the Frequency Slope to further reduce system noise. In one form, the “slow response” moving average filter 814 may be implemented by calculating the EWMA for the Frequency Slope at 818 in accordance with the frequency slope moving average equation 820 and alpha value (α′) 822:
S′tf=α′Y′tf+(1−α′)S′tf-1 (4)
Where:
S′tf=the current moving average of the frequency slope of the sampled frequency signal;
S′tf-1=the previous moving average of the frequency slope of the sampled frequency signal;
α′=the smoothing factor; and
Y′tf=current slope data point of the sampled frequency signal.
The α″ value 822 varies from about 0 to about 1, as previously discussed with respect to digital filter block 810 in accordance with a desired filtering or smoothing factor, wherein small α″ value 822 approaching 0 provide a large amount of filtering or smoothing and large α″ value 822 approaching 1 provide a small amount of filtering or smoothing. The α″ value 822 may be selected based on the ultrasonic instrument type and power level.
The calculated Frequency Slope data points are provided to a “fast response” filter 816 to calculate the moving average for the Frequency Slope. At 824, the “fast response” filter 816 calculates the moving average for the Frequency Slope based on a number of data points 826.
In the illustrated form, the output of the “slow response” moving average filter 814 “Slope EWMA” is applied to a (+) input of an adder 828 and the output of the “fast response” filter 816 “Slope Avg” is applied to (−) input of the adder 828. The adder 828 computes the difference between the outputs of the “slow response” moving average filter 814 and the “fast response” filter 816. The difference between these outputs is compared at 830 to a predetermined limit 832. The limit 832 is determined based on the type of ultrasonic instrument and the power level at which the particular type of ultrasonic instrument is energized at. The limit 832 value may be predetermined and stored in memory in the form of a look-up table or the like. If the difference between the “Slope EWMA” and the “Slope Avg” is not greater than the limit 832, the processor 400 continues along the “No” branch and returns a value 834 to the results 710 block that indicates that no inflection point was found in the sampled frequency signal and, therefore, no change in tissue state was detected. However, if the difference between the “Slope EWMA” and the “Slope Avg” is greater than the limit 832, the processor 400 continues along the “Yes” branch and determines that a frequency inflection point 836 was found and returns point index 838 to the results 710 block indicating that an inflection point was found in the sampled frequency data and, therefore, a change in tissue state was detected. As previously discussed with reference to
Stv=αYtv+(1−α)Stv-1 (5)
Where:
Stv=the current moving average of the sampled voltage signal;
Stv-1=the previous moving average of the sampled voltage signal;
α=the smoothing factor; and
Ytf=current data point of the sampled voltage signal.
As previously discussed, the α value 908 may vary from 0 to 1 in accordance with a desired filtering or smoothing factor and may be selected based on the ultrasonic instrument type and power level. In one form, blocks 904, 906, and 908 may be implemented as a variable digital low pass filter 910 with the α value 908 determining the cutoff point of the filter 910. Once the voltage samples are filtered, the slope of the voltage samples is calculated at 912 as:
Voltage Slope=deltav/deltat (6)
The calculated Voltage Slope data points are provided to a “slow response” moving average filter 914 to calculate the EWMA moving average for the Voltage Slope to further reduce system noise. In one form, the “slow response” moving average filter 914 may be implemented by calculating the EWMA for the Voltage Slope at 918 in accordance with the voltage slope moving average equation 920 and alpha value (α′) 822:
S′tv=α′Y′tv+(1−α′)S′tv-1 (7)
Where:
S′tv=the current moving average of the voltage slope of the sampled voltage signal;
S′tv-1=the previous moving average of the voltage slope of the sampled voltage signal;
α″=the smoothing factor; and
Y′tv=current slope data point of the sampled voltage signal.
The α″ value 922 varies from about 0 to about 1, as previously discussed with respect to digital filter block 910 in accordance with a desired filtering or smoothing factor, wherein small α″ value 922 approaching about 0 provide a large amount of filtering or smoothing and large α′ value 922 approaching about 1 provide a small amount of filtering or smoothing. The α″ value 922 may be selected based on the ultrasonic instrument type and power level.
The calculated Voltage Slope data points are provided to a “fast response” filter 916 to calculate the moving average for the Voltage Slope. At 924, the “fast response” filter 916 calculates the moving average for the Voltage Slope based on a number of data points 926.
In the illustrated form, the output of the “slow response” moving average filter 914 “Slope EWMA” is applied to a (+) input of an adder 928 and the output of the “fast response” filter 916 “Slope Avg” is applied to (−) input of the adder 928. The adder 928 computes the difference between the outputs of the “slow response” moving average filter 914 and the “fast response” filter 916. The difference between these outputs is compared at 930 to a predetermined limit 932. The limit 932 is determined based on the type of ultrasonic instrument and the power level at which the particular type of ultrasonic instrument is energized at. The limit 932 value may be predetermined and stored in memory in the form of a look-up table or the like. If the difference between the “Slope EWMA” and the “Slope Avg” is not greater than the limit 932, the processor 400 continues along the “No” branch and resets a counter to zero at 940, then returns a value 934 to the results 710 block that indicates that no voltage drop point was found in the sampled voltage signals and, therefore, no change in tissue state was detected. However, if the difference between the “Slope EWMA” and the “Slope Avg” is greater than the limit 932, the processor 400 continues along the “Yes” branch and increments a counter at 942. At 944, the processor 400 decides whether the counter is greater than 1, or some other predetermined threshold value for example. In other words, the processor 400 takes at least two data points in regards to the voltage drop point. If the counter is not greater than the threshold (e.g., 1 in the illustrated form) the processor 400 continues along the “No” branch and returns a value 934 to the results 710 block that indicates that no voltage drop point was found in the sampled voltage signals and, therefore, no change in tissue state was detected. If the counter is greater than the threshold (e.g., 1 in the illustrated form) the processor 400 continues along the “Yes” branch and determines that a voltage drop point 936 was found and returns a point index 938 to the results 712 block indicating that a voltage drop point was found in the sampled voltage signals and, therefore, a change in tissue state was detected. As previously discussed with reference to
In accordance with the described forms, the ultrasonic generator module 1008 may produce a drive signal or signals of particular voltages, currents, and frequencies, e.g., 55,500 cycles per second (Hz). The drive signal or signals may be provided to the ultrasonic device 1004, and specifically to the transducer 1014, which may operate, for example, as described above. The transducer 1014 and a waveguide extending through the shaft 1015 (waveguide not shown in
The generator 1002 may be activated to provide the drive signal to the transducer 1014 in any suitable manner. For example, the generator 1002 may comprise a foot switch 1020 coupled to the generator 1002 via a footswitch cable 1022. A clinician may activate the transducer 1014 by depressing the foot switch 1020. In addition, or instead of the foot switch 1020 some forms of the ultrasonic device 1004 may utilize one or more switches positioned on the hand piece that, when activated, may cause the generator 1002 to activate the transducer 1014. In one form, for example, the one or more switches may comprise a pair of toggle buttons 1036a, 1036b (
Additionally or alternatively, the one or more switches may comprises a toggle button 1036c that, when depressed, causes the generator 1002 to provide a pulsed output. The pulses may be provided at any suitable frequency and grouping, for example. In certain forms, the power level of the pulses may be the power levels associated with toggle buttons 1036a, 1036b (maximum, less than maximum), for example.
It will be appreciated that a device 1004 may comprise any combination of the toggle buttons 1036a, 1036b, 1036c. For example, the device 1004 could be configured to have only two toggle buttons: a toggle button 1036a for producing maximum ultrasonic energy output and a toggle button 1036c for producing a pulsed output at either the maximum or less than maximum power level. In this way, the drive signal output configuration of the generator 1002 could be 5 continuous signals and 5 or 4 or 3 or 2 or 1 pulsed signals. In certain forms, the specific drive signal configuration may be controlled based upon, for example, EEPROM settings in the generator 1002 and/or user power level selection(s).
In certain forms, a two-position switch may be provided as an alternative to a toggle button 1036c. For example, a device 1004 may include a toggle button 1036a for producing a continuous output at a maximum power level and a two-position toggle button 1036b. In a first detented position, toggle button 1036b may produce a continuous output at a less than maximum power level, and in a second detented position the toggle button 1036b may produce a pulsed output (e.g., at either a maximum or less than maximum power level, depending upon the EEPROM settings).
In accordance with the described forms, the electrosurgery/RF generator module 1010 may generate a drive signal or signals with output power sufficient to perform bipolar electrosurgery using radio frequency (RF) energy. In bipolar electrosurgery applications, the drive signal may be provided, for example, to electrodes of the electrosurgical device 1006, for example. Accordingly, the generator 1002 may be configured for therapeutic purposes by applying electrical energy to the tissue sufficient for treating the tissue (e.g., coagulation, cauterization, tissue welding).
The generator 1002 may comprise an input device 1045 (
The generator 1002 may also comprise an output device 1047 (
Although certain modules and/or blocks of the generator 1002 may be described by way of example, it can be appreciated that a greater or lesser number of modules and/or blocks may be used and still fall within the scope of the forms. Further, although various forms may be described in terms of modules and/or blocks to facilitate description, such modules and/or blocks may be implemented by one or more hardware components, e.g., processors, Digital Signal Processors (DSPs), Programmable Logic Devices (PLDs), Application Specific Integrated Circuits (ASICs), circuits, registers and/or software components, e.g., programs, subroutines, logic and/or combinations of hardware and software components. Also, in some forms, the various modules described herein may be implemented utilizing similar hardware positioned within the instruments 100, 120, 1004, 1006 (i.e., the generator 30, 50, 1002 may be omitted).
In one form, the ultrasonic generator drive module 1008 and electrosurgery/RF drive module 1010 may comprise one or more embedded applications implemented as firmware, software, hardware, or any combination thereof. The modules 1008, 1010 may comprise various executable modules such as software, programs, data, drivers, application program interfaces (APIs), and so forth. The firmware may be stored in nonvolatile memory (NVM), such as in bit-masked read-only memory (ROM) or flash memory. In various implementations, storing the firmware in ROM may preserve flash memory. The NVM may comprise other types of memory including, for example, programmable ROM (PROM), erasable programmable ROM (EPROM), electrically erasable programmable ROM (EEPROM), or battery backed random-access memory (RAM) such as dynamic RAM (DRAM), Double-Data-Rate DRAM (DDRAM), and/or synchronous DRAM (SDRAM).
In one form, the modules 1008, 1010 comprise a hardware component implemented as a processor for executing program instructions for monitoring various measurable characteristics of the devices 1004, 1006 and generating a corresponding output control signals for operating the devices 1004, 1006. In forms in which the generator 1002 is used in conjunction with the device 1004, the output control signal may drive the ultrasonic transducer 1014 in cutting and/or coagulation operating modes. Electrical characteristics of the device 1004 and/or tissue may be measured and used to control operational aspects of the generator 1002 and/or provided as feedback to the user. In forms in which the generator 1002 is used in conjunction with the device 1006, the output control signal may supply electrical energy (e.g., RF energy) to the end effector 1032 in cutting, coagulation and/or desiccation modes. Electrical characteristics of the device 1006 and/or tissue may be measured and used to control operational aspects of the generator 1002 and/or provide feedback to the user. In various forms, as previously discussed, the hardware component may be implemented as a DSP, PLD, ASIC, circuits, and/or registers. In one form, the processor may be configured to store and execute computer software program instructions to generate the step function output signals for driving various components of the devices 1004, 1006, such as the ultrasonic transducer 1014 and the end effectors 1026, 1032.
Forms of the generator 1002 do not rely on a tuning inductor Lt to monitor the motional branch current Im. Instead, the generator 1002 may use the measured value of the static capacitance Co in between applications of power for a specific ultrasonic surgical device 1004 (along with drive signal voltage and current feedback data) to determine values of the motional branch current Im on a dynamic and ongoing basis (e.g., in real-time). Such forms of the generator 1002 are therefore able to provide virtual tuning to simulate a system that is tuned or resonant with any value of static capacitance Co at any frequency, and not just at single resonant frequency dictated by a nominal value of the static capacitance Co.
In certain forms, the ultrasonic and electrosurgical drive signals may be provided simultaneously to distinct surgical instruments and/or to a single surgical instrument having the capability to deliver both ultrasonic and electrosurgical energy to tissue. An example of a blade 79 and clamp arm assembly 415 of one example form of such a surgical instrument is provided above in conjunction with
The non-isolated stage 1054 may comprise a power amplifier 1062 having an output connected to a primary winding 1064 of the power transformer 1056. In certain forms the power amplifier 1062 may be comprise a push-pull amplifier. For example, the non-isolated stage 1054 may further comprise a logic device 1066 for supplying a digital output to a digital-to-analog converter (DAC) 1068, which in turn supplies a corresponding analog signal to an input of the power amplifier 1062. In certain forms the logic device 1066 may comprise a programmable gate array (PGA), a field-programmable gate array (FPGA), programmable logic device (PLD), among other logic circuits, for example. The logic device 1066, by virtue of controlling the input of the power amplifier 1062 via the DAC 1068, may therefore control any of a number of parameters (e.g., frequency, waveform shape, waveform amplitude) of drive signals appearing at the drive signal outputs 1060a, 1060b, 1060c. In certain forms and as discussed below, the logic device 1066, in conjunction with a processor (e.g., a digital signal processor discussed below), may implement a number of digital signal processing (DSP)-based and/or other control algorithms to control parameters of the drive signals output by the generator 1002.
Power may be supplied to a power rail of the power amplifier 1062 by a switch-mode regulator 1070. In certain forms the switch-mode regulator 1070 may comprise an adjustable buck regulator, for example. The non-isolated stage 1054 may further comprise a first processor 1074, which in one form may comprise a DSP processor such as an Analog Devices ADSP-21469 SHARC DSP, available from Analog Devices, Norwood, Mass., for example, although in various forms any suitable processor may be employed. In certain forms the processor 1074 may control operation of the switch-mode power converter 1070 responsive to voltage feedback data received from the power amplifier 1062 by the DSP processor 1074 via an analog-to-digital converter (ADC) 1076. In one form, for example, the DSP processor 1074 may receive as input, via the ADC 1076, the waveform envelope of a signal (e.g., an RF signal) being amplified by the power amplifier 1062. The DSP processor 1074 may then control the switch-mode regulator 1070 (e.g., via a pulse-width modulated (PWM) output) such that the rail voltage supplied to the power amplifier 1062 tracks the waveform envelope of the amplified signal. By dynamically modulating the rail voltage of the power amplifier 1062 based on the waveform envelope, the efficiency of the power amplifier 1062 may be significantly improved relative to a fixed rail voltage amplifier schemes.
In certain forms, the logic device 1066, in conjunction with the DSP processor 1074, may implement a direct digital synthesizer (DDS) control scheme to control the waveform shape, frequency and/or amplitude of drive signals output by the generator 1002. In one form, for example, the logic device 1066 may implement a DDS control algorithm by recalling waveform samples stored in a dynamically-updated look-up table (LUT), such as a RAM LUT, which may be embedded in an FPGA. This control algorithm is particularly useful for ultrasonic applications in which an ultrasonic transducer, such as the ultrasonic transducer 1014, may be driven by a clean sinusoidal current at its resonant frequency. Because other frequencies may excite parasitic resonances, minimizing or reducing the total distortion of the motional branch current may correspondingly minimize or reduce undesirable resonance effects. Because the waveform shape of a drive signal output by the generator 1002 is impacted by various sources of distortion present in the output drive circuit (e.g., the power transformer 1056, the power amplifier 1062), voltage and current feedback data based on the drive signal may be input into an algorithm, such as an error control algorithm implemented by the DSP processor 1074, which compensates for distortion by suitably pre-distorting or modifying the waveform samples stored in the LUT on a dynamic, ongoing basis (e.g., in real-time). In one form, the amount or degree of pre-distortion applied to the LUT samples may be based on the error between a computed motional branch current and a desired current waveform shape, with the error being determined on a sample-by-sample basis. In this way, the pre-distorted LUT samples, when processed through the drive circuit, may result in a motional branch drive signal having the desired waveform shape (e.g., sinusoidal) for optimally driving the ultrasonic transducer. In such forms, the LUT waveform samples will therefore not represent the desired waveform shape of the drive signal, but rather the waveform shape that is required to ultimately produce the desired waveform shape of the motional branch drive signal when distortion effects are taken into account.
The non-isolated stage 1054 may further comprise an ADC 1078 and an ADC 1080 coupled to the output of the power transformer 1056 via respective isolation transformers 1082, 1084 for respectively sampling the voltage and current of drive signals output by the generator 1002. In certain forms, the ADCs 1078, 1080 may be configured to sample at high speeds (e.g., 80 MSPS) to enable oversampling of the drive signals. In one form, for example, the sampling speed of the ADCs 1078, 1080 may enable approximately 200× (depending on frequency) oversampling of the drive signals. In certain forms, the sampling operations of the ADC 1078, 1080 may be performed by a singe ADC receiving input voltage and current signals via a two-way multiplexer. The use of high-speed sampling in forms of the generator 1002 may enable, among other things, calculation of the complex current flowing through the motional branch (which may be used in certain forms to implement DDS-based waveform shape control described above), accurate digital filtering of the sampled signals, and calculation of real power consumption with a high degree of precision. Voltage and current feedback data output by the ADCs 1078, 1080 may be received and processed (e.g., FIFO buffering, multiplexing) by the logic device 1066 and stored in data memory for subsequent retrieval by, for example, the DSP processor 1074. As noted above, voltage and current feedback data may be used as input to an algorithm for pre-distorting or modifying LUT waveform samples on a dynamic and ongoing basis. In certain forms, this may require each stored voltage and current feedback data pair to be indexed based on, or otherwise associated with, a corresponding LUT sample that was output by the logic device 1066 when the voltage and current feedback data pair was acquired. Synchronization of the LUT samples and the voltage and current feedback data in this manner contributes to the correct timing and stability of the pre-distortion algorithm.
In certain forms, the voltage and current feedback data may be used to control the frequency and/or amplitude (e.g., current amplitude) of the drive signals. In one form, for example, voltage and current feedback data may be used to determine impedance phase. The frequency of the drive signal may then be controlled to minimize or reduce the difference between the determined impedance phase and an impedance phase setpoint (e.g., 0°), thereby minimizing or reducing the effects of harmonic distortion and correspondingly enhancing impedance phase measurement accuracy. The determination of phase impedance and a frequency control signal may be implemented in the DSP processor 1074, for example, with the frequency control signal being supplied as input to a DDS control algorithm implemented by the logic device 1066.
In another form, for example, the current feedback data may be monitored in order to maintain the current amplitude of the drive signal at a current amplitude setpoint. The current amplitude setpoint may be specified directly or determined indirectly based on specified voltage amplitude and power setpoints. In certain forms, control of the current amplitude may be implemented by control algorithm, such as, for example, a PID control algorithm, in the processor 1074. Variables controlled by the control algorithm to suitably control the current amplitude of the drive signal may include, for example, the scaling of the LUT waveform samples stored in the logic device 1066 and/or the full-scale output voltage of the DAC 1068 (which supplies the input to the power amplifier 1062) via a DAC 1086.
The non-isolated stage 1054 may further comprise a second processor 1090 for providing, among other things user interface (UI) functionality. In one form, the UI processor 1090 may comprise an Atmel AT91SAM9263 processor having an ARM 926EJ-S core, available from Atmel Corporation, San Jose, Calif., for example. Examples of UI functionality supported by the UI processor 1090 may include audible and visual user feedback, communication with peripheral devices (e.g., via a Universal Serial Bus (USB) interface), communication with the footswitch 1020, communication with an input device 1009 (e.g., a touch screen display) and communication with an output device 1047 (e.g., a speaker). The UI processor 1090 may communicate with the processor 1074 and the logic device 1066 (e.g., via serial peripheral interface (SPI) buses). Although the UI processor 1090 may primarily support UI functionality, it may also coordinate with the DSP processor 1074 to implement hazard mitigation in certain forms. For example, the UI processor 1090 may be programmed to monitor various aspects of user input and/or other inputs (e.g., touch screen inputs, footswitch 1020 inputs (
In certain forms, both the DSP processor 1074 and the UI processor 1090, for example, may determine and monitor the operating state of the generator 1002. For the DSP processor 1074, the operating state of the generator 1002 may dictate, for example, which control and/or diagnostic processes are implemented by the DSP processor 1074. For the UI processor 1090, the operating state of the generator 1002 may dictate, for example, which elements of a user interface (e.g., display screens, sounds) are presented to a user. The respective DSP and UI processors 1074, 1090 may independently maintain the current operating state of the generator 1002 and recognize and evaluate possible transitions out of the current operating state. The DSP processor 1074 may function as the master in this relationship and determine when transitions between operating states are to occur. The UI processor 1090 may be aware of valid transitions between operating states and may confirm if a particular transition is appropriate. For example, when the DSP processor 1074 instructs the UI processor 1090 to transition to a specific state, the UI processor 1090 may verify that requested transition is valid. In the event that a requested transition between states is determined to be invalid by the UI processor 1090, the UI processor 1090 may cause the generator 1002 to enter a failure mode.
The non-isolated stage 1054 may further comprise a controller 1096 for monitoring input devices 1045 (e.g., a capacitive touch sensor used for turning the generator 1002 on and off, a capacitive touch screen). In certain forms, the controller 1096 may comprise at least one processor and/or other controller device in communication with the UI processor 1090. In one form, for example, the controller 1096 may comprise a processor (e.g., a Mega168 8-bit controller available from Atmel) configured to monitor user input provided via one or more capacitive touch sensors. In one form, the controller 1096 may comprise a touch screen controller (e.g., a QT5480 touch screen controller available from Atmel) to control and manage the acquisition of touch data from a capacitive touch screen.
In certain forms, when the generator 1002 is in a “power off” state, the controller 1096 may continue to receive operating power (e.g., via a line from a power supply of the generator 1002, such as the power supply 2011 discussed below). In this way, the controller 196 may continue to monitor an input device 1045 (e.g., a capacitive touch sensor located on a front panel of the generator 1002) for turning the generator 1002 on and off. When the generator 1002 is in the power off state, the controller 1096 may wake the power supply (e.g., enable operation of one or more DC/DC voltage converters 2013 of the power supply 2011) if activation of the “on/off” input device 1045 by a user is detected. The controller 1096 may therefore initiate a sequence for transitioning the generator 1002 to a “power on” state. Conversely, the controller 1096 may initiate a sequence for transitioning the generator 1002 to the power off state if activation of the “on/off” input device 1045 is detected when the generator 1002 is in the power on state. In certain forms, for example, the controller 1096 may report activation of the “on/off” input device 1045 to the processor 1090, which in turn implements the necessary process sequence for transitioning the generator 1002 to the power off state. In such forms, the controller 196 may have no independent ability for causing the removal of power from the generator 1002 after its power on state has been established.
In certain forms, the controller 1096 may cause the generator 1002 to provide audible or other sensory feedback for alerting the user that a power on or power off sequence has been initiated. Such an alert may be provided at the beginning of a power on or power off sequence and prior to the commencement of other processes associated with the sequence.
In certain forms, the isolated stage 1052 may comprise an instrument interface circuit 1098 to, for example, provide a communication interface between a control circuit of a surgical device (e.g., a control circuit comprising hand piece switches) and components of the non-isolated stage 1054, such as, for example, the programmable logic device 1066, the DSP processor 1074 and/or the UI processor 190. The instrument interface circuit 1098 may exchange information with components of the non-isolated stage 1054 via a communication link that maintains a suitable degree of electrical isolation between the stages 1052, 1054, such as, for example, an infrared (IR)-based communication link. Power may be supplied to the instrument interface circuit 1098 using, for example, a low-dropout voltage regulator powered by an isolation transformer driven from the non-isolated stage 1054.
In one form, the instrument interface circuit 198 may comprise a logic device 2000 (e.g., logic circuit, programmable logic circuit, PGA, FPGA, PLD) in communication with a signal conditioning circuit 2002. The signal conditioning circuit 2002 may be configured to receive a periodic signal from the logic circuit 2000 (e.g., a 2 kHz square wave) to generate a bipolar interrogation signal having an identical frequency. The interrogation signal may be generated, for example, using a bipolar current source fed by a differential amplifier. The interrogation signal may be communicated to a surgical device control circuit (e.g., by using a conductive pair in a cable that connects the generator 102 to the surgical device) and monitored to determine a state or configuration of the control circuit. The control circuit may comprise a number of switches, resistors and/or diodes to modify one or more characteristics (e.g., amplitude, rectification) of the interrogation signal such that a state or configuration of the control circuit is uniquely discernable based on the one or more characteristics. In one form, for example, the signal conditioning circuit 2002 may comprises an ADC for generating samples of a voltage signal appearing across inputs of the control circuit resulting from passage of interrogation signal therethrough. The logic device 2000 (or a component of the non-isolated stage 1054) may then determine the state or configuration of the control circuit based on the ADC samples.
In one form, the instrument interface circuit 1098 may comprise a first data circuit interface 2004 to enable information exchange between the logic circuit 2000 (or other element of the instrument interface circuit 1098) and a first data circuit disposed in or otherwise associated with a surgical device. In certain forms, for example, a first data circuit 2006 (
In certain forms, the first data circuit 2006 may store information pertaining to the particular surgical device with which it is associated. Such information may include, for example, a model number, a serial number, a number of operations in which the surgical device has been used, and/or any other type of information. This information may be read by the instrument interface circuit 1098 (e.g., by the logic device 2000), transferred to a component of the non-isolated stage 1054 (e.g., to logic device 1066, DSP processor 1074 and/or UI processor 1090) for presentation to a user via an output device 1047 and/or for controlling a function or operation of the generator 1002. Additionally, any type of information may be communicated to first data circuit 2006 for storage therein via the first data circuit interface 2004 (e.g., using the logic device 2000). Such information may comprise, for example, an updated number of operations in which the surgical device has been used and/or dates and/or times of its usage.
As discussed previously, a surgical instrument may be detachable from a hand piece (e.g., instrument 1024 may be detachable from hand piece 1014) to promote instrument interchangeability and/or disposability. In such cases, conventional generators may be limited in their ability to recognize particular instrument configurations being used and to optimize control and diagnostic processes accordingly. The addition of readable data circuits to surgical device instruments to address this issue is problematic from a compatibility standpoint, however. For example, designing a surgical device to remain backwardly compatible with generators that lack the requisite data reading functionality may be impractical due to, for example, differing signal schemes, design complexity, and cost. Forms of instruments discussed herein address these concerns by using data circuits that may be implemented in existing surgical instruments economically and with minimal design changes to preserve compatibility of the surgical devices with current generator platforms.
Additionally, forms of the generator 1002 may enable communication with instrument-based data circuits. For example, the generator 1002 may be configured to communicate with a second data circuit 2007 contained in an instrument (e.g., instrument 1024) of a surgical device (
In certain forms, the second data circuit and the second data circuit interface 2010 may be configured such that communication between the logic device 2000 and the second data circuit can be effected without the need to provide additional conductors for this purpose (e.g., dedicated conductors of a cable connecting a hand piece to the generator 1002). In one form, for example, information may be communicated to and from the second data circuit using a 1-wire bus communication scheme implemented on existing cabling, such as one of the conductors used transmit interrogation signals from the signal conditioning circuit 2002 to a control circuit in a hand piece. In this way, design changes or modifications to the surgical device that might otherwise be necessary are minimized or reduced. Moreover, because different types of communications implemented over a common physical channel can be frequency-band separated, the presence of a second data circuit may be “invisible” to generators that do not have the requisite data reading functionality, thus enabling backward compatibility of the surgical device instrument.
In certain forms, the isolated stage 1052 may comprise at least one blocking capacitor 2096-1 connected to the drive signal output 1060b to prevent passage of DC current to a patient. A single blocking capacitor may be required to comply with medical regulations or standards, for example. While failure in single-capacitor designs is relatively uncommon, such failure may nonetheless have negative consequences. In one form, a second blocking capacitor 2096-2 may be provided in series with the blocking capacitor 2096-1, with current leakage from a point between the blocking capacitors 2096-1, 2096-2 being monitored by, for example, an ADC 2098 for sampling a voltage induced by leakage current. The samples may be received by the logic circuit 2000, for example. Based changes in the leakage current (as indicated by the voltage samples in the form of
In certain forms, the non-isolated stage 1054 may comprise a power supply 2011 for outputting DC power at a suitable voltage and current. The power supply may comprise, for example, a 400 W power supply for outputting a 48 VDC system voltage. The power supply 2011 may further comprise one or more DC/DC voltage converters 2013 for receiving the output of the power supply to generate DC outputs at the voltages and currents required by the various components of the generator 1002. As discussed above in connection with the controller 1096, one or more of the DC/DC voltage converters 2013 may receive an input from the controller 1096 when activation of the “on/off” input device 1045 by a user is detected by the controller 1096 to enable operation of, or wake, the DC/DC voltage converters 2013.
Having described operational details of various forms of the surgical systems 19 (
In various forms, feedback may be provided by the output indicator 412 shown in
In one form, the logic flow diagrams 1200, 1300, 1400 may be implemented as executable modules (e.g., algorithms) comprising computer readable instructions to be executed by the processor 400 (
A brief summary of a tissue algorithm represented by way of the logic flow diagrams 1200, 1300, 1400 will now be described in connection with any one of the ultrasonic surgical instruments 100, 120, 1004 driven by a corresponding generator 30 (
The tissue algorithm represented by the logic flow diagrams 1200, 1300, 1400 and any of the algorithms described herein may be employed in conjunction with any of the generators 30, 500, 1002 described herein, and other suitable generators such as the GEN 04, GEN 11 generators available from Ethicon Endo-Surgery, Inc. of Cincinnati, Ohio, and related devices, systems, that may leverage the algorithm or technology disclosed herein. Accordingly, in the description of the tissue algorithm in conjunction with the flow diagrams 1200, 1300, 1400 reference is made to the generators 30, 500, 1002 described in connection with corresponding
Accordingly, with reference now to
In addition, the description of the tissue algorithm described in connection with logic flow diagrams 1200, 1300, 1400 will be accompanied with illustrative examples via data obtained using any one of the ultrasonic surgical instruments 100, 120, 1004 comprising a corresponding generator 30, 500, 1002 described herein.
The tissue algorithm described in connection with logic flow diagrams 1200, 1300, 1400 relies on the monitoring of electrical drive signals, especially those correlating to the resonant frequency of the drive signal. The algorithm monitors the resonant frequency and its change with time (i.e., the first derivative of frequency with respect to time). Throughout this disclosure, this change in frequency with time is referred to as frequency slope. Frequency slope is calculated locally (from a time perspective) by calculating the change in frequency of adjacent (or relatively near) data points and dividing by the corresponding change in time. Because of signal transients, averaging or any of a multitude of applicable filtering or smoothing techniques (such that trends are more easily discernable and prevents turning on/off condition sets rapidly) may be employed. The data plots shown in
(1) Condition Set—a set of logic conditions that electrical signals are monitored against in real time.
(2) Response Set—one or more responses of the generator 30, 500, 1002 system to a Condition Set having been met.
At 1202, the generator 30, 500, 1002 is placed in an ultrasonic drive mode in a ready state.
At 1204, the generator 30, 500, 1002 is activated at a predetermined power level N. When the user activates the surgical system 19, 190, 1000, the corresponding generator 30, 500, 1002 responds by seeking the surgical system 19, 190, 1000 resonance and then ramping the output to the end effectors 81, 810, 1026 to the targeted levels for the commanded power level.
At 1206, the tissue algorithm determines whether parameters associated with the tissue algorithm are in use by determining when at least one Condition Sets/Response Sets flag is enabled. When no such flags are enabled, the algorithm proceeds along “NO” path where at 1208 the surgical system 19, 190, 1000 is operated in normal ultrasonic mode and at 1210, the corresponding generator 30, 500, 1002 is deactivated when the tissue procedure is completed.
When at least one flag for setting Condition Sets/Response Sets is enabled, the algorithm proceeds along “YES” path and the generator 30, 500, 1002 utilizes the tissue algorithm 1300 signal evaluation after resetting a Timer X and Timer X latch. The tissue algorithm 1300, described in more detail below, may return an indication of whether a given Condition Set is currently met or “true.” In one form, the at least one flag for setting Condition Sets/Response Sets may be stored in an EEPROM image of an instrument 100, 120, 1004 attached to the respective generator 30, 500, 1002. The EEPROM flags for setting the Condition Sets/Response Sets to an enabled state are contained in TABLE 1.
In one form, the tissue algorithm 1300 signal evaluation portion of the logic flow diagram 1200 utilizes two Condition Sets and each of these two Conditions Sets has a Response Set, which are described in more detail in connection with logic flow diagrams 1300, 1400. The tissue algorithm 1300 logic may be illustrated as follows: when Condition Set 1 is met, Response Set 1 is triggered. Having two condition sets enables a hierarchical response (differentiated responses based upon condition level) and also provides the ability to manage a complicated series of events.
At 1210, responses for Condition Sets that are met are triggered. Loop 1212 is repeated until the Condition Sets are met and the generator 30, 500, 1002 is deactivated at 1214.
The pulsing response is more detailed and requires further explanation than the relatively simple audio and LCD display responses. When a pulsing response is triggered, the generator 30, 500, 1002 drives a pulsed output as defined by the by the following four parameters:
(1) First Pulse Amplitude (EEPROM parameter, one value for each power level)—the drive amplitude for the first pulse;
(2) First Pulse Time (EEPROM parameter)—the time over which the first pulse amplitude is driven;
(3) Second Pulse Amplitude (EEPROM parameter, one value for each power level)—the drive amplitude for the second pulse; and
(4) Second Pulse Time (EEPROM parameter)—the time over which the second pulse amplitude is driven.
In certain forms, the First Pulse Amplitude and Second Pulse Amplitude may increase, decrease or stay the same relative to one another. For example, in certain forms, the First Pulse Amplitude and Second Pulse Amplitude may be equal. Also, in certain forms, the First Pulse Time Period and Second Pulse Time Period may take any suitable values including, for example, fractions of a second, minutes, hours, etc. In one example form, the First Pulse Time Period and the Second Pulse Time Period may be 55 seconds.
When driving a pulsed output, the generator 30, 500, 1002 drives the first pulse, then the second pulse and then repeats. The pulse amplitude may be expressed in units of: percentage of the commanded power level's output current. The commanded power level may be set by the activation switch (MIN or MAX) and the generator setting when MIN is activated.
At 1302, the algorithm calculates the time since activation was initiated at 1204 (
During this time, the associated signal transients can make the application of algorithm logic difficult. The algorithm, therefore, utilizes the “time to wait” parameter 1304 that is stored in the EEPROM image located in a hand piece portion of the ultrasonic surgical instrument 100, 120, 1004. The “time to wait” parameter 1304 (EEPROM parameter) is defined as the time at the beginning of an activation during which the generator 30, 500, 1002 does not apply the tissue algorithm to lessen the influence of resonance seek and drive ramp signal transients on algorithm logic. A typical “time to wait” parameter 1304 value is about 0.050 to 0.600 seconds (50 to 600 msec).
At 1306, TElapse is compared to the “time to wait” parameter 1304 value. When TElapse is less than or equal to the “time to wait” parameter 1304 value, the algorithm proceeds along “NO” path to calculate at 1302 a new TElapse. When TElapse is greater than the “time to wait” parameter 1304 value, the algorithm proceeds along “YES” path to evaluate the signal.
At 1308, the algorithm performs the Signal Evaluation/Monitoring function. As previously stated, one aspect of the function algorithm is to monitor frequency slope. In a physical sense, frequency slope correlates to heat flux into or out of the resonant system comprising the blade and the hand piece acoustical subassembly, such as the ultrasonic systems 100, 120, 1004 disclosed herein. The changes in frequency and frequency slope during activation on tissue are dominated by the changing conditions occurring at the end-effector (tissue drying out, separating and blade contacting the clamp arm pad). When the blade is being heated (i.e., heat flux into the blade), the frequency slope is negative. When the blade is being cooled (i.e., heat flux out of the blade), the frequency slope is positive. Accordingly, the algorithm calculates the slope between frequency data points, i.e., incoming frequency data points 1310 (Ft) and previous Ft data points 1312. The calculated frequency slope also may be referred to as a local frequency slope because it is a running calculation. The local frequency slope may be referred to as FSlope_Freq, Ft, which is the frequency slope (FSlope_Freq) at the resonance frequency (Ft). The local frequency slope may be routed to a Condition Set 1, Condition Set 2 1400, for example, for evaluation in accordance with the flow diagram 1400 shown in
In accordance with the tissue algorithm, at 1402, the local frequency slope calculated at 1308 (
In accordance with the tissue algorithm, also at 1402, the resonant frequency is compared against a frequency threshold parameter 1406 value for Condition set X. The frequency threshold parameter 1406 value may be stored in an EEPROM located in the attached instrument 100, 120, 1004. When the resonant frequency drops below the threshold frequency parameter 1406 value, a second Response Set may be triggered at 1210 (
In some forms, frequency slope and resonant frequency may be utilized in a common Condition Set. For example, a Condition Set may not be met unless the frequency slope and resonant frequency both meet given thresholds. For example, at 1402, when the frequency slope (FSlope_Freq) is less than the frequency slope threshold parameter 1404 value and the resonant frequency (Ft) is less than the frequency threshold parameter 1406 value, the algorithm proceeds along “YES” path to 1408 to increment a Timer X (where X corresponds to the particular Condition Set being evaluated by the tissue algorithm).
In comparing the electrical signals, e.g., the frequency slope (FSlope_Freq) and the resonant frequency (Ft), against respective thresholds parameters 1404, 1406, borderline conditions where the signal bounces back-and-forth across the threshold can be taken into consideration as follows. In one aspect, the tissue algorithm employs a “required time before trigger” parameter 1412 value (which also may be stored in the instrument EEPROM) for the particular Condition Set X to account for this consideration. The “required time before trigger” parameter 1412 value is defined as the time required before trigger (EEPROM parameter)—required time for frequency slope and/or frequency to be less than their respective thresholds for a Response Set to be triggered. This is intended to prevent rapid “back and forth” triggering of a response. It may be useful, however, to track non-rapid “back and forth” triggering, which may occur.
Thus, at 1414 the algorithm determines whether the Timer X value is greater than the “required time before trigger” parameter 1412 value for Condition Set X. When the Timer X value is greater than the “required time before trigger” parameter 1412 value, the algorithm proceeds along “YES” path to set a latch for Condition Set X at 1416. Output 1418 indicates that the Condition Set X is met. When the Timer X value is less than or equal to the “required time before trigger” parameter 1412 value, the algorithm proceeds along “NO” path to indicate at output 1420 that the Condition Set X is not met.
At 1402, when either the frequency slope (FSlope_Freq) is greater than or equal to the frequency slope threshold parameter 1404 value or the resonant frequency (Ft) is greater than then or equal to the frequency threshold parameter 1406 value, the algorithm proceeds along “NO” path to reset the Timer X at 1410 (where X corresponds to the particular Condition Set being evaluated by the tissue algorithm).
For additional robustness, two latching parameters are employed by the algorithm. Without the use of latching, the algorithm is configured to end a response set when either (a) the system is deactivated or (b) when the signal or signals are no longer below their respective thresholds. Two latching parameters can be utilized. They are a “minimum latch time” parameter 1422 and a “cross-back frequency slope threshold” parameter 1424. These latch parameters 1422, 1424 are important for robustness around: (a) clamp arm pad surfaces that become more lubricious with elevated temperature and (b) pulsing output where signal transients at the pulse transitions are expected.
The minimum latch time parameter 1422 (EEPROM parameter) can be defined as the minimum amount of time for response(s) to a Condition Set X to be triggered. Considerations for minimum latch time include: (a) the length of time required to play a triggered audible response (e.g., in one form, a “pre-alert” WAV audio file may be about 0.5 seconds long), (b) the typical (about 0.5 to 1.0 sec) or extreme (about 1.5 to 2.0 sec) user response times for an event, or (c) the typical tissue re-grasp time for a multi-cut (known as “marching”) application (about 1.1-2.0 seconds with a mean of about 1.6 seconds).
The cross-back frequency slope threshold parameter 1424 (EEPROM parameter) can be defined as the frequency slope threshold above which a triggered response stops (i.e., is no longer triggered). This provides for a higher “cross-back-over” frequency slope threshold that is tasked with distinguishing between activating against the pad and jaw opened (versus distinguishing between activating on tissue and activating on the pad).
In accordance with the tissue algorithm portion represented by logic flow diagram 1400, after the Timer X is reset at 1410, at 1426, the tissue algorithm determines whether either the latch for Condition Set X or the Cross-back Frequency Slope Latch is set. When both latches are not set, the algorithm proceeds along “NO” to indicate at output 1420 that the Condition Set X is not met. When either one of the latches is set, the algorithm proceeds along “YES” path to 1428.
At 1428, the algorithm determines whether the Latched Time for Condition Set X is greater than the minimum latch time parameter 1422 value for Condition Set X and whether the frequency slope (FSlope_Freq) is greater than the cross-back frequency slope threshold parameter 1424 value the algorithm proceeds along “YES” path to reset the Latch for Timer X at 1430 and to indicate at output 1420 that the Condition Set X is not met. When the Latched Time for Condition Set X is less than or equal to the minimum latch time parameter 1422 value for Condition Set X and the frequency slope (FSlope_Freq) is less than or equal to the cross-back frequency slope threshold parameter 1424 value the algorithm proceeds along “NO” path to indicate at output 1432 that the Condition Set X is met.
As shown in
TABLE 2 contains a summary of the replicated algorithm EEPROM parameters for each of the Condition Sets and the number parameters per Condition Set.
TABLE 3 contains a summary of the shared algorithm EEPROM parameters for each of the Condition Sets (not replicated) and the number parameters.
For clarity of disclosure, the tissue algorithm described in connection with the logic flow diagrams 1200, 1300, 1400 shown in respective
A first example case includes the monitoring of frequency slope against a respective threshold is illustrated with reference to
The use of only the frequency slope to trigger a Response Set may be further demonstrated in the “burn-in” scenario or test.
The response time of an ultrasonic instrument may be defined as the time required for an ultrasonic system (instrument, hand piece, and generator with tissue algorithm) to respond to the clamp arm pad coming into contact with the blade. The ultrasonic system is usually initially activated “in-air” (i.e., unloaded), the clamp arm is closed against the blade and held for a period of time and then the clamp arm is opened and the ultrasonic system is deactivated. The response time is the time between the point at which the quiescent power (power in-air) begins to change due to the clamp arm pad initiating contact with the blade and the point at which the Response Set is triggered. This is also a test that enables quantification of the rate of cooling—the higher the rate of cooling (assuming similar convective boundary conditions) the more thermal energy or residual heat there is in the blade. The rate of cooling is proportional to the frequency slope (to reinforce: a positive frequency slope value correlates to the instantaneous heat flux out of the blade). As will be detailed later, the rate of cooling also may be monitored and used for control purposes so that, for example, if the rate of cooling as defined by a positive frequency slope is greater than a threshold value, one knows that the blade is “carrying” a large amount of thermal energy and is dissipating it rapidly.
A second example case includes triggering a Response Set based only on the frequency threshold with reference to
The selection of 55,100 Hz as the frequency threshold in TABLE 5 was based on test data for two abuse cases: (1) where an ultrasonic instrument is activated against the tissue pad for a prolonged period of time; and (2) where an ultrasonic instrument is used to make 10 successive cuts on excised porcine jejunum tissue as quickly as possible while keeping the generator running throughout. Each of these two abuse cases will be discussed in more detail with reference to respective
The representative data in
Accordingly, with reference now to
The remaining Examples 3 and 4 relate to the use of multiple Condition Sets, which require a more complex application of the tissue algorithm and includes the monitoring of frequency slope and/or frequency against their respective thresholds and may include a hierarchical approach to triggering response sets.
A third example case includes triggering a Response Set based on both the frequency slope threshold and the frequency threshold. TABLE 6 contains representative parameters for this objective in connection with surgical instruments such as any one of the surgical instruments 19, 190, 1000 disclosed herein comprising corresponding ultrasonic instruments such as the ultrasonic instruments 100, 120, 1004 disclosed herein.
In this case of Example 3, a tiered or hierarchical response is demonstrated. The combined logic of the frequency slope threshold and the frequency threshold will be illustrated using the same graphical representations shown in
A fourth example extends to the application of both frequency and frequency slope thresholds during abusive conditions of the surgical instrument. For various reasons, the frequency slope signal levels may diminish (i.e., become less negative) with extended application.
In abusive conditions, frequency, frequency slope, and current waveforms may deviate from normal operation may be generated while the ultrasonic instrument is constantly activated at a power level 5, where the jaws of the ultrasonic instrument were opened for 1 second, then closed for 1 second and repeated for 17 cycles.
When an ultrasonic instrument is activated multiple times directly against the pad, the characteristic frequency slope waveform in a first region before the generator saturates becomes less negative than in a second after the generator saturates due, in large part, to the system efficiency and resulting displacement/current drop. In the non-saturation region of the frequency slope waveform, the ultrasonic system has not yet saturated and current is maintained at or near the target current for power level 5. In the saturation region of the frequency slope waveform, the current (and therefore blade tip displacement) continually drops causing the frequency slope to increase (rate of heating drops). Note that at after several abusive cycles, e.g., the fourth abuse cycle, which is the approximate demarcation between the non-saturation and saturation regions, the resonant frequency drops consistent with
A weighted frequency slope (kHz/sec) versus time waveform may be of one form of a generator. When the instrument is used abusive conditions against the pad, the characteristic frequency slope waveform in the non-saturation region becomes less negative than in the saturation region due to material softening and a corresponding reduction in pad coefficient of friction. In the non-saturation region of the frequency slope waveform corresponds to when the tissue pad has not yet begun to heat significantly. In the saturation region of the frequency slope waveform, the pad begins to soften and the interface between the blade and the pad becomes more lubricious causing the frequency slope waveform to increase (rate of heating drops). Separate Conditions Sets for each of the non-saturation and saturation regions may be warranted. A first frequency slope threshold may be employed in the non-saturation region when resonant frequency conditions are above a predetermined frequency slope threshold and a second, less negative frequency slope threshold may be employed in the saturation region when the resonant frequency is below the same predetermined frequency slope threshold.
Another example case is now considered. TABLE 7 contains parameters for an ultrasonic instrument where two Condition Sets are used to account for diminishing frequency slope signal levels due to system saturation and dropping current.
The data generated for this example run were generated using an ultrasonic instrument to make ten successive cuts in jejunum tissue as quickly as possible. Using the parameter values from TABLE 7, the Frequency vs. Time plots for the example sample case are shown in
The frequency waveform 1802 shown in
Having described the basic application of the tissue algorithm discussed in connection with the logic flow diagrams 1200, 1300, 1400 shown in
The present disclosure now turns to considerations for power level and clamp pressure profile in an ultrasonic instrument. The rate of heating of a blade to pad interface is proportional to blade displacement, interface coefficient of friction and load (clamp pressure or normal force). Testing was performed to assess the tissue algorithm at a range of displacements (power levels) and device specific combinations of clamp pressure and coefficient of friction (defined largely by pad materials and blade coatings).
Based on predetermined tests and test data from
System stiffness includes both blade stiffness (cantilevered beam) and pad stiffness/pad thermal stability. The more differentiated the unloaded (no tissue) system stiffness is from the loaded (clamped on tissue) system stiffness, the more robust the tissue algorithm performance. Other constraints, of course, may limit system stiffness on the high end.
Further exploration of displacement effects were analyzed based on a larger set of data. For the ultrasonic system, power levels are essentially differentiated by output current target values and, current, which is proportional to vibratory amplitude or displacement. Analysis of this data also may include digital smoothing of the frequency data to obtain usable frequency slope curves.
In
Other aspects of the tissue algorithm described herein may be applied to situations when little to no intervening tissue remains (between the ultrasonic blade and the clamp arm) and waste energy is being dumped into the end effector. Accordingly, in one form, the tissue algorithm may be modified to provide feedback to the user relative to this situation. Specifically, the tissue algorithm leverages the fact that the resonance of an ultrasonic blade changes relative to temperature (decreases with increasing temperature and increases with decreasing temperature).
In one aspect the tissue algorithm disclosed herein may be employed to monitor the frequency slope of a waveform where the algorithm monitors the change in resonant frequency slope to indicate the changing condition of the tissue. In the case shown in
In another aspect, the tissue algorithm disclosed herein may be employed to monitor the frequency threshold of a waveform, where the algorithm monitors the change in frequency as the waveform crosses some threshold or difference from some known state (e.g., room temperature). Similar to monitoring the frequency slope, as the change in frequency drops below some threshold value or difference, an indication can be given to the user that the device end effector is heating at an accelerated rate. Again,
In yet another aspect, the tissue algorithm disclosed herein may be employed to monitor the frequency slope change and the frequency threshold in combination. The combination of a significant change in frequency slope and a drop in frequency below some threshold can be used to provide an indication of high temperature.
Turning now to
In some example forms, surgical and/or instrument-related conditions may reduce the ability of the Condition Sets described above to accurately reflect the state of the instrument. In some situations, the blade may heat more slowly than normal, causing the resonant frequency to be higher and the frequency slope to be more gradual that expected. One example of such a situation may occur when tissue is adhered to a non-clamping surface of the blade. In this and other situations, a more gradual rate of heating is seen, even upon completion of a tissue bite when minimal or no tissue is present between the blade and clamp arm pad. This may, in turn, delay the meeting of various Condition Sets based on comparing local frequency slope to a frequency slope threshold parameter and/or comparing local resonant frequency to a frequency threshold parameter. As a result, Response Sets implementing audible tones, pulsed modes, current deactivation, etc., may be unnecessarily delayed.
In certain forms, generators, such as 30, 500, 1002, and/or ultrasonic surgical instruments, such as 100, 120, 1004, may be implemented with one or more Condition Sets that consider a dynamic frequency cut-off. These, and other condition sets described herein, may be actuated by the clinician upon receipt of an input signal from a switch, button or pedal or, in some forms, run on background while other algorithms are executed (e.g., instrument control algorithms). For example, a baseline resonant frequency may be captured when ultrasonic impedance exceeds a threshold impedance. For example, exceeding the threshold impedance may indicate that the clamp arm is closed (e.g., a tissue bite is about to begin). One or more Condition Sets may comprise a baseline frequency cut-off condition that is met when the resonant frequency of the blade differs from the baseline frequency by more than a baseline deviation threshold parameter. In certain forms, the baseline frequency cut-off condition is met even when other conditions based on resonant frequency or frequency slope are not met. When utilized in a logical “Or” arrangement with other conditions, baseline frequency cut-off conditions may allow certain Condition/Response Set pairs to be triggered in situations, such as those described above, where blade heating is more gradual than normal.
Referring back to 2124, the algorithm 2120 may utilize any suitable threshold time period that extends beyond the dissipation of all or most signal transients or blips. For example, in some forms, the threshold time period may be between 0.1 and 1.0 seconds. In some example forms, the threshold time period may be between 0.2 and 0.5 seconds. In one example form, the threshold time period may be about 0.2 seconds. At, 2126 the generator may receive an indication of the ultrasonic impedance. In various example forms, the ultrasonic impedance represents an electrical impedance of the transducer blade system, and/or an impedance of the “motional branch,” as described herein above. At 2128, the generator may determine whether the ultrasonic impedance is greater than a threshold impedance. For example, this may the closing of the clamp arm either against the blade or against tissue. In some forms, the generator at 2128 may not conclude that the ultrasonic impedance is greater than the threshold unless it is greater than the threshold for a set amount of time (a “time above impedance” period). The time above impedance period may be any suitable value and may be between 10 and 100 msec including, for example, 30 msec.
If the ultrasonic impedance is not above the threshold impedance at 2128 (or is not above the threshold impedance for the “time above impedance” period), the generator may return to 2126 and 2128, continuing to monitor the ultrasonic impedance until it does exceed the threshold impedance. If the ultrasonic impedance is above the threshold impedance at 2128, the generator may capture a local resonant frequency of the blade as a baseline frequency at 2130. As the activation continues, the generator may, at 2132, determine whether a frequency delta, or difference between the baseline frequency and the local resonant frequency of the blade exceeds a baseline deviation threshold parameter. If the frequency delta exceeds the baseline deviation threshold parameter, then the baseline cut-off condition may be met. If the meeting of the baseline cut-off condition causes a complete Condition Set to be met, than a corresponding Response Set may be triggered at 2134. In some forms, the baseline cut-off condition is not met until or unless the frequency delta is above the baseline deviation threshold parameter value for a time above frequency delta period.
In some example forms, utilizing a baseline frequency and frequency delta, as described with respect to the algorithm 2120, also addresses issues arising in surgical situations where the resonant frequency of the ultrasonic blade floats between activations or cuts. This may occur, for example, when an ultrasonic blade is used for multiple cuts without being deactivated.
In certain forms, a baseline frequency cut-off condition may be utilized in a common Condition Set with one or more other conditions.
If the other conditions are met at 2154, the Condition Set may be considered met, and the generator may trigger the appropriate Response Set at 2158. If the other conditions are not met at 2154, the generator may determine if the frequency delta is greater than the baseline deviation threshold parameter at 2156. If not, then the other conditions may be applied again at 2154. If yes, then the Condition Set may be considered met even though the other conditions are not met. Once a Response Set is triggered at 2128, the Response Set may continue to be executed until parameters for exiting the Response Set are determined to be met at 2160 and the triggered condition is exited at 2162. Such parameters may include, for example, the expiration of a Condition Set minimum latch time parameter, frequency slope exceeding a cross-back frequency slope threshold, etc.
In various example forms, a baseline frequency cut-off condition may be utilized in the context of the logic flow diagrams 1200, 1300, 1400 of
If the load monitoring flag 2167 is not set, the frequency delta may be set to zero (e.g., a frequency delta of zero may never exceed the baseline derivation threshold, allowing the algorithm 1300′ to operate in a manner similar to that of the algorithm 1300). If the load monitoring flag 2167 is set, the generator may execute a load monitoring algorithm 2166, which may receive as input a maintain status flag 2168. The maintain status flag may indicate to the generator whether to wait a threshold time period before considering ultrasonic impedance so as to avoid transient features or blips as illustrated with respect to
The load monitoring algorithm 2166 may return the frequency delta. Additional details of how the load monitoring algorithm returns the frequency delta are provided herein below with respect to
At 2190, the generator may determine if the load timer is greater than the time above threshold impedance 2188. If yes, the generator may determine whether a baseline frequency latch is set at 2194. The baseline frequency latch may prevent the baseline frequency from bouncing during a jaw closure event, indicated by ultrasonic impedance. For example if the baseline frequency latch is set, it may indicate that a baseline frequency has already been taken for a given load event. If the baseline frequency latch is not set, the generator may set the latch and set the baseline frequency as the current resonant frequency of the system at 2196. At 2206, the generator may again determine whether the baseline frequency latch is set. If yes, the frequency delta may be set to the baseline frequency minus the local resonant frequency at 2208. If the baseline latch is not set, then the frequency delta may be set to zero at 2210.
Referring back to 2184, if the ultrasonic impedance is not greater than the threshold impedance, the generator may reset the load timer at 2198. At 2202, the generator may determine whether the ultrasonic impedance is less than a reset threshold impedance (|Z|mot Reset Threshold). If the ultrasonic impedance is less than the reset threshold impedance, the generator may reset the baseline frequency latch at 2204 and proceed to 2206, as described above. If the ultrasonic impedance is not less than the reset threshold impedance, the generator may proceed to 2206, as described above, without resetting the baseline frequency latch.
If the unfiltered condition set is not met at 2220, the generator may evaluate whether the Condition Set is still met at 2222. For example, the generator may determine (i) whether the filtered Condition Set latch timer has exceeded a minimum latch timer 1422; and (ii) whether the frequency slope is greater than a cross-back frequency slope threshold 1424; and (iii) [whether load monitoring 2167 is disabled OR whether a load event has completed] (e.g., whether ultrasonic impedance is less than the impedance reset threshold 2228). If these conditions are met, the generator may, at 2224, release the filtered Condition Set latch; reset the debounce timer (e.g., TIMER X in
Referring now back to 2214, if the filtered Condition Set latch is not set, the generator may determine if the unfiltered condition set is met at 2216 (e.g., based on the return of 2212). If not, the debounce timer may be reset at 1410 and the logic flow 1400′ may return an indication that the filtered Condition Set is not met. If yes, the generator may increment the debounce timer at 1408. At 1414, the generator may determine whether the debounce timer is greater than a required time before trigger parameter 1412, as described above. If so, algorithm 1400′ may proceed along the YES path, latching the filtered condition set latch at 1416 and returning an indication that the filtered Condition Set is met.
If the conditions evaluated at 2232 and 2236 are not met (in whatever logical arrangement is used), the generator may determine, at 2240, whether the difference between the baseline frequency (e.g., as set at 2196) and the local resonant frequency (e.g., the frequency delta) exceeds a baseline deviation threshold parameter 2242. If yes, the algorithm 2212 may return an indication that the unfiltered Condition Set is met. If no, the algorithm 2212 may return an indication that the unfiltered Condition Set is not met.
In certain forms, generators, such as 30, 500, 1002, and/or ultrasonic surgical instruments, such as 100, 120, 1004, may be implemented with one or more Condition Sets that utilize load events to arm Response Set triggers. For example, the generator may detect load events, as described herein. A load event may occur, for example, when the load on the ultrasonic blade experiences a change (e.g., a sudden or rapid change). Physical conditions that may cause a load change include, for example, the opening and/or closing of the clamp arm, a sudden drop of the ultrasonic blade through tissue, etc. In various forms, upon detection of a load event, Response Set triggers may be armed, or capable of being triggered upon the occurrence of other conditions in the corresponding Condition Set. When no load event is detected, the Response Set triggers may be disarmed, or incapable of being triggered even upon occurrence of other conditions in the corresponding Condition Set. The existence of a load event may serve as an alternate indicator of the types of physical conditions to be detected by various Condition Sets (e.g., changes in tissue state, such as tissue separation, desiccation, etc.). Accordingly, Condition Sets that utilize load event triggers are less likely to return false positives (e.g., situations where the Condition Set is met, but the underlying physical condition is not present). As a result, Condition Sets utilizing load events may also utilize lower and more sensitive thresholds for frequency slope thresholds 1404, frequency thresholds 1406, etc.
According to various forms, load events may be detected by examining changes in the frequency slope over time.
In view of this, certain forms detect the presence of a load event by examining changes in frequency slope over a rolling window. For example, a present or local frequency slope is compared to a past frequency slope offset from the local frequency slope by a window offset time. Continuing results of the comparison may be referred to as a rolling delta. The window offset time may be any suitable time and, in certain forms, may be about 100 msec. When the rolling delta exceeds a frequency slope threshold parameter, a load event may be detected. In certain forms, load events beginning when the blade is unloaded may not be considered (e.g., Response Set triggers may not be armed). For example, before examining the frequency slope over the rolling window, the generator may first detect an increase in ultrasonic impedance above an impedance threshold. (In some forms, the impedance threshold must be held for a time above impedance threshold parameter before the generator will detect a load event.) The impedance threshold may be any suitable value and, in certain forms, is between about 5 ohms and about 260 ohms, with a resolution of about 5 ohms. In one example form, the impedance threshold is about 100 ohms. The increase in ultrasonic impedance above the threshold may indicate, for example, that the clamp arm is closed, therefore, making a load event more likely.
In various example forms, Condition Sets that utilize load events to arm Response Set triggers may be utilized in the context of the logic flow diagrams 1200, 1300, 1400 of
At 2368, the generator may determine whether a filtered Condition Set latch is set. The filtered Condition Set latch may be set, as described below, when the filtered Condition Set is met, for example, so as to ensure that the filtered Condition Set is indicated to be set for a threshold period of time. If the filtered Condition Set latch is set, the generator may increment a latch timer at 2365 and determine whether the unfiltered Condition Set is met at 2366. If the unfiltered condition set is met, then the logic flow 1400″ may return an indication that the filtered Condition Set is met.
If the unfiltered condition set is not met at 2366, the generator may evaluate the whether the Condition Set is still met at 2368. For example, the generator may determine (i) whether the filtered Condition Set latch timer has exceeded a minimum latch timer 1422; and (ii) whether the frequency slope is greater than a cross-back frequency slope threshold 1424. If these conditions are met, the generator may, at 2378, release the filtered Condition Set latch; reset the debounce timer (e.g., TIMER X in
Referring now back to 2362, if the filtered Condition Set latch is not set, the generator may determine if the unfiltered condition set is met at 2364 (e.g., based on the return of 2360). If not, the debounce timer may be reset at 1410 and the logic flow 1400″ may return an indication that the filtered Condition Set is not met. If yes, the generator may increment the debounce timer at 1408. At 1414, the generator may determine whether the debounce timer is greater than a required time before trigger parameter 1412, as described above. If so, algorithm 1400″ may proceed along the YES path, latching the filtered condition set latch at 1416 and returning an indication that the filtered Condition Set is met.
At 2384, the generator may determine whether the load timer is greater than a required time above threshold parameter 2386. If yes, the generator may arm the load trigger at 2396 and proceed to 2398. For example, the load trigger may be armed when a load is indicated by the ultrasonic impedance. If no at 2384, the generator may proceed directly to 2398 without arming the load trigger. At 2398, the generator may determine whether the load trigger is armed. If no, the load set monitoring algorithm 2356 may return with the both the load trigger and the Response Set trigger unarmed. If yes, the generator may determine at 2400 whether the rolling delta exceeds the frequency slop threshold parameter 2402. If no, then the algorithm 2356 may return with the load trigger set and the Response Set trigger unarmed. If yes, then the Response Set trigger may be armed at 2404 and the algorithm 2356 may return. Referring back to 2380, if the ultrasonic impedance is not above the impedance threshold, the generator may reset the load timer at 2388. At 2390, the generator may determine whether the ultrasonic impedance is less than an impedance reset threshold parameter 2392. If yes, then the generator may disarm the Response Set trigger and load trigger at 2394. If no, the generator may proceed to 2398 as described above.
In some forms, the conditions 2406 and 2408 may be implemented in a logical “OR” manner instead of the logical “AND” manner shown. For example, after a determination that the local frequency slope is less than the frequency slope threshold parameter 1404, the algorithm 2360 may jump directly to 2410. Similarly, upon a determination that the local frequency slope is not less than the frequency slope threshold parameter 1404, the algorithm may evaluate the resonant frequency and frequency threshold parameter 1406 at 2408.
Various forms of algorithms 1400, 1400′ and 1400″ for evaluating Condition Sets for the signal evaluation tissue algorithms 1300, 1300′, 1300″ are described. It will be appreciated that any number of Condition Set evaluation algorithms may be implemented with any of the signal evaluation tissue algorithms 1300, 1300′, 1300″ described herein. For example, in certain forms, the generator may implement a Condition Set evaluation algorithm 1400, as described herein above, in conjunction with a Condition Set evaluation algorithm 1400″ utilizing a load event trigger. Any suitable combination of algorithms 1300, 1300′, 1300″, 1400, 1400′, 1400″ may be used.
In some example forms of the ultrasonic surgical instrument and generator, current is maintained so as to be relatively constant. This may establish a substantially constant displacement for the ultrasonic blade that, in turn, establishes a substantially constant rate of tissue-effecting activity. In some forms, the current is maintained, even over changing mechanical loads, where the mechanical load is reflected by the ultrasonic impedance. To achieve this, differences in mechanical load may be compensated for substantially by modulating applied voltage.
As described herein, to operate efficiently (e.g., minimize waste heat at the transducer), the surgical instrument (e.g., blade and transducer combination) may be driven at or near the system's resonant frequency. The frequency of the system may be determined via a phase difference between the current and voltage signals. As described herein, the resonant frequency of the system changes with thermal changes. For example, the additional of thermal energy (e.g., heat) results in a softening of the blade and/or other system components, thereby changing the system's resonant frequency. Accordingly, the generator, in some example forms, implements two control loops. A first loop maintains a substantially constant current across varying loads, while a second control loop tracks the system resonant frequency and modifies the driving electrical signals accordingly.
As described herein, various algorithms for use with ultrasonic surgical instruments approximate physical conditions of the instrument (e.g., the ultrasonic blade thereof) based on the electrical signals provided to the instrument. For example, with respect to
Also, for example, load events are described herein, for example, with respect to
According to various forms, an ultrasonic instrument, such as the instruments 100, 120, 1004 may be driven according to a control algorithm that involves driving the instrument sequentially at different power levels. For example, when the ultrasonic surgical instrument is activated, it may be driven at a first power level. For example, a generator (e.g., generators 30, 500, 1002 and/or an internal generator) may provide a drive signal at a first power level. After the expiration of a first period, the generator may provide a second drive signal at a second power level less than the first power level. In some applications, the first, higher power level may serve to separate the inner muscle layer of a vessel from the adventilia layer, as described herein.
At 3020, the generator may receive a trigger signal provided by a clinician. The trigger signal may be provided in any suitable manner. For example, in some forms, the clinician provides the trigger signal utilizing a button or other input device on the instrument itself (e.g., buttons 312a, 1036a, 1036b, 1036c, footswitches 434, 1020, etc.). At 3022, the generator may activate the instrument by providing a first drive signal. Referring to
The generator determines whether the first period has expired at 3026. The first period may be measured in any suitable manner. For example, in some forms, the first period is a set time period that expires after a predetermined amount of time has passed since the activation of the instrument. This is the case in the example shown in
When the first period expires, the generator provides a second drive signal at a second power level at 3028. In the example of
The algorithm 3021 may improve the performance of the instrument relative to simply activating the instrument at a single power level.
In use, the algorithm 3021 has a potential for misuse by clinicians. For example,
In various forms, the algorithm 3021′ may be implemented utilizing an alternate logic condition in place of the rest time. For example, instead of determining whether the rest time has expired at 3050, the generator may determine whether the alternate logic condition has been met. The alternate logic condition may be any suitable condition including, for example, an indicator of a state of the instrument and/or tissue being acted upon. In some forms, the logic condition may be, or be related to, a temperature of the end effector. For example, the alternate logic condition may be based on the resonant frequency of the ultrasonic drive system and end effector, as indicated by the frequency of the drive signal. If the frequency is above a threshold value (indicating that the temperature of the end effector temperature is below a threshold value), then the algorithm 3021′ may proceed to actions 3022, 3024, 3026, 3028 as described. The frequency of the drive frequency may be measured in any way including, for example, those described herein above with respect to
In various forms, the algorithm 3021″ may lead to higher burst pressures and shorted transection times relative to the algorithm 3021 illustrated in
In some forms, the algorithms 3021, 3021′, 3021″ may be implemented in conjunction with various other algorithms described herein. For example, any of the algorithms 3021, 3021′, 3021″ may be implemented in conjunction with a condition set and/or response set based on a measured characteristic of the instrument and/or tissue acted upon by the instrument. For example, the algorithms 3021, 3021′, 3021″ may be implemented with one of the algorithms described herein above with respect to
As described above, any of the algorithms described herein including, 3021, 3021′, 3021″, 3100, 3120, etc., may be implemented in conjunction with an algorithm for implementing a condition set and response set. The condition set, for example, may be true based on the presence or absence of a particular state of the ultrasonic instrument and/or tissue acted upon by the ultrasonic instrument. The response set may define actions to be taken by the instrument and/or the generator upon the condition set being true. In some forms, various condition sets may be estimated utilizing one or more multi-variable models. Examples of multi-variable models may include, for example, neural network models, genetic algorithm models, classification tree algorithm models, recursive Bayesian models, etc.
One suitable type of multi-variable model comprises a neural network. Neural networks may be effective for recognizing complex patterns in input variables, which may make them well suited to detect condition sets based on tissue state (e.g., whether transection has occurred, whether sealing has occurred, etc.).
Neural networks may be fully connected, as shown in
x=ω1ξ1+ω2ξ2+ω3ξ3+ . . . +θ (8)
In Equation (8), ξ corresponds to the values of the input neurons, ω corresponds to the weights given to each input, θ corresponds to a constant. When the neural network is fully connected, the values of all input neurons are passed to all hidden neurons, meaning the activation function for each hidden neuron will include a term ξ corresponding to each input node. The weights given to each input (ω) may be unique for each hidden neuron and/or each input value. The constant θ may also be unique for each hidden neuron 3154. The results at each node may be given by Equations (9) and (10) below:
O=σ(x) (10)
The output of the sigmoid function is illustrated in
In various forms, each hidden neuron has I inputs, which is equal to the number of inputs to the neural network. If there are J hidden neurons 3154, then there are I×J unique values for omega (ω) and J unique values for theta (θ). In some forms, the output neuron(s) 3156 may utilize the same activation equation. Accordingly, there may be J×K unique omega (ω) values connecting the hidden neurons 3154 to the output neuron 3156, where K is the number of output neurons, and K unique values of theta (θ) for the output node(s) 3156.
The output of the neural network may indicate the truth of falsity of a condition set comprising one or more conditions of the ultrasonic surgical instrument, tissue acted upon by the surgical instrument, or some combination thereof. For example, a neural network may be used to model a condition set indicating whether to provide feedback indicating tissue transection at or near the separation point. For example, in some forms, the output of the neural network may indicate whether 80% transection has been achieved. Any suitable number or type of neurons 3152, 3154, 3156 may be used. For example, the neural network 3150 may comprise twelve input neurons 3152, (I=12), four hidden neurons (J=4), and one output neuron (K=1). The data cycle may be 10 milliseconds. Accordingly, values for the 12 inputs may be fed into the network 3150, and results calculated, every 10 milliseconds.
Input variables (e.g., variables corresponding to the input nodes 3152) may comprise any variables that could, in some circumstances, affect the value of an output node 3156. The example input variables described below may be utilized in a neural network, such as 3154, having an output node or nodes corresponding to any suitable ultrasonic instrument-related value such as, for example, 80% transection. It will be appreciated that the input variables described herein may also be used any other suitable type of model including, for example, genetic algorithm models, classification tree algorithm models, recursive Bayesian models, etc.
In some forms, input variables corresponding to input nodes 3152 include variables describing the operation of the surgical system during the treatment of tissue. A tissue treatment, for example, may begin when the surgical system is activated on tissue. Example tissue treatment input variables are described below:
An elapsed time since activation input variable may represent a time since the activation of the instrument (e.g., at the beginning of a tissue treatment). Time may be measured in any suitable increments including, for example, 10 milliseconds (0.010 seconds) beginning at instrument activation (e.g., 0.00 seconds). In some forms, the elapsed time since activation is measured and stored by the generator.
Different variables may be utilized to describe the operation of the ultrasonic transducer or hand piece including, for example, a voltage drop across the transducer, a current drawn by the transducer, and an impedance of the transducer. Values for these and similar variables may be captured and stored (e.g., by the generator) at any suitable interval. For example, voltage current and/or impedance values may be captured at an interval equal to the data cycle of the neural network 3150.
Additional input variables describe different permutations of voltage, current and/or impedance of the transducer over predetermined time periods. For example, averages of voltage, current or impedance may be taken over the entire activation period (e.g., described by the elapsed time since activation). Also, in some forms, averages of voltage, current or impedance are taken over a predetermined number of prior samples. For example, an average impedance may be taken across the last A impedance samples, where A may be equal to 10. Power, energy and various other values derivable from voltage, current and/or impedance may also be calculated as stand-alone input variables or in different permutations. For example, total energy is used as an input variable in some forms. Total energy may indicate a sum of energy delivered to the ultrasonic system since activation. This may be derived, for example, by multiplying a summation of power by time throughout the activation. An impedance curve or shape indicates changes in impedance since activation. In some forms, a spline fit or other smoothing function may be applied to the impedance curve. Application of a smoothing function may accentuate inflection points, the presence or position of which may be utilized as input variables. For example, the impedance curve, in some forms, may experience a sudden drop as cutting occurs. Various example input variables, such as the impedance curve, are described as a curve or array of values. Such variables may be input to the neural network 3150 or similar model in any suitable form including, for example, by taking an area under the curve, taking one or more peak values, taking an average or running average of the curve, etc. In some forms, integrals, peaks, averages, etc. of various curves may be bounded, for example, to exclude transient effects from activation. Additional variables may include, for example, a total energy (e.g., since activation), a total change in impedance (e.g., since activation), etc.
Various input variables are based on the resonant frequency of the surgical system (e.g., transducer, waveguide and blade). The resonant frequency of the surgical system may be manifested in the frequency of the drive signal. For example, as described herein, the generator may be tuned to drive the surgical system (e.g., provide a drive signal) at the system's resonant system. In some forms, the resonant frequency itself (e.g., a current or instantaneous resonant frequency) may be an input variable. Resonant frequency may be sampled at any suitable interval such as, for example, at the data cycle of the neural network or other model. Another example resonant frequency variable describes a change in the resonant frequency over the course of tissue treatment. For example, the change in resonant frequency may be set equal to a difference between a current resonant frequency value and a frequency value at the activation and/or at a set point after the activation (e.g., 0.5 seconds after activation). Yet another resonant frequency variable describes a frequency derivative dF/dt, or an instantaneous slope of the resonant frequency. An additional resonant frequency variable may be derived by taking an average of frequency derivative values. One example average includes all frequency derivative values since activation and/or frequency derivative values over a predetermined period such as, for example, the past 10 data cycles of the neural network 3150. In some forms, multiple average frequency derivative variables may be used, with each variable calculated over a different period (e.g., a different number of past data cycles of the neural network 3150 or other model). Various different permutations of the resonant frequency variables described herein may also be used. One example resonant frequency variable describes a maximum average frequency derivative calculated over a preceding A average dFdt values, where A may correspond to a number of data cycles of the neural network 3150 or other model. For example, A may be equal to 10. Another example input variable is a phase margin. The phase margin describes a difference in phase between the drive signal and the displacement of the blade. The phase margin may be measured in any suitable manner for example, as described in commonly-owned U.S. Pat. No. 6,678,621, entitled “Output Displacement Control Using Phase Margin In An Ultrasonic Hand Piece,” which is incorporated herein by reference in its entirety.
In various forms, the neural network 3150 or other model receives input variables having values that describe a specific surgical system (e.g., system-specific variables). System-specific variables may describe properties any component or group of components of a surgical system including, for example, a hand piece, a blade, a waveguide, an end effector, a clamp arm, a clamp pad, etc. In this way, system-specific variables may serve to provide a “fingerprint” of each surgical system. Different system-specific variables may be measured and utilized in various ways. For example, system-specific variables may be used in both the training and execution of the neural network 3150 or other model.
Some system-specific variables describe properties of the surgical system, or components thereof, that can be physically measured. System length describes the length of the surgical system (e.g., the waveguide and blade thereof). Example system lengths include 23 cm, 36 cm and 45 cm. In some forms, separate neural networks 3150 may be trained and utilized for systems having different lengths, however, this may be avoided by utilizing system length as an input variable.
Some system-specific input variables describe properties of the ultrasonic blade. For example, an individual blade gain describes a ratio of an increase or decrease in displacement from a transducer to the tip of a blade (e.g., the blade gain may describe the combination of a blade and a wave guide). The gain of any given ultrasonic blade may be determined by the physical properties of the blade itself including, for example, discontinuities in the diameter of the blade. Different blades manufactured to the same specifications may have slightly different blade gains, for example, due to manufacturing tolerances. For example, the gain for one suitable blade may be 3.5±0.2. In various forms, blade gain is measured during the manufacturing and/or testing of the surgical system. For example, a laser vibrometer or other suitable instrument may be utilized to measure the displacement of the blade when driven by a generator and hand piece with known gains.
Another blade-specific variable is the natural resonant frequency of the blade. This may also be referred to as the quiescent resonant frequency. The natural resonance frequency is a function of the physical properties of the blade. In various forms, natural resonant frequency is measured during manufacturing or testing of a blade (or associated system), for example utilizing an impulse excitation or ping test. According to a ping test, sound waves or vibrations over a range of frequencies are provided to the (usually unloaded) blade. The frequency at which the blade is caused to resonate is noted. For example, a microphone or other audio sensor may be used to record the response of the blade to pings of various frequencies. The frequency content of the measured values may be analyzed to identify resonance. Yet another blade-specific variable is the Q factor for the blade. The Q factor describes the bandwidth of the blade relative to its center frequency. In other words, the Q factor describes how tightly packed the frequency spectrum of the blade is around the resonant frequency. Q factor may be measured, for example, utilizing commonly available spectrum analyzer equipment, for example, during manufacture or testing of a blade or associated system.
An additional blade-specific variable is the blade length. For example, due to manufacturing tolerances, not every blade of the same design will have the same length. Exact blade lengths may be measured using any suitable measurement technique or equipment including, for example, micrometers, optical systems, coordinate measurement machines, etc. Blade deflection describes the degree that the blade deflects when in contact with the clamp arm. The degree of blade deflection may be measured, for example, utilizing a non-contact laser displacement instrument, a dial indicator, or any other suitable instrument. Various acoustic properties of blades may also be utilized as blade-specific input variables. A Poisson's ratio for different blades may be measured utilizing strain gauges to measure transverse and axial strain and/or may be derived from the blade material. The speed of sound in different blades may also be measured and/or derived from blade materials. Other acoustic properties that are potential input variables include the phase velocity, density, compressibility or stiffness, bulk modulus, etc. For example, many acoustic properties of blades, clamp pads, etc. are provided by the material manufacturers.
Additional blade-specific variables include a surface coefficient of friction and a projected sealing surface. The surface coefficient of friction may be relevant to models of tissue effect because the coefficient of surface friction may relate to the power delivered to tissue, for example, according to Equation (11) below:
Power=μ×2π*d*f*N (11)
In Equation (11), μ is the coefficient of surface friction (e.g., dynamic friction); f is the frequency of the drive signal (e.g., the resonant frequency of the system); N is the normal force; and d is the displacement of the blade. The coefficient of surface friction may be measured in any suitable manner. For example, the blade may be mounted to a turn table and rotated while a known normal force is applied. In some forms, Equation (11) above also considers the projected sealing surface, as indicated by Equation (12) below:
Power density=(μ×2π*d*f*N)/SS (12)
In Equation (12), SS is the projected sealing surface. The projected sealing surface may be estimated, for example, based on the geometric configuration of the blade. For example, the blade length, width and curvature may be relevant. A related example input variable is blade clock. For example, in some forms the blade is curved. A blade clock describes an angular direction of blade curvature about the longitudinal axis.
In various forms, the way in which a surgical system acts on tissue depends on the way that the clamp arm and blade engage the tissue. This may, in turn, depend on various system-specific dimensions other properties. For example, various system-specific variables describe the interrelationship between the blade, the clamp arm and the clamp pad. One such example input variable is the clamping force provided between the blade and the clamp arm. For example, the clamping force may correspond to FT, described herein above with respect to Equation (1). Clamping force may be measured in any suitable manner. For example, with reference to the surgical system 19 shown with respect to
Similar variables include a trigger displacement, a trigger force, and a tube sub-assembly spring force. The trigger displacement is the distance that the trigger 34, 4120 (
Other suitable clamping-related variables relate to a pressure profile. The pressure profile describes a distribution of pressure along the blade and clamp arm when the clamp arm is closed. A clamping profile may be measured in any suitable manner. For example, a pressure sensor, such as a sensor available from TEKSCAN, may be placed between the blade and the clamp arm. The clamp arm may then be closed (e.g., utilizing trigger 34 and/or trigger 4120 described herein) and the resulting force (and/or force distribution) is measured. In some forms, clamping forces may be taken over less than the entire length of the clamp arm. For example, clamping force at a particular position on the clamp arm or blade (e.g., at a proximal portion of the clamp arm) may be utilized as an input variable to the neural network 3150 or other suitable model.
Various other clamping-related input variables comprise a clamp arm deflection, a clamp arm position or ride, a jaw angle at full open trigger, and pad height. Clamp arm deflection is a measure of the degree of deflection in the clamp arm when closed against the blade. A clamp arm position or ride, also referred to as a jaw angle at full open trigger, describes a distance or angle between the clamp arm and the blade. For example, the jaw angle at full open trigger may be measured utilizing a vision system, an optical comparator, a protractor, etc. A pad height may describe a thickness of the clamp arm pad. These values may be measured in any suitable manner. For example, a vision system may be utilized to capture images of the blade and derive clamp arm deflections, etc. Also, various mechanical or optical range finding techniques may be used to measure specific dimensions. Additional clamping-related variables may describe properties of the pad (e.g., clamp pad 58). Examples of such parameters may include, a pad lot number, dimensions of the pad, a material distribution of the pad, a material hardness of the pad, thermal properties of the pad, as well as average values for these or similar values over a production lot.
In some forms, system-specific variables are assigned values based on measurements made during test procedures. For example, some input variables are determined during a system burn-in. One form of a burn-in is described herein above, with respect to
In some forms, a frequency slope or other value is taken under burn-in conditions with the generator power set across different power levels. For example, a frequency slope or other measurement may be taken with the generator set at a first power and a second frequency slope or other measurement may be taken with the generator set at a second power level. In some forms, the burn-in may be performed with a tissue (e.g., porcine tissue) or a tissue surrogate (sponge material, etc.) positioned between the clamp arm and the blade. In some forms, the frequency slope and related variables may change as the tissue surrogate is transected. For example, the frequency slope may be taken at various different points in the burn-in cycle, averaged over all or a portion of the burn-in cycle, etc. Another test-related variable is the number of burn-in cycles that are performed. For example, in some forms, multiple burn-in cycles may be performed, for example, if there is a problem with the instrument or with the test procedure at the first burn-in.
After performing a burn-in, various other characteristics of the surgical system may be measured (and used as input variables). For example, the burn-in may create an indentation on the clamp pad corresponding to the blade. Analysis of the indentation may yield a burn-in depth (e.g., the depth of the indentation). The depth may be measured with any suitable device. In some forms, the burn-in depth may be measured with a vision system, laser range finder and/or other mechanical or optical measurement tool. In some forms, the burn-in depth is taken at various points on the clamp pad to indicate a burn-in depth distribution (e.g., a contact profile). Also, in some forms, a point of clamp arm contact may also be derived from the indentation. For example, the deepest portion of the indentation may correspond to the point of first contact.
Still other system-specific input variables are measured in a free state. A free state may be recreated with the clamp not in contact with the blade, and the blade running in air. Variables measured in a free state may include power consumption, device impedance, frequency slopes across different power levels, blade impedance at different power levels, current, voltage and impedance of the hand piece, etc. In various forms, system and environment-related variables may be measured during a pre-run. For example, various surgical systems are configured to require a pre-run test prior to operation on tissue. This may serve, for example, to ensure that the surgical system has been properly assembled. During the pre-run test, however, various system-specific variable values may be captured including, for example, voltage, current, impedance, resonant frequency and permutations thereof, for example, as described herein.
Additional system-specific variables relate to the temperature response of the blade and/or clamp arm. For example, a clamp arm temperature response describes the way that a particular clamp arm heats when exposed to a heat influx. The temperature of a clamp arm may be measured, for example, with an infrared thermometer. A clamp arm temperature response may be expressed as a number of degrees of heating in temperature per watt of heat influx. Similarly, a clamp arm temperature cooling curve may be a measure of how a given blade cools in room temperature air per unit time, for example, expressed in degrees per unit time. Similar input variables may be based on the blade including, for example, a blade temperature response and a blade cooling curve. Another example temperature response variable comprises a blade impedance versus temperature. This may be a measure of an acoustic impedance of the blade (e.g., as expressed by an electrical impedance of the transducer) as a function of temperature. Since a change in blade temperature may cause a change in frequency, the components securing the blade and waveguide within the shaft may not be necessary be at exact nodal points (e.g., positions on the waveguide with zero transverse displacement). Accordingly, when the components are not at the exact nodal points, they may cause acoustic impedance in the system when in air. Measuring how this changes and resulting changes in frequency may make it possible to model not only blade temperature, but also how far back on the blade (e.g., toward the handle) the blade temperature has changed. The respective temperature responses and/or cooling curves may be used as inputs to the neural network 3150 in any suitable manner. For example, the slope of the respective curves, a knee value where the slope changes, or any other suitable value may be selected.
Other example, system-specific variables comprise the age of the production line on which a system was produced and a transverse frequency measured within the blade, for example, at a burn-in. For example, production machinery may change over its lifetime, causing blades and other components produced at different point in the production machinery lifecycle to behave differently. Transverse frequencies describe vibrations in the blade that are in a direction orthogonal to that of the shaft and may be measured, for example, utilizing a vector signal analyzer or spectrum analyzer, such as the N9030A PXA Signal Analyzer available from AGILENT TECHNOLOGIES. Transverse frequencies may be measured in any suitable conditions including, for example, in a predetermined condition set such as a burn-in or free state.
Various input variables for the neural network 3150 may be based on the hand piece or transducer used by the surgical system to treat tissue. Examples of such variables may include an impedance of the transducer, as described above, a resonant frequency of the hand piece, a current set point of the hand piece, etc. The resonant frequency of a hand piece describes the resonant frequency of the hand piece independent of the waveguide or blade. For example, the resonant frequency of the hand piece may be measured at the time of manufacture. The current set point for a hand piece describes a level of current that is to be provided to a particular hand piece to provide a predetermined displacement. For example, different hand pieces may have different current set points based on different manufacturing tolerances. The current set point, resonant frequency, and other variable values describing a hand piece may be stored, for example, at an electrically erasable programmable read only memory (EEPROM) or other storage device associated with the hand piece. For example, the generator may interrogate the hand piece to retrieve hand piece-specific variables. In some forms, utilizing hand piece-specific variables may provide additional clarity to various other system-specific variables measured during manufacturing and/or testing. For example, when the system is utilized by a clinician, a different and often newer hand piece may be utilized. Hand piece specific variables may correct for this.
It will be appreciated that the neural network 3150 may utilize any of the input variables described herein above. In some forms, the neural network 3150 may be evaluated utilizing matrix algebra. For example, four matrices maybe used. A 1×I input matrix (O_i) may include (e.g., scaled) values for the I input neurons. An I×J hidden neuron omega matrix (W_ij) comprises omega (ω) values used to calculate values of hidden neurons 3154. A J×K output neuron omega matrix (W_jk) comprises omega (ω) values used to calculate the values of output neuron or neurons 3156. A 1×J hidden neuron constant matrix (O_j) comprises constant θ values for the hidden neurons 3154. A 1×K output neuron constant matrix (O_k) comprises constant θ values for the output neuron(s) 3156. For any given cycle, the output of the neural network may be calculated by evaluating the matrices as indicated by Equations (13)-(16) below:
x_j=O_i*W_ij+O_j (13)
The result of Equation (13), x_j, may be the weighted sums of the input neuron values for each hidden neuron 3154. Matrix x_j may be processed element-by-element through an equation, such as Equation (14) below, resulting in a matrix of equal size, O_j.
O_j=(1+exp(−x_j))·{circumflex over ( )}(−1*Z) (14)
The result of Equation (14), O_j may be the values for each of the hidden neurons 3154. In Equation (12), Z corresponds to an matrix of ones having a size K×J.
x_k=O_j*W_jk+O_k (15)
The result of Equation (15), x_k, may be the weighted sums of the hidden neuron values for each output neuron 3156. Matrix x_k is processed element-by-element through an equation, e.g., Equation (16), resulting in a matrix of equal size, O_k.
O_k=(1+exp(−x_k)){circumflex over ( )}(−1*Z1) (16)
The result of Equation (16), O_k, may be the output of the neural network. In Equation (15), Z1 may be a matrix of ones having a size K×1.
The neural network may be trained in any suitable manner. For example, in some forms, the neural network may be trained utilizing back-propagation. During back-propagation training, the data flow of the neural network is reversed. For example, values for error versus actual output are used to modify individual weight and constant parameters.
At 3174, the neural network may be created. For example, the values for the weights and constants of the various neurons 3154, 3156 maybe randomly initialized (e.g., utilizing the MATLAB “rand” function, which generates a uniform distribution). In some forms, a value range of −2.5 to 2.5 may be utilized as these values tend to result in outputs in the range of 0-1 when processed by a sigmoid activation function. At 3176, the network 3150 may be run forward on the input data to generate a predicted output (or outputs if there are multiple output nodes). At 3178, an error may be calculated. The error is a difference between the predicted output from 3176 and the actual value of the tissue or instrument property, as described herein. In various forms, the output or outputs may be denoted as binary numbers where one (1) corresponds to the existence or truth of the condition and zero (0) corresponds to the non-existence or falsity of the condition. For example, when the condition is 80% transection, the output should be 1 when the tissue is 80% transected and 0 when the tissue is not (yet) 80% transected. In some forms, the condition may be considered true when the output of the neural network 3150 exceeds a threshold value (e.g., 0.85).
At 3180, the weights for each node are evaluated. For example, for each weight a partial derivative is found of the output or error (E) with respect to the weight (omega (ω)). This may be represented as δE/δ ωij for connections between the input layer 3152 and the hidden layer 3154 and as δE/δ ωjk for connections between the hidden layer 3154 and the output layer 3156. At 3182, the constants for each node are evaluated. For example, for each constant, a partial derivative is found of the output or error (E) with respect to the constant θ. This may be represented as δE/δ θi for connections between the input layer 3152 and the hidden layer 3154 and to δE/δ θj for connections between the hidden layer 3154 and output layer 3156. At 3184, deltas may be calculated for each weight and constant. The deltas may found by multiplying each partial derivative by a gradient constant, η. In some forms, a value of 0.1 may be used for η. The deltas may then be added to the original values of each weight and constant. Actions 3176, 3178, 3180, 3182, and 3184 may be repeated for subsequent cycles of the input data. In some form, the network 3150, once trained, may be tested. For example, the network 3150 may be tested, as described herein, on a testing data set distinct from the training data set. In various forms, a neural network or other multi-variable model may be pre-trained. Resulting model parameters (e.g., network configuration, values for weights and constants, etc.) may be determined and stored at a generator and/or instrument. The values may be utilized to execute the model during use.
Although a neural networks, such as the network 3150 are described herein, it will be appreciated that any other suitable type of multi-variable model may be utilized in addition to or instead of a neural network including, for example, genetic algorithm models, classification tree algorithm models, recursive Bayesian models, etc. For example, a recursive Bayesian model models the probability of an output event occurring (e.g., a threshold transection state), where the probably is equal to zero at the beginning of the transection (e.g., t=0) and continually increases with each time step. The amount of increase in the probability is based on whether certain criteria are met. The criteria may represent threshold values of different input variables. For example, if “frequency slope<threshold 1” is true, it may increase the probability by a certain amount for each time step at which it is true. If “frequency delta<threshold 2” is true, it could increase the probability by an additional amount, where the sum of increases due to different criteria at each time step indicates the increase in probability at the time. When the probability reaches a threshold value (e.g., 0.85), the recursive Bayesian model may indicate that the modeled condition is true.
Another type of suitable multi-variable model is a classification or decision tree. A classification or decision tree comprises a plurality of binary decisions arranged according to a hierarchy tree structure For example, in some embodiments, the generator may first determine if a frequency slope characterizing a drive signal provided to a surgical instrument is less than a threshold If not, then the change in frequency may be measured against a second threshold. If the change in frequency is less than the threshold, then the generator may provide feedback indicating the end of the transection. If the change in frequency is greater than the threshold, then the generator may not provide feedback. Referring back to the initial decision, if the frequency slop is less than the first threshold, then the generator may determine if a required time before trigger is greater than a threshold. The required time before trigger may refer to a threshold amount of time after the frequency slope is met before the generator provides feedback indicating the end of the transection. For example, this may correct for bounciness in the frequency slope signal. If the required time before trigger has passed, then the generator provides feedback indicating the end of the transection. If not, then no feedback is provided.
Referring first to thread 3571, that control thread may be similar to the algorithm 3021″ of
Referring now to the condition thread 3573, the generator may, at 3582, execute a multivariable model, such as the neural network 3150 described herein or any other multivariable model. At 3584, the generator may determine whether an output of the model meets a predetermined threshold. The threshold may indicate the truth or presence of one or more of the conditions of the modeled condition set. If not, then the generator may continue to execute the model at 3582. If yes, the generator may wait an alert time period at 3586. At an expiration of the alert time period, the generator may generate feedback (e.g., audible, visual or tactile feedback) at 3588. The feedback may indicate the truth or presence of the detected condition. At 3590, the generator may wait a thermal management time period. While waiting, the feedback initiated at 3588 may be maintained. At 3592, the generator may determine whether both the first and second time periods (see thread 3571) have expired. If so, the generator may modify the power provided to the end effector at 3596. If not, then, in some forms, the generator may wait until the first and second time periods expire, at 3594, before modifying the power provided to the end effector at 3596. For example, the generator may enter the thermal management level or stage.
As illustrated, upon activation the end effector may be driven at the first power level, as indicated by 3572 (
If the transection condition is met at 3216, it may indicate that transection has occurred, or is set to occur, before sealing. As this may be an undesirable occurrence, the generator may deactivate the surgical instrument at 3528 to prevent transection from occurring before sealing. At 3222, the generator may wait a first period. Waiting the first period, for example, may allow the tissue to complete sealing either before transection occurs and/or before the clinician is provided with an indication to open the end effector to release the tissue. The first period may be a predetermined time period or, in various forms, may be based on the seal condition output of the model. At the expiration of the first period, the generator may provide feedback indicating the end of the seal and transect operation at 3224. Alternatively, after the expiration of the first period, the generator may apply an amount of energy for a second period and then subsequently deactivate the instrument and provide feedback indicating the end of the seal and transect operation. If the transection condition is not met at 3216, it may indicate that transection is not set to occur before sealing. The generator may then determine at 3220 whether the seal condition is true. If not, the generator may return to the monitoring actions 3212, 3210. If the seal condition is set to occur, the generator may generate the feedback at 3224. In some forms, if the instrument is still activated at 3224, the generator may deactivate the instrument and/or deactivate the instrument after a delay period.
Various algorithms herein are described herein as being executed by a generator. It will be appreciated, however, that in certain example forms, all or a part of these algorithms may be performed by internal logic 2009 of a surgical instrument (
Multi-function capabilities of many ultrasonic surgical instruments, challenge the ability of a user to comfortably access and operate the multiple functions and controls of the instrument. This includes, for example, the ability to comfortably actuate the jaws of a clamping mechanism and activate hand control buttons/switches, sometimes simultaneously. As such, various user interface controls may be desirable. One user interface design to control functions of the ultrasonic surgical instrument may include a rotation mechanism between two portions of the device requiring a rotatable electrical connection. Rotatable electrical connections may fail over time, requiring costly repairs or replacement of associated instrument components that may otherwise have valuable operation life remaining. Accordingly, there is a need to extend the operational life of various ultrasonic surgical instruments by providing alternate solutions to costly repairs and premature component replacements.
Ultrasonic surgical instruments, including both hollow core and solid core instruments, are used for the safe and effective treatment of many medical conditions. Ultrasonic surgical instruments, and particularly solid core ultrasonic surgical instruments, are advantageous because they may be used to cut and/or coagulate tissue using energy in the form of mechanical vibrations transmitted to a surgical end effector at ultrasonic frequencies. Ultrasonic vibrations, when transmitted to tissue at suitable energy levels and using a suitable end effector, may be used to cut, dissect, coagulate, elevate or separate tissue. Ultrasonic surgical instruments utilizing solid core technology are particularly advantageous because of the amount of ultrasonic energy that may be transmitted from the ultrasonic transducer, through an ultrasonic transmission waveguide, to the surgical end effector. Such instruments may be used for open procedures or minimally invasive procedures, such as endoscopic or laparoscopic procedures, where the end effector is passed through a trocar to reach the surgical site.
Activating or exciting the end effector (e.g., cutting blade, ball coagulator) of such instruments at ultrasonic frequencies induces longitudinal vibratory movement that generates localized heat within adjacent tissue, facilitating both cutting and coagulating. Because of the nature of ultrasonic surgical instruments, a particular ultrasonically actuated end effector may be designed to perform numerous functions, including, for example, cutting and coagulating.
Ultrasonic vibration is induced in the surgical end effector by electrically exciting a transducer, for example. The transducer may be constructed of one or more piezoelectric or magnetostrictive elements in the instrument hand piece. Vibrations generated by the transducer section are transmitted to the surgical end effector via an ultrasonic waveguide extending from the transducer section to the surgical end effector. The waveguides and end effectors are designed to resonate at the same frequency as the transducer. When an end effector is attached to a transducer the overall system frequency may be the same frequency as the transducer itself. The transducer and the end effector may be designed to resonate at two different frequencies and when joined or coupled may resonate at a third frequency. In some forms, the zero-to-peak amplitude of the longitudinal ultrasonic vibration at the tip, d, of the end effector behave as a simple sinusoid at the resonant frequency as given by:
d=A sin(ωt) (17)
where: ω=the radian frequency which equals 2π times the cyclic frequency, f; and A=the zero-to-peak amplitude. The longitudinal excursion is described by a as the peak-to-peak (p-t-p) amplitude, which may be twice the amplitude of the sine wave or 2 A.
Various forms of ultrasonic surgical instruments described herein comprise a first structure and a second structure where the second structure is rotatable relative to the first structure. In some forms, electrical communication between the first structure and the second structure may be provided through a rotatable electrical connection. In one form, the first structure comprises an ultrasonic hand piece comprising an ultrasonic transducer, which in many designs, may be used to rotate a shaft extending distally from the hand piece. Rotation of the hand piece may include rotation relative to a second structure, such as a handle assembly or another component of the instrument in which electrical coupling is required. For example, in one form, the second structure may comprise a user interface. According to one form, the user interface may be engaged by the user to provide operation instructions or signals between the hand piece, power generator, or another component of the ultrasonic surgical system. In one form, instructions or signals provided at the user interface may be electrically coupled through the rotatable electrical connection to provide signals that may be used to control or provide information related to an operation associated with the ultrasonic surgical instrument. In one form, the user interface may comprise buttons, switches, knobs, or other various interfaces known in the art. In one form, the rotatable electrical connection may electrically couple an end effector that is rotatable relative to another component of the instrument, such as a hand piece or handle assembly, to provide electrical communication therebetween.
The ultrasonic transducer of the ultrasonic hand piece 4114 converts an electrical signal from a power source, such as the ultrasonic signal generator 4116 or battery (not shown), into mechanical energy that results in primarily a standing acoustic wave of longitudinal vibratory motion of the transducer and the blade 4152 portion of the end effector assembly 4112 at ultrasonic frequencies. As shown in
In one form, the handle assembly 4102 comprises a trigger 4120 and a fixed handle 4122. The fixed handle 4122 may be integrally associated with the handle assembly 4102 and the trigger 4120 may be movable relative to the fixed handle 4122. The trigger 4120 is movable in direction 4121a toward the fixed handle 4122 when the user applies a squeezing force against the trigger 4120. The trigger 4120 may be biased in the direction 4121b such that the trigger 4120 is caused to move in direction 4121b when the user releases the squeezing force against the trigger 4120. The example trigger 4120 also includes a trigger hook 4124 extension to provide an additional interface portion from which the trigger 4120 may be operated.
Further to the above, the distal rotation assembly 4106 may be located at a distal end of the handle assembly 4102 when the ultrasonic hand piece 4114 is received for and mechanically and acoustically coupled to the handle assembly 4102. In one form, the distal rotation assembly 4106 comprises a ring or collar shaped knob 4134. The distal rotation knob 4134 is configured to mechanically or frictionally engaged with the ultrasonic hand piece 4114. As previously discussed, the ultrasonic hand piece 4114 is mechanically engaged to the elongated endoscopic shaft assembly 4110. Thus, rotating the rotation knob 4134 rotates the ultrasonic hand piece 4114 and the elongated endoscopic shaft assembly 4110 in the same direction 4170.
In various forms, the ultrasonic surgical instrument 4100 may comprise on or more user interfaces to provide electrical control instructions to control the operation of the instrument 4100. For example, in one form, a user may employ a footswitch 4111 to activate power delivery to the ultrasonic hand piece 4114. In some forms, the ultrasonic surgical instrument 4100 comprises one or more electrical power setting switches to activate the ultrasonic hand piece 4114 and/or to set one or more power settings for the ultrasonic hand piece 4114.
As those having skill in the art will appreciate, a generator 4116 may provide activation power to the ultrasonic hand piece 4114 via cable 4118, for example. As described above, the handle assembly 4102 may be conveniently used to provide electrical power control instructions to the generator 4116 to control power delivery to the ultrasonic hand piece 4114, for example, through one or more switches associated with the switch assembly 4108. For example, in operation, the one or more switches 4108 may be configured for electrical communication with the generator 4116 to control electrical power delivery and/or electrical power operation features of the ultrasonic surgical instrument 4100. It is to be appreciated that in at least one form, the generator 4116 may be internal to the hand piece 4114.
As introduced above, the ultrasonic hand piece 4114 may be configured to rotate relative to the handle assembly 4102 or component thereof via the distal rotation knob 4134, to rotate the ultrasonic transmission waveguide 4128 and locate the end effector assembly 4112 in the proper orientation during a surgical procedure. Accordingly, in various forms, the ultrasonic hand piece 4114 may be electrically coupled at one or more points to the electrical power control operations provided by the handle assembly 4102. For example, in certain forms, the surgical instrument may comprise a rotatable electrical connection allowing the electrical power control operations provided by the handle assembly 4102 to electrically communicate with the generator 4116 via the ultrasonic hand piece 4114. That is, in one form, the handle assembly 4102 and the ultrasonic hand piece 4114 are electrically coupled via a rotatable electrical connection of a connector module 4190.
In the illustrated form, the control or user interface circuit comprises the flex circuit 4202. For example, the rotatable electrical connection may comprise an electrical communication or conductive path along which electrical control operating instructions or signals provided by a user at a user interface, e.g., via the switch assembly 4108, may be electrically coupled to the generator 4116, e.g., via the ultrasonic hand piece 4114. Accordingly, the electrical control operating instructions or signals may be received by the generator 4116, which may respond by altering power delivery to the ultrasonic hand piece 4114 to control the operation of the instrument 4100. Further to the above, the switch assembly 4108 may comprise or be electrically coupled to the flex circuit 4202, which in turn may be configured to provide an electro-mechanical interface between the switches 4132a, 4132b and the generator 4116 via the hand piece 4114. For example, the flex circuit 4202 may comprise one or more switch points 4202a, 4202b configured for mechanical actuation via the toggle switches 4132a, 4132b. In one form, the flex circuit 4202 may comprise electrical contact switches, such as dome switches, that may be depressed to provide an electrical signal to the generator 4116. The flex circuit 4202 may comprise one or more conductors, such as conductive pathways, shown generally as 4211, which may be provided by wires, traces, or other conductive pathways as is known to those in the art. The conductive pathways may electrically couple to one or more switch conductors or ring conductors 4212, 4214, as shown in the exploded view of the connector module 4200 in
The connector module 4200 comprises an outer ring conductor 4212 and an inner ring conductor 4214. The outer ring conductor 4212 and the inner ring conductor 4214 each define a generally open-ended O-shaped structure and are configured for relative rotation with respect to the hand piece 4114. Each of the outer and inner ring conductors 4212, 4214 may further comprise a conductive connection, e.g., a lead 4216, 4218, that may be electrically coupled to the flex circuit 4202 via one or more conductive pathways 4211, thereby providing a conductive path to the connector module 4200 for rotatable electrical communication to the generator 4116 via the hand piece 4114. Accordingly, a control circuit may be established wherein the connector module 4200 provides a rotatable electrical connection between the user interface, e.g., switch assembly 4108, and the hand piece 4114.
Referring generally to
Further to the above, in various forms, the links 4220, 4220a, 4220a may be rotatable relative to a respective ring conductor 4212, 4214. The ring conductor contacts 4224a, 4224b, 4226a, 4226b may be positioned to rotate about or along a surface of the ring conductors 4212, 4214 when the hand piece 4114 rotates with relative to the housing 4206. In one form, the ring conductors 4212, 4214 comprise arcuate surfaces or tracks about which the ring conductor contacts 4224a, 4224b, 4226a, 4226b may rotationally contact through an arcuate rotation extending from or between a first position and a second position. For example, in some forms, the ring conductor contacts 4224a, 4224b, 4226a, 4226b may comprise pressure contacts configured for pressure contact with a respective ring conductor 4212, 4214 along an arcuate conductive path. In one form, one or more links 4220, 4222a, 4222b comprise a tensioning member, such as a spring arm 4236a, 4236b, 4238a, 4238b, to tension or bias one or more ring conductor contacts 4224a, 4224b, 4226a, 4226b toward a ring conductor 4212, 4214 to maintain electrical coupling with respect to the ring conductor 4212, 4214 when the link 4220, 4222a, 4222b rotates relative to the ring conductor 4212, 4214. In certain forms, the ring conductor contacts 4224a, 4224b, 4226a, 4226b may be biased against an inner or outer surface of the ring conductor 4212, 4214 such that the ring conductor may electrically couple the link 4220, 4222a, 4222b with the ring conductor 4212, 4214 along one or more portions of an arcuate motion associated with the ultrasonic hand piece and/or a corresponding link 4220, 4222a, 4222b. In other forms, for example, the link 4212, 4214 may comprise a ring conductor contact 4224a, 4224b, 4226a, 4226b that may be engageable with the ring conductor 4212, 4214 along a conductive path via a hooked or looped portion about or around the ring conductor 4212, 4214.
Referring generally to
The outer link may comprise a pair of ring conductor contacts 4224a, 4224b that may be coupled to spring arms 4236a, 4236b to bias the contacts 4224a, 4224b toward an inner surface of the outer ring 4212. In one form, the inner link 4214 comprises a pair of ring conductor contacts 4226a, 4226b attached to spring arms 4238a, 4238b structured to bias the contacts 4226a, 4226b toward an outer surface of the inner ring 4214. The inner link 4222a, 4222b comprises a first portion 4222a and second portion 4222b, however, in certain forms, the inner link 4222a, 4222b may comprise a unitary structure. For example, the inner link 4222a, 4222b may comprise a conductive or non-conductive body portion extending between the pair of ring conductor contacts 4226a, 4226b.
As introduced above, in various forms, a connector module 4202 comprises one or more links 4220, 4222a, 4222b positioned to rotate relative to a handle assembly, a housing 4206, a user interface 4108, a trigger 4120, and or a conductive path associated with a ring conductor 4212, 4214 (see
In one form, the outer link 4220 comprises a pair of outer hand piece coupling contacts 4228a, 4228b electrically coupled with the pair of outer ring contacts 4224a, 4224b to provide an electrical conductive path from the distal portion of the hand piece to the outer ring conductor 4212. Each of the pair of hand piece coupling contacts 4228a, 4228b is structured to extend through a respective slot 4246a, 4246b defined in the rotation coupling 4210. As explained in more detail below, the rotation coupling 4210 may be configured to couple with the rotation of the ultrasonic hand piece 4114. For example, in various forms, the rotation coupling 4210 is configured to provide a rotatable framework to couple the rotation of the ultrasonic hand piece 4114 to the links 4220, 4222a, 4222b.
The pair of hand piece coupling contacts 4228, 4228b illustrated in
In one form, the inner link 4222a, 4222b comprises a pair of inner hand piece coupling contacts 4230a, 4230b electrically coupled to the pair of inner ring conductor contacts 4226a, 4226b to provide an electrical conductive path from the ultrasonic hand piece 4114 to the inner ring conductor 4214. The pair of outer hand piece coupling contacts 4230a, 4230b are each structured to extend through a slot 4254a, 4254b defined in the rotation coupling 4210 and comprise curved extensions defining edges structured to engage and electrically couple to one or more electrical contacts disposed along a second distal surface 4234a, 4234b of the distal portion 4204 of the ultrasonic hand piece 4114. As illustrated, the curved extensions may operate to at least partially assist in coupling the rotation of the ultrasonic hand piece 4114 (
In various forms, the distal portion 4204 of the ultrasonic hand piece 4114 may comprise one or more distal contact surfaces 4232a, 4232b, 4234a, 4234b, shown generally in the hatched isolation window of
In one form, the hand piece 4114 may comprise distal contact surfaces 4232a, 4232b, 4234a, 4234b disposed on or within a distal rim 4205 positioned along the distal portion 4204 of the hand piece 4114. The distal rim 4205 may define one or grooves defining the distal contact surfaces 4232a, 4232b, 4234a, 4234b comprising one or more electrical contacts or contact surfaces. The contact surfaces may comprise, for example, gold plating or other suitable conductive electrical contact material known in the art. In one form, this distal rim 4205 may define longitudinal or circumferential grooves dimensioned to complement or receive a hand piece coupling contact 4228a, 4228b, 4230a, 4230b. For example the distal rim 4205 may define one or more grooves along the distal contact surfaces 4232a, 4232b, 4234a, 4234b to fittably engage a respective hand piece coupling contact 4228a, 4228b, 4230a, 4230b such that the distal contact surfaces 4232a, 4232b, 4234a, 4234b and respective hand piece coupling contacts 4228a, 4228b, 4230a, 4230b may frictionally, electrically, and rotationally coupled when the connector module 4200 receives the hand piece 4114. In one form, the distal contact surfaces 4232a, 4232b, 4234a, 4234b and the respective hand piece coupling contacts 4228a, 4228b, 4230a, 4230b may couple in a male-female or lock-and-key relationship. In certain forms, the distal contact surfaces 4232a, 4232b, 4234a, 4234b comprise on or more circumferential ridges extending about an inner circumference of the distal rim 4205 to electrically couple with respective hand piece coupling contacts 4228a, 4228b, 4230a, 4230b along all or part of the circumferential ridges. In various forms, the distal contact surfaces 4232a, 4232b, 4234a, 4234b comprise gold plated circumferential electrical contacts disposed on the circumferential ridges within the inner surface of the distal rim 4205, as shown in
The distal contact surfaces 4232a, 4232b, 4234a, 4234b may be electrically coupled to the generator 4116 via leads extending through the hand piece 4114 and wire 4118 to communicating electrical control signals from the user interface, e.g., the switch assembly 4108, to control an operation of the ultrasonic surgical instrument 4100. Accordingly, in one form, the flex circuit 4202 may be configured to interface with the switches 4132a, 4132b and to provide electrical signals along the conductive pathways 4211 to the conductive leads 4216, 4218, which in turn provide electrical connection to the links 4220, 4222a, 4222b via the ring conductors 4212, 4214, which in turn electrically couple, via the hand piece coupling contacts 4228a, 4228b, 4230a, 4230b, to distal contact surfaces 4232a, 4232b, 4234a, 4234b disposed at the distal portion of the ultrasonic hand piece 4114 to provide a conductive path to the generator 4116 via the ultrasonic hand piece 4114 a cable 4118.
According to various forms, the connector module 4202 comprises a spindle 4240. The spindle may extend from the housing 606 along the longitudinal axis “T” and may define a central bore 4210 along the longitudinal axis “T” dimensioned to receive a length of the hand piece 4114 and/or waveguide 4128 therethrough. As shown in
The rotation coupling further defines a bore 4294 dimensioned to be mounted about the spindle 4240. A proximal inner circumferential surface 4296a of the rotation coupling defines a portion of the bore 4294 that comprises a decreased diameter relative to a more distal inner circumferential surface that defines slot 4296b. The decreased diameter of the proximal inner circumferential surface defining slot 4296a may reduce rotational friction about the spindle 4240 and may provide additional space for components, such as ring conductors 4212, 4214 and links 4220, 4222a, 4222b, to be positioned about the spindle 4240 within the rotational coupling 4210. The rotational coupling 4210 further includes a proximal outer circumferential surface 4298a comprising a decreased diameter relative to a distal outer circumferential surface 4298b. The decreased diameter of the distal outer circumferential surface 4298a may provide additional space for components, such as ring conductors 4212, 4214 and links 4220, 4222a, 4222b, to be positioned about the spindle 4240 within the rotational coupling 4210. It is to be appreciated that additional ring conductors and links may be provided to, for example, provide additional rotatable electrical connections.
The switch assembly 4300 includes a pair of outer hand piece coupling contacts 4328, 4328b comprising pressure contacts structured to electrically couple to one or more electrical contacts disposed along a first distal surface 4332a, 4332b of the of the ultrasonic hand piece. The outer hand piece coupling contacts 4328a, 4328b may extend from tensioning members or spring arms 4348a, 4348b (see
In one form, the switch assembly 4300 includes a pair of inner hand piece coupling contacts 4330a, 4330b comprising pressure contacts structured to electrically couple to one or more electrical contacts disposed along a second distal surface 4334a, 4334b of the of the ultrasonic hand piece. The inner hand piece coupling contacts 4330a, 4330b may extend from tensioning members or spring arms 4358a, 4358b (see
As shown most clearly in
The outer link 4312 comprises a pair of ring conductor contacts 4324a, 4324b coupled to spring arms 4336a, 4336b structured to bias the contacts 4324a, 4324b toward an inner surface of the outer ring 4312. The pair of outer hand piece coupling contacts 4328a, 4328b electrically coupled with the pair of outer ring contacts 4324a, 4324b to provide an electrical conductive path from the distal portion 4304 of the hand piece to the outer ring. The inner link 4314 comprises a pair of ring conductor contacts 4326a, 4326b electrically coupled to the pair of hand piece coupling contacts 4320a, 4320b and are attached to spring arms 4338a, 4338b structured to bias the ring conductor contacts 4326a, 4326b toward an outer surface of the inner ring 4314. The inner link 4322a, 4322b comprises a first portion 4322a and second portion 4322b.
The rotation coupling 4310 forms a central bore 4394 defined by a proximal rotation surface 4396a and a distal slot 4396b. The rotation coupling 4310 comprises a plurality of slots dimensioned to receive the ring conductors 4312, 4314 and corresponding links 4320, 4322a, 4322b. The slot configuration shown in
In at least one form, the handle assembly 5000 may comprise two handle housing segments that are configured to be coupled together to form a handle housing 5002. For example, a left handle housing segment 5004 is shown in
As indicated above, the handle assembly 5000 includes a switch assembly 5020 that may include a first switch arrangement 5030 and a second switch arrangement 5060. In at least one form, the first switch 5030 includes a first button assembly 5032 that is supported for pivotal travel relative to a “forward portion” 5003 of the handle housing 5002. The first button assembly 5032 may be formed from, for example, a polymer or other suitable material and include a first finger button 5034 and a second finger button 5036 that are interconnected by a journal portion 5038. The journal portion 5038 serves to pivotally support the first button assembly 5032 on a first pivot pin 5040 that extends between the left and right housing segments 5004, 5006. The first pivot pin 5040 may be molded into one of the housing segments 5004, 5006 and be received in a corresponding socket (not shown) formed in the other housing segment 5004, 5006. The first pivot pin 5040 may be attached to the handle housing segments 5004, 5006, by other means as well. The first pivot pin 5040 defines a first switch axis FS-FS about which the first button assembly 5032 may be “rocked”. See
As can be seen in
In some forms, the first switch arrangement 5030 is coupled to a generator, such as any of the generators 30, 500, 1002. For example, the respective contact pads 5054, 5056 may be in electrical communication with the generator via a connector module 5057, which, in some forms, is similar to the connector module 4200 described herein above. The connector module 5057 is coupled to an internal or external generator. Signals indicating activation of the respective contact pads 5054, 5056 may cause the generator to modify the operation of the instrument 5000. For example, when the clinician selects the first finger button 5034, it may cause the generator to increase the level of power provided to the end effector. When the clinician selects the second finger button 5036, it may cause the generator to decrease the level of power provided to the end effector. In various embodiments, the generator may be configurable between a minimum power level (e.g., MIN) and maximum power level (e.g., MAX). For example, some forms of the GEN11 generator available from Ethicon Endo-Surgery, Inc. of Cincinnati Ohio provide five power levels. The finger buttons may be used to toggle the generator among the power levels. Also, in some forms, one or both of the finger buttons 5034, 5036 may be associated with an algorithm, such as those described herein. For example, when the user selects one of the buttons 5034, the generator may execute an algorithm, such as, for example, one or more of algorithms 3021, 3021′, 3021″, 3120, 3170 any of the algorithms described with respect to
In various forms, the switch assembly 5020 also includes a second switch arrangement 5060. Referring to
In at least one form, the right and left buttons 5062 and 5066 may have a general “barrel-shape” to facilitate ease of actuation by the clinician's thumb and/or finger. This ease of actuation is further enhanced by the fact that the right and left buttons 5062, 5066 are strategically located in the general thumb groove areas associated with each handle housing segment. For example, if the clinician is holding the pistol grip 5008 in his or her right hand, the clinician may activate the right switch button 5062 by sweeping his or her right thumb down across the right switch button 5062 in a contacting sweeping motion. Similarly, if the clinician was holding the pistol grip 5008 in his or her left hand, he or she may activate the left switch button 5066 by sweeping her left thumb down across the left switch button 5066 in a contacting sweeping motion. Such unique and novel switch arrangements enable activation of the left and right switch buttons 5062, 5066 by avoiding inadvertent activation from direct inward forces to the switch buttons.
As can be seen in
Still referring to
In at least one form, the right switch button 5462 has a right link 5480 extending therefrom which is pivotally coupled to the switch frame 5450. Likewise, the left switch button has a left link 5470 extending therefrom to be pivotally coupled to the switch frame 5460. The right and left links 5480, 5470 may be pivoted to the switch frame 5450 by a common pin (not shown) to define the switch axis SA about which the buttons 5462 and 5466 may pivot. A right actuation pin or lug 5482 extends inwardly from the right switch link 5480 such that when clinician rocks or pivots the right switch button 5462 in a manner described above, the right actuation pin 5482 is brought into actuation contact with the corresponding right contact pad 5458 supported on the switch frame 5450. Likewise, a left actuation pin or lug 5472 extends inwardly from the left switch link 5470 such that when the clinician rocks or pivots the left switch button 5466 in a manner described above, the left actuation pin 5472 is brought into actuation contact with the corresponding left contact pad 5459 on the switch frame 5450. Each of the switch arms 5470 and 5480 may be biased into unactuated positions by corresponding springs or biasing arrangements (not shown) positioned, for example, between switch link 5470, 5480 and the frame 5450.
A right biasing member 5590 and a left biasing member 5592 may be positioned within the second switch actuator 5561 and configured to cooperate with a centrally disposed portion of the switch frame 5550 to keep the second switch actuator 5561 centrally disposed in an unactuated position as shown in
In at least one form, the button carriage arm 5633 may include a pair of pivot pins 5637, 5639 that are movably received within an elongate slot 5671 in a switch housing 5670 that is operably supported within the handle housing. The button pivot pins 5637, 5639 facilitate axial movement of the button carriage arm 5633 (
Operation of the switch assembly 5620 may be understood from reference to
Different clinicians often have different techniques for using ultrasonic surgical instruments and systems as described herein. For example, some clinicians routinely activate an ultrasonic surgical instrument without fully closing the clamp arm against the blade. Although some clinicians believe that this technique improves system performance, in practice it often does not and has the potential to damage tissue, for example, by requiring longer transection times and sometimes causing transection and/or coagulation to be compromised.
In various forms, this and other problems may be addressed by configuring a surgical instrument with a closure switch indicating when the clamp arm is fully closed. The generator may be configured to refrain from activating the surgical instrument until or unless the closure switch indicates that the clamp arm is fully closed. Referring now to
The switch 5900 may be positioned such that the trigger 4124 contacts the switch 5900 at its proximal-most position. For example, the switch 5900 may be positioned at an end of the stroke of the trigger 4124 (e.g., in the direction of arrow 4121a in
The encoded transmission frame, which is described in detail hereinbelow in connection with
The instrument 6004 comprises a circuit 6006, which may include at least one switch that, in conjunction with the generator 6002, supports activation switch inputs and instrument EEPROMs. The circuit 6006 may be provided within the instrument (as shown above with respect to data circuits 2006, 2007. In some embodiments, the circuit 6006 may be positioned on the hand piece, such as hand piece 1014 and may provide the generator with hand piece specific data such as, for example, a current set point, a gain, etc. The instruments 6004 provides various I/O capabilities and may employ a plurality of switch inputs, analog inputs as well as discrete outputs, analog outputs. In order to implement the functionality of the plurality of switch inputs and outputs, the circuit 6006 communicates with the generator 6002 using a novel serial communication protocol, the timing diagrams of which are illustrated in connection with
Forms of the generator 6002 may enable communication with one or more circuits 6006 contained in the instrument 6004. In certain forms, the circuit 6006 may generally be any circuit for transmitting and/or receiving data. In one form, for example, the circuit 6006 may store information pertaining to the particular surgical instrument 6004 with which it is associated. Such information may include, for example, a model number, a serial number, a number of operations in which the surgical instrument has been used, and/or any other type of information. Additionally or alternatively, any type of information may be communicated to circuit 6006 for storage therein. Such information may comprise, for example, an updated number of operations in which the instrument 6004 has been used and/or dates and/or times of its usage. In certain forms, the circuit 6006 may transmit data acquired by one or more sensors (e.g., an instrument-based temperature sensor). In certain forms, the circuit 6006 may receive data from the generator 6002 and provide an indication to a user (e.g., an LED, power switch information, and audible and/or visible indication) based on the received data.
In certain forms, the circuit 6006 may be configured such that communication between instrument 6004 and the generator 6002 can be effected without the need to provide additional conductors for this purpose (e.g., dedicated conductors of a cable connecting a hand piece to the generator 6002). In one form, for example, information may be communicated to and from the circuit using a 1-wire bus communication scheme implemented on existing cabling, such as one of the conductors used to transmit interrogation signals from the signal conditioning circuit to the circuit 6006 in the instrument. In this way, design changes or modifications to the instrument 6004 that might otherwise be necessary are minimized or reduced. Moreover, because different types of communications can be implemented over a common physical channel (either with or without frequency-band separation), the presence of the circuit 6004 may be “invisible” to the generators that do not have the requisite data reading functionality, thus enabling backward compatibility of the instrument 6004.
The generator 6002 may exchange information with the circuit 6006 that is specific to a surgical device integral with, or configured for use with, the cable 6008 and may comprise, for example, a model number, a serial number, a number of operations in which the surgical device has been used, and/or any other type of information. Information may also be communicated from the generator 6002 to the circuit 6006 for storage therein. In one form, the circuit 6006 need not be located on or in the instrument 6004, but may be disposed in an adaptor for interfacing a specific instrument 6004 type or model with the generator 6002.
The controller 6014 may be an application specific integrated circuit (ASIC), a microcontroller comprising a processor and memory, a digital signal processing circuit, a programmable logic device, field programmable gate array, discrete circuit, and the like. The controller comprises a plurality of inputs S0 to Sn, where n is a suitable integer. As illustrated in
The controller 6014 also comprises a plurality of outputs O0 to Om, where m is any suitable integer, and may be the same as n. The outputs O0 to Om are driven by the controller 6014 to control functions associated with the instrument 6004 in accordance with information communicated by the generator 6002.
In various forms, the circuit 6006 also may comprise one or more data circuits 6016, 6018 that communicate over a 1-wire protocol. In certain forms, the data circuits 6016, 6018 include storage elements that may be a single-wire bus device (e.g., a single-wire protocol EEPROM), or other single-wire protocol or local interconnect network (LIN) protocol device. In one form, for example, the data storage element 302 may comprise a single wire EEPROM. The data storage element is one example of a circuit element that may be contained in the data circuits 6016, 6018. The data circuit may additionally or alternatively comprise one or more other circuit elements or components capable of transmitting or receiving data. Such circuit elements or components may be configured to, for example, transmit data acquired by one or more sensors (e.g., an instrument-based temperature sensor) and/or receive data from the generator 6002 and provide an indication to a user (e.g., an LED indication or other visible indication) based on the received data.
During operation, the generator 6002 and the circuit 6006 communicate over a robust, flexible, highly noise-immune communications protocol according to the present disclosure. The protocol is used over the two instrument conductive elements 6010, 6012 (HS, HSR) to allow the generator 6002 to communicate up to 8 or more discrete inputs and outputs to the instrument 6004, while coexisting on the same lines as the 1-Wire EEPROM (e.g., data circuits 6016, 6018) communications, and maintaining backward compatibility with existing legacy circuits. The protocol comprises a frame that is repeatedly transmitted. The frame comprises overhead pulses (bits) such as start/stop and header pulses and simultaneously encoded information pulses (bits) that encode both input and output information into a single pulse (bit) by modulating both the amplitude and width (pulse duration) of each information pulse.
One form of such a protocol is illustrated in connection with
The frame information pulses are simultaneously encoded both in regards to width and amplitude. The width of the start/stop pulses 6204a, 6024b is to. The current pulses following the start pulse 6024a are header pulses represent header pulses 6026, 6028 and also have a pulse width t0. In the context of encoding output pulses carrying information from the generator 6002 to the instrument 6004, the information pulses 6025 are encode as a logic “1” output pulse 6030 by increasing the pulse to width to t1 whereas a logic “0” output pulse 6032 may have the same pulse width t0 as the start pulse 6024 the header pulses 6026, 6028. Output logic “1” maps to the output active state, where the instrument 6004 is drawing power from the generator 6002. As previously discussed, a frame is initiated with the rising edge 6023a of the start current pulse 6024 by short circuiting the first conductive element 6010 (HS) to the second conductive element 6012 (SR), which are the power and signal lines connecting the generator 6002 with the instrument 6004.
With reference now to the timing diagrams 6020, 6022 shown in
The information pulses 6044 are encoded to carry information about both input and output. Accordingly, each information pulse 6044 defines a first logic state associated with an input from the instrument 6004 to the generator 6002 as well as a second logic state associated with an output from the generator 6002 to the instrument 6002. The simultaneous encoding of I/O signals is discussed in more detail in connection with
With reference back to
The number of I/O pulses per frame may be the greater of the number of used inputs or outputs for a given instrument 6004 or may be a fixed number. Although the maximum number of both inputs and outputs is a predetermined number, for example 8 (16 total), unused inputs and outputs for a given instrument 6004 may or may not be implemented or pinned out. Unused inputs (if there are more outputs than inputs) can be set by the circuit 6006 to logic “0”. Unused outputs can be set by the generator 6002 to logic state “0” or “1” as appropriate, to optimize either polling speed or energy transfer to the circuit 6006. The circuit 6006 will store energy from the negative pulses to power both its own circuitry, and any output devices (e.g., LEDs, switches, power switches including transistors, feedback devices, e.g., audio, visual, tactile). EEPROM 6016, 6018 communications will occur on the positive voltage side of the signal.
Turning to the legend 6054 below the timing diagram 6022, it can be seen that each information pulse 6044 has two possible input logic states (input logic “1” and input logic “0”) indicated by two negative voltage levels −V1, −V0, and two possible output logic states (output logic “1” and output logic “0”) indicated by two pulse width t1, t0. Accordingly, if a switch (SW0-SWn) closure occurs, the next information pulse drops to the input logic “1” state −V1 and if a switch (SW0-SWn) remains open the next information pulse drops to the input logic “0” state −V0. At the same time interval, if the instrument 6004 is drawing power from the generator 6002, the output logic “1” pulse width is t1, and if instrument 6004 is not drawing power from the generator 6002, the output logic “0” pulse width is t0.
As indicated in the timing diagram 6022, the pulse width of the reset pulse 6034, the header pulses 6040, 6042, the output logic “0” pulses, and the return to zero pulses 6048 each have pulse widths of t0. Only the output logic “1” pulses have a pulse width of t1, where t0<t1. It will be appreciated that the specific voltage levels and pulse widths illustrated herein may be selected otherwise such that −V1<−V2 and t0>t1. Also, the reset pulse 6034, the header pulses 6040, 6042, the output logic “0” pulses, and the return to zero pulses 6048 each may have different pulse widths.
As illustrated in
As shown in
As shown in
While various details have been set forth in the foregoing description, it will be appreciated that the various aspects of the serial communication protocol for medical device may be practiced without these specific details. For example, for conciseness and clarity selected aspects have been shown in block diagram form rather than in detail. Some portions of the detailed descriptions provided herein may be presented in terms of instructions that operate on data that is stored in a computer memory. Such descriptions and representations are used by those skilled in the art to describe and convey the substance of their work to others skilled in the art. In general, an algorithm refers to a self-consistent sequence of steps leading to a desired result, where a “step” refers to a manipulation of physical quantities which may, though need not necessarily, take the form of electrical or magnetic signals capable of being stored, transferred, combined, compared, and otherwise manipulated. It is common usage to refer to these signals as bits, values, elements, symbols, characters, terms, numbers, or the like. These and similar terms may be associated with the appropriate physical quantities and are merely convenient labels applied to these quantities.
Unless specifically stated otherwise as apparent from the foregoing discussion, it is appreciated that, throughout the foregoing description, discussions using terms such as “processing” or “computing” or “calculating” or “determining” or “displaying” or the like, refer to the action and processes of a computer system, or similar electronic computing device, that manipulates and transforms data represented as physical (electronic) quantities within the computer system's registers and memories into other data similarly represented as physical quantities within the computer system memories or registers or other such information storage, transmission or display devices.
It is worthy to note that any reference to “one aspect,” “an aspect,” “one form,” or “an form” means that a particular feature, structure, or characteristic described in connection with the aspect is included in at least one aspect. Thus, appearances of the phrases “in one aspect,” “in an aspect,” “in one form,” or “in an form” in various places throughout the specification are not necessarily all referring to the same aspect. Furthermore, the particular features, structures or characteristics may be combined in any suitable manner in one or more aspects.
Some aspects may be described using the expression “coupled” and “connected” along with their derivatives. It should be understood that these terms are not intended as synonyms for each other. For example, some aspects may be described using the term “connected” to indicate that two or more elements are in direct physical or electrical contact with each other. In another example, some aspects may be described using the term “coupled” to indicate that two or more elements are in direct physical or electrical contact. The term “coupled,” however, also may mean that two or more elements are not in direct contact with each other, but yet still co-operate or interact with each other.
It is worthy to note that any reference to “one aspect,” “an aspect,” “one form,” or “an form” means that a particular feature, structure, or characteristic described in connection with the aspect is included in at least one aspect. Thus, appearances of the phrases “in one aspect,” “in an aspect,” “in one form,” or “in an form” in various places throughout the specification are not necessarily all referring to the same aspect. Furthermore, the particular features, structures or characteristics may be combined in any suitable manner in one or more aspects.
Although various forms have been described herein, many modifications, variations, substitutions, changes, and equivalents to those forms may be implemented and will occur to those skilled in the art. Also, where materials are disclosed for certain components, other materials may be used. It is therefore to be understood that the foregoing description and the appended claims are intended to cover all such modifications and variations as falling within the scope of the disclosed forms. The following claims are intended to cover all such modification and variations.
In a general sense, those skilled in the art will recognize that the various aspects described herein which can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or any combination thereof can be viewed as being composed of various types of “electrical circuitry.” Consequently, as used herein “electrical circuitry” includes, but is not limited to, electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g., a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein), electrical circuitry forming a memory device (e.g., forms of random access memory), and/or electrical circuitry forming a communications device (e.g., a modem, communications switch, or optical-electrical equipment). Those having skill in the art will recognize that the subject matter described herein may be implemented in an analog or digital fashion or some combination thereof.
The foregoing detailed description has set forth various forms of the devices and/or processes via the use of block diagrams, flowcharts, and/or examples. Insofar as such block diagrams, flowcharts, and/or examples contain one or more functions and/or operations, it will be understood by those within the art that each function and/or operation within such block diagrams, flowcharts, or examples can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or virtually any combination thereof. In one form, several portions of the subject matter described herein may be implemented via Application Specific Integrated Circuits (ASICs), Field Programmable Gate Arrays (FPGAs), digital signal processors (DSPs), or other integrated formats. However, those skilled in the art will recognize that some aspects of the forms disclosed herein, in whole or in part, can be equivalently implemented in integrated circuits, as one or more computer programs running on one or more computers (e.g., as one or more programs running on one or more computer systems), as one or more programs running on one or more processors (e.g., as one or more programs running on one or more microprocessors), as firmware, or as virtually any combination thereof, and that designing the circuitry and/or writing the code for the software and or firmware would be well within the skill of one of skill in the art in light of this disclosure. In addition, those skilled in the art will appreciate that the mechanisms of the subject matter described herein are capable of being distributed as a program product in a variety of forms, and that an illustrative form of the subject matter described herein applies regardless of the particular type of signal bearing medium used to actually carry out the distribution. Examples of a signal bearing medium include, but are not limited to, the following: a recordable type medium such as a floppy disk, a hard disk drive, a Compact Disc (CD), a Digital Video Disk (DVD), a digital tape, a computer memory, etc.; and a transmission type medium such as a digital and/or an analog communication medium (e.g., a fiber optic cable, a waveguide, a wired communications link, a wireless communication link (e.g., transmitter, receiver, transmission logic, reception logic, etc.), etc.).
All of the above-mentioned U.S. patents, U.S. patent application publications, U.S. patent applications, foreign patents, foreign patent applications, non-patent publications referred to in this specification and/or listed in any Application Data Sheet, or any other disclosure material are incorporated herein by reference, to the extent not inconsistent herewith. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.
One skilled in the art will recognize that the herein described components (e.g., operations), devices, objects, and the discussion accompanying them are used as examples for the sake of conceptual clarity and that various configuration modifications are contemplated. Consequently, as used herein, the specific exemplars set forth and the accompanying discussion are intended to be representative of their more general classes. In general, use of any specific exemplar is intended to be representative of its class, and the non-inclusion of specific components (e.g., operations), devices, and objects should not be taken limiting.
With respect to the use of substantially any plural and/or singular terms herein, those having skill in the art can translate from the plural to the singular and/or from the singular to the plural as is appropriate to the context and/or application. The various singular/plural permutations are not expressly set forth herein for sake of clarity.
The herein described subject matter sometimes illustrates different components contained within, or connected with, different other components. It is to be understood that such depicted architectures are merely exemplary, and that in fact many other architectures may be implemented which achieve the same functionality. In a conceptual sense, any arrangement of components to achieve the same functionality is effectively “associated” such that the desired functionality is achieved. Hence, any two components herein combined to achieve a particular functionality can be seen as “associated with” each other such that the desired functionality is achieved, irrespective of architectures or intermedial components. Likewise, any two components so associated can also be viewed as being “operably connected,” or “operably coupled,” to each other to achieve the desired functionality, and any two components capable of being so associated can also be viewed as being “operably couplable,” to each other to achieve the desired functionality. Specific examples of operably couplable include but are not limited to physically mateable and/or physically interacting components, and/or wirelessly interactable, and/or wirelessly interacting components, and/or logically interacting, and/or logically interactable components.
In some instances, one or more components may be referred to herein as “configured to,” “configurable to,” “operable/operative to,” “adapted/adaptable,” “able to,” “conformable/conformed to,” etc. Those skilled in the art will recognize that “configured to” can generally encompass active-state components and/or inactive-state components and/or standby-state components, unless context requires otherwise.
While particular aspects of the present subject matter described herein have been shown and described, it will be apparent to those skilled in the art that, based upon the teachings herein, changes and modifications may be made without departing from the subject matter described herein and its broader aspects and, therefore, the appended claims are to encompass within their scope all such changes and modifications as are within the true spirit and scope of the subject matter described herein. It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to claims containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations.
In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). It will be further understood by those within the art that typically a disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms unless context dictates otherwise. For example, the phrase “A or B” will be typically understood to include the possibilities of “A” or “B” or “A and B.”
With respect to the appended claims, those skilled in the art will appreciate that recited operations therein may generally be performed in any order. Also, although various operational flows are presented in a sequence(s), it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently. Examples of such alternate orderings may include overlapping, interleaved, interrupted, reordered, incremental, preparatory, supplemental, simultaneous, reverse, or other variant orderings, unless context dictates otherwise. Furthermore, terms like “responsive to,” “related to,” or other past-tense adjectives are generally not intended to exclude such variants, unless context dictates otherwise.
In certain cases, use of a system or method may occur in a territory even if components are located outside the territory. For example, in a distributed computing context, use of a distributed computing system may occur in a territory even though parts of the system may be located outside of the territory (e.g., relay, server, processor, signal-bearing medium, transmitting computer, receiving computer, etc. located outside the territory).
A sale of a system or method may likewise occur in a territory even if components of the system or method are located and/or used outside the territory. Further, implementation of at least part of a system for performing a method in one territory does not preclude use of the system in another territory.
Although various forms have been described herein, many modifications, variations, substitutions, changes, and equivalents to those forms may be implemented and will occur to those skilled in the art. Also, where materials are disclosed for certain components, other materials may be used. It is therefore to be understood that the foregoing description and the appended claims are intended to cover all such modifications and variations as falling within the scope of the disclosed forms. The following claims are intended to cover all such modification and variations.
In summary, numerous benefits have been described which result from employing the concepts described herein. The foregoing description of the one or more forms has been presented for purposes of illustration and description. It is not intended to be exhaustive or limiting to the precise form disclosed. Modifications or variations are possible in light of the above teachings. The one or more forms were chosen and described in order to illustrate principles and practical application to thereby enable one of ordinary skill in the art to utilize the various forms and with various modifications as are suited to the particular use contemplated. It is intended that the claims submitted herewith define the overall scope.
In one general aspect, a surgical instrument assembly embodying the principles of the described forms is configured to permit selective dissection, cutting, coagulation, and clamping of tissue during surgical procedures. A generator may generate at least one electrical signal, which may be monitored against a first set of logic conditions. When the first set of logic conditions is met, a first response of the generator may be triggered.
In certain forms, ultrasonic impedance of the surgical instrument is monitored. When the ultrasonic impedance of the surgical instrument exceeds a threshold impedance, a resonant frequency of the at least one electrical signal may be stored as a baseline frequency. Also, the first response of the generator may be triggered when either the first set of logic conditions is met or the resonant frequency of the at least one electrical signal differs from the baseline frequency by a baseline deviation threshold.
In certain forms, load events at an end effector of the surgical instrument may be monitored. The first response of the generator may be triggered when the first set of logic conditions is met and a load event is detected.
In accordance with one general form, there is provided a switch assembly for an ultrasonic surgical instrument that includes a handle housing that is configured to be supported in one hand. In at least one form, the switch assembly comprises a first switch arrangement that is operably supported on a forward portion of the handle housing and is selectively movable relative to at least one first switch contact. The switch assembly further comprises a second switch arrangement that may comprise at least one of a right switch button and a left switch button. The right switch button may be movably supported on a right side of the handle housing and be selectively movable relative to at least one right switch contact supported by the handle housing. The left switch button may be movably supported on a left side of the handle housing and be selectively movable relative to at least one left switch contact supported by the handle housing. The first and second switch arrangements may be configured to be selectively operated by a single hand supporting the handle housing.
In accordance with at least one other general form, there is provided an ultrasonic surgical instrument. In at least one form, the ultrasonic surgical instrument comprises a generator for generating ultrasonic signals and a handle assembly that includes a handle housing that is configured to be operably supported in one hand. The instrument may further comprise a switch assembly that includes a first switch arrangement that is operably supported on a forward portion of the handle housing and is selectively movable relative to at least one first switch contact that communicates with the generator. The switch assembly may further include a second switch arrangement that comprises at least one of a right switch button and a left switch button. The right switch button may be movably supported on a right side of the handle housing and be selectively movable relative to at least one right switch contact that is supported by the handle housing. The at least one right switch contact may communicate with the generator. The left switch button may be movably supported on a left side of the handle housing and be selectively movable relative to at least one left switch contact that is supported by the handle housing and may operably communicate with the generator. The first and second switch arrangements may be configured to be selectively operated by a single hand supporting the handle housing.
In accordance with still another general form, there is provided a switch assembly for an ultrasonic surgical instrument that includes a handle housing that is configured to be supported in one hand. In at least one form, the switch assembly comprises a button assembly that is movably supported by the handle housing for selective axial and pivotal travel relative to a right switch contact, a central switch contact and a left switch contact such that axial movement of the button assembly in a first direction causes the button assembly to actuate the central switch contact and pivotal movement of the button assembly in a first pivotal direction causes the button assembly to actuate the left switch contact and pivotal movement of the button assembly in a second pivotal direction causes the button assembly to actuate the right switch contact.
According to various forms, the connector module may be a modular component that may be provided as an accessory with the ultrasonic surgical instrument or components thereof but not attached thereto or may be used to repair, replace, or retrofit ultrasonic surgical instruments. In certain forms, however, the connector module may be associated with the handle assembly or the ultrasonic transducer. In one form, the connector module may comprise an assembly that may be easily removed and/or replaced by a user. The connector module may also comprise removable features allowing the user to, for example, remove and/or replace rotation couplings, switch conductors, or links. Accordingly, in certain forms, one or more connector modules may be included in a kit. The kit may comprise various rotation couplings configured for adaptable use with one or more ultrasonic transducers or hand pieces. The kit may include connector modules, rotation couplings, or housings comprising various configurations of user interfaces that may require one, two, or more conductive paths.
In one aspect, the present disclosure is directed to an ultrasonic surgical instrument. The ultrasonic instrument may comprise an end effector, a waveguide extending proximally from the end effector along a longitudinal axis, and a connector module for receiving an ultrasonic hand piece. The connector module may comprise a housing defining a spindle extending along the longitudinal axis, a coupling positioned on the spindle and rotatable relative to the housing, a first conductor mechanically coupled to the housing and extending at least partially around the longitudinal axis, and a first link rotatable about the longitudinal axis relative to the first conductor between a first position and a second position. The first link may comprise a first contact positioned to electrically contact the first conductor when the first link is in the first position and the second position and a second contact electrically coupled to the first contact and positioned to electrically contact the ultrasonic hand piece when the first link is in the first position and the second position.
In one aspect, the first and second conductors each comprise a conductive lead configured to electrically couple to a user interface configured for receiving power control signals from a user. The ultrasonic hand piece may be adapted to electrically couple to a generator and rotationally couple to the first and second links when received by the connector module. The connector module may be configured to electrically couple the user interface circuit and the generator via the ultrasonic hand piece when the first and second links are in respective first and second positions. In one aspect, the user interface comprises a toggle switch operatively coupled to a handle assembly and the connector module is secured to the handle assembly. The ultrasonic hand piece may be rotatable relative to the handle assembly when received by the connector module. In one aspect, the housing electrically isolates the first and second conductors with respect to each other.
Various aspects of the subject matter described herein are directed to an apparatus, comprising a circuit configured to transmit a signal as a serial protocol over a pair of electrical conductors. The serial protocol may be defined as a series of pulses distributed over at least one transmission frame. At least one pulse in the transmission frame is simultaneously encoded by modulating an amplitude of the pulse to represent one of two first logic states and modulating a width of the pulse to represent one of two second logic states.
Various aspects of the subject matter described herein are directed to an instrument, comprising a circuit configured to transmit a signal as a serial protocol over a pair of electrical conductors. The serial protocol may be defined as a series of pulses distributed over at least one transmission frame. At least one pulse in the transmission frame may be simultaneously encoded by modulating an amplitude of the pulse to represent one of two first logic states and modulating a width of the pulse to represent one of two second logic states. The instrument may also comprise an output device coupled to an output of the circuit; and an input device coupled to an input of the circuit.
Various aspects of the subject matter described herein are directed to a generator, comprising a conditioning circuit configured to communicate to an instrument over a two wire interface. The generator may comprises a control circuit configured to transmit a signal as a serial protocol over a pair of electrical conductors. The serial protocol may be defined as a series of pulses distributed over at least one transmission frame. At least one pulse in the transmission frame is simultaneously encoded by modulating an amplitude of the pulse to represent one of two first logic states and modulating a width of the pulse to represent one of two second logic states. The generator may also comprise an energy circuit configured to drive the instrument.
Various aspects are directed to methods of driving an end effector coupled to an ultrasonic drive system of an ultrasonic surgical instrument. A trigger signal may be received. In response to the trigger signal, a first drive signal may be provided to the ultrasonic drive system to drive the end effector at a first power level. The first drive signal may be maintained for a first period. At the end of the first period a second drive signal may be provided to the ultrasonic drive system to drive the end effector at a second power level less than the first power level.
In another aspect, after receiving a trigger signal, a surgical system generates feedback indicating that the ultrasonic surgical instrument is activated while maintaining the ultrasonic instrument in a deactivated state. At an end of the threshold time period, the ultrasonic surgical instrument is activated by providing a drive signal to the ultrasonic drive system to drive the end effector.
In another aspect, the ultrasonic surgical instrument is activated by generating a drive signal provided to the ultrasonic drive system to drive the end effector. A plurality of input variables may be applied to a multi-variable model to generate a multi-variable model output, where the multi-variable model output corresponds to an effect of the ultrasonic instrument on tissue. The plurality of input variables may comprise at least one variable describing the drive signal and at least one variable describing a property of the ultrasonic surgical instrument. When the multi-variable model output reaches a threshold value, feedback may be generated indicating a corresponding state of at least one of the ultrasonic surgical instrument and tissue acted upon by the ultrasonic surgical instrument.
In another aspect, in response to a trigger signal, a first drive signal at a first power level is provided to the ultrasonic drive system to drive the end effector. The first drive signal is maintained at the first level for a first period. A second drive signal is provided to the ultrasonic drive system to drive the end effector at a second power level less than the first power level. A plurality of input variables may be applied to a multi-variable model to generate a multi-variable model output. The multi-variable model output may correspond to an effect of the ultrasonic instrument on tissue, and the plurality of variables may comprise at least one variable describing the drive signal and at least one variable describing a property of the ultrasonic surgical instrument. After the multi-variable model output exceeds a threshold value for a threshold time period, a first response may be triggered.
While several forms have been illustrated and described, it is not the intention of the applicant to restrict or limit the scope of the appended claims to such detail. Numerous variations, changes, and substitutions will occur to those skilled in the art without departing from the scope of the invention. Moreover, the structure of each element associated with the described forms can be alternatively described as a means for providing the function performed by the element. Accordingly, it is intended that the described forms be limited only by the scope of the appended claims.
Reference throughout the specification to “various forms,” “some forms,” “one form,” or “an form” means that a particular feature, structure, or characteristic described in connection with the form is included in at least one form. Thus, appearances of the phrases “in various forms,” “in some forms,” “in one form,” or “in an form” in places throughout the specification are not necessarily all referring to the same form. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more forms. Thus, the particular features, structures, or characteristics illustrated or described in connection with one form may be combined, in whole or in part, with the features structures, or characteristics of one or more other forms without limitation.
This application is a divisional application claiming priority under 35 U.S.C. § 121 to U.S. patent application Ser. No. 15/260,882, entitled SWITCH ARRANGEMENTS FOR ULTRASONIC SURGICAL INSTRUMENTS, filed Sep. 9, 2016, now U.S. Patent Application Publication No. 2016/0374709, which is a divisional application claiming priority under 35 U.S.C. § 121 to U.S. patent application Ser. No. 13/839,093, entitled SWITCH ARRANGEMENTS FOR ULTRASONIC SURGICAL INSTRUMENTS, filed Mar. 15, 2013, now U.S. Pat. No. 9,439,668, which claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 61/621,876, entitled DEVICES AND TECHNIQUES FOR CUTTING AND COAGULATING TISSUE, filed Apr. 9, 2012, the entire disclosures of which are hereby incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
969528 | Disbrow | Sep 1910 | A |
1570025 | Young | Jan 1926 | A |
1813902 | Bovie | Jul 1931 | A |
2188497 | Calva | Jan 1940 | A |
2366274 | Luth et al. | Jan 1945 | A |
2425245 | Johnson | Aug 1947 | A |
2442966 | Wallace | Jun 1948 | A |
2458152 | Eakins | Jan 1949 | A |
2510693 | Green | Jun 1950 | A |
2597564 | Bugg | May 1952 | A |
2704333 | Calosi et al. | Mar 1955 | A |
2736960 | Armstrong | Mar 1956 | A |
2748967 | Roach | Jun 1956 | A |
2845072 | Shafer | Jul 1958 | A |
2849788 | Creek | Sep 1958 | A |
2867039 | Zach | Jan 1959 | A |
2874470 | Richards | Feb 1959 | A |
2990616 | Balamuth et al. | Jul 1961 | A |
RE25033 | Balamuth et al. | Aug 1961 | E |
3015961 | Roney | Jan 1962 | A |
3033407 | Alfons | May 1962 | A |
3053124 | Balamuth et al. | Sep 1962 | A |
3082805 | Royce | Mar 1963 | A |
3166971 | Stoecker | Jan 1965 | A |
3322403 | Murphy | May 1967 | A |
3432691 | Shoh | Mar 1969 | A |
3433226 | Boyd | Mar 1969 | A |
3489930 | Shoh | Jan 1970 | A |
3513848 | Winston et al. | May 1970 | A |
3514856 | Camp et al. | Jun 1970 | A |
3525912 | Wallin | Aug 1970 | A |
3526219 | Balamuth | Sep 1970 | A |
3554198 | Tatoian et al. | Jan 1971 | A |
3580841 | Cadotte et al. | May 1971 | A |
3606682 | Camp et al. | Sep 1971 | A |
3614484 | Shoh | Oct 1971 | A |
3616375 | Inoue | Oct 1971 | A |
3629726 | Popescu | Dec 1971 | A |
3636943 | Balamuth | Jan 1972 | A |
3668486 | Silver | Jun 1972 | A |
3702948 | Balamuth | Nov 1972 | A |
3703651 | Blowers | Nov 1972 | A |
3776238 | Peyman et al. | Dec 1973 | A |
3777760 | Essner | Dec 1973 | A |
3805787 | Banko | Apr 1974 | A |
3809977 | Balamuth et al. | May 1974 | A |
3830098 | Antonevich | Aug 1974 | A |
3854737 | Gilliam, Sr. | Dec 1974 | A |
3862630 | Balamuth | Jan 1975 | A |
3875945 | Friedman | Apr 1975 | A |
3885438 | Harris, Sr. et al. | May 1975 | A |
3900823 | Sokal et al. | Aug 1975 | A |
3918442 | Nikolaev et al. | Nov 1975 | A |
3924335 | Balamuth et al. | Dec 1975 | A |
3946738 | Newton et al. | Mar 1976 | A |
3955859 | Stella et al. | May 1976 | A |
3956826 | Perdreaux, Jr. | May 1976 | A |
3989952 | Hohmann | Nov 1976 | A |
4005714 | Hiltebrandt | Feb 1977 | A |
4012647 | Balamuth et al. | Mar 1977 | A |
4034762 | Cosens et al. | Jul 1977 | A |
4058126 | Leveen | Nov 1977 | A |
4074719 | Semm | Feb 1978 | A |
4156187 | Murry et al. | May 1979 | A |
4167944 | Banko | Sep 1979 | A |
4188927 | Harris | Feb 1980 | A |
4200106 | Douvas et al. | Apr 1980 | A |
4203430 | Takahashi | May 1980 | A |
4203444 | Bonnell et al. | May 1980 | A |
4220154 | Semm | Sep 1980 | A |
4237441 | van Konynenburg et al. | Dec 1980 | A |
4244371 | Farin | Jan 1981 | A |
4281785 | Brooks | Aug 1981 | A |
4300083 | Heiges | Nov 1981 | A |
4302728 | Nakamura | Nov 1981 | A |
4304987 | van Konynenburg | Dec 1981 | A |
4306570 | Matthews | Dec 1981 | A |
4314559 | Allen | Feb 1982 | A |
4353371 | Cosman | Oct 1982 | A |
4409981 | Lundberg | Oct 1983 | A |
4445063 | Smith | Apr 1984 | A |
4461304 | Kuperstein | Jul 1984 | A |
4463759 | Garito et al. | Aug 1984 | A |
4491132 | Aikins | Jan 1985 | A |
4492231 | Auth | Jan 1985 | A |
4494759 | Kieffer | Jan 1985 | A |
4504264 | Kelman | Mar 1985 | A |
4512344 | Barber | Apr 1985 | A |
4526571 | Wuchinich | Jul 1985 | A |
4535773 | Yoon | Aug 1985 | A |
4541638 | Ogawa et al. | Sep 1985 | A |
4545374 | Jacobson | Oct 1985 | A |
4545926 | Fouts, Jr. et al. | Oct 1985 | A |
4549147 | Kondo | Oct 1985 | A |
4550870 | Krumme et al. | Nov 1985 | A |
4553544 | Nomoto et al. | Nov 1985 | A |
4562838 | Walker | Jan 1986 | A |
4574615 | Bower et al. | Mar 1986 | A |
4582236 | Hirose | Apr 1986 | A |
4593691 | Lindstrom et al. | Jun 1986 | A |
4608981 | Rothfuss et al. | Sep 1986 | A |
4617927 | Manes | Oct 1986 | A |
4633119 | Thompson | Dec 1986 | A |
4633874 | Chow et al. | Jan 1987 | A |
4634420 | Spinosa et al. | Jan 1987 | A |
4640279 | Beard | Feb 1987 | A |
4641053 | Takeda | Feb 1987 | A |
4646738 | Trott | Mar 1987 | A |
4646756 | Watmough et al. | Mar 1987 | A |
4649919 | Thimsen et al. | Mar 1987 | A |
4662068 | Polonsky | May 1987 | A |
4674502 | Imonti | Jun 1987 | A |
4694835 | Strand | Sep 1987 | A |
4708127 | Abdelghani | Nov 1987 | A |
4712722 | Hood et al. | Dec 1987 | A |
4735603 | Goodson et al. | Apr 1988 | A |
4761871 | O'Connor et al. | Aug 1988 | A |
4808154 | Freeman | Feb 1989 | A |
4819635 | Shapiro | Apr 1989 | A |
4827911 | Broadwin et al. | May 1989 | A |
4830462 | Karny et al. | May 1989 | A |
4832683 | Idemoto et al. | May 1989 | A |
4836186 | Scholz | Jun 1989 | A |
4838853 | Parisi | Jun 1989 | A |
4844064 | Thimsen et al. | Jul 1989 | A |
4849133 | Yoshida et al. | Jul 1989 | A |
4850354 | McGurk-Burleson et al. | Jul 1989 | A |
4852578 | Companion et al. | Aug 1989 | A |
4860745 | Farin et al. | Aug 1989 | A |
4862890 | Stasz et al. | Sep 1989 | A |
4865159 | Jamison | Sep 1989 | A |
4867157 | McGurk-Burleson et al. | Sep 1989 | A |
4878493 | Pasternak et al. | Nov 1989 | A |
4880015 | Nierman | Nov 1989 | A |
4881550 | Kothe | Nov 1989 | A |
4896009 | Pawlowski | Jan 1990 | A |
4903696 | Stasz et al. | Feb 1990 | A |
4910389 | Sherman et al. | Mar 1990 | A |
4915643 | Samejima et al. | Apr 1990 | A |
4920978 | Colvin | May 1990 | A |
4922902 | Wuchinich et al. | May 1990 | A |
4936842 | D'Amelio et al. | Jun 1990 | A |
4954960 | Lo et al. | Sep 1990 | A |
4965532 | Sakurai | Oct 1990 | A |
4979952 | Kubota et al. | Dec 1990 | A |
4981756 | Rhandhawa | Jan 1991 | A |
5001649 | Lo et al. | Mar 1991 | A |
5009661 | Michelson | Apr 1991 | A |
5013956 | Kurozumi et al. | May 1991 | A |
5015227 | Broadwin et al. | May 1991 | A |
5020514 | Heckele | Jun 1991 | A |
5026370 | Lottick | Jun 1991 | A |
5026387 | Thomas | Jun 1991 | A |
5035695 | Weber, Jr. et al. | Jul 1991 | A |
5042461 | Inoue et al. | Aug 1991 | A |
5042707 | Taheri | Aug 1991 | A |
5052145 | Wang | Oct 1991 | A |
5061269 | Muller | Oct 1991 | A |
5075839 | Fisher et al. | Dec 1991 | A |
5084052 | Jacobs | Jan 1992 | A |
5099840 | Goble et al. | Mar 1992 | A |
5104025 | Main et al. | Apr 1992 | A |
5105117 | Yamaguchi | Apr 1992 | A |
5106538 | Barma et al. | Apr 1992 | A |
5108383 | White | Apr 1992 | A |
5109819 | Custer et al. | May 1992 | A |
5112300 | Ureche | May 1992 | A |
5113139 | Furukawa | May 1992 | A |
5123903 | Quaid et al. | Jun 1992 | A |
5126618 | Takahashi et al. | Jun 1992 | A |
D327872 | McMills et al. | Jul 1992 | S |
5152762 | McElhenney | Oct 1992 | A |
5156633 | Smith | Oct 1992 | A |
5160334 | Billings et al. | Nov 1992 | A |
5162044 | Gahn et al. | Nov 1992 | A |
5163421 | Bernstein et al. | Nov 1992 | A |
5163537 | Radev | Nov 1992 | A |
5163945 | Ortiz et al. | Nov 1992 | A |
5167619 | Wuchinich | Dec 1992 | A |
5167725 | Clark et al. | Dec 1992 | A |
5172344 | Ehrlich | Dec 1992 | A |
5174276 | Crockard | Dec 1992 | A |
D332660 | Rawson et al. | Jan 1993 | S |
5176677 | Wuchinich | Jan 1993 | A |
5176695 | Dulebohn | Jan 1993 | A |
5184605 | Grzeszykowski | Feb 1993 | A |
5188102 | Idemoto et al. | Feb 1993 | A |
D334173 | Liu et al. | Mar 1993 | S |
5190517 | Zieve et al. | Mar 1993 | A |
5190518 | Takasu | Mar 1993 | A |
5190541 | Abele et al. | Mar 1993 | A |
5196007 | Ellman et al. | Mar 1993 | A |
5205459 | Brinkerhoff et al. | Apr 1993 | A |
5205817 | Idemoto et al. | Apr 1993 | A |
5209719 | Baruch et al. | May 1993 | A |
5213569 | Davis | May 1993 | A |
5214339 | Naito | May 1993 | A |
5217460 | Knoepfler | Jun 1993 | A |
5218529 | Meyer et al. | Jun 1993 | A |
5221282 | Wuchinich | Jun 1993 | A |
5222937 | Kagawa | Jun 1993 | A |
5226909 | Evans et al. | Jul 1993 | A |
5226910 | Kajiyama et al. | Jul 1993 | A |
5231989 | Middleman et al. | Aug 1993 | A |
5234428 | Kaufman | Aug 1993 | A |
5241236 | Sasaki et al. | Aug 1993 | A |
5241968 | Slater | Sep 1993 | A |
5242339 | Thornton | Sep 1993 | A |
5242460 | Klein et al. | Sep 1993 | A |
5246003 | DeLonzor | Sep 1993 | A |
5254129 | Alexander | Oct 1993 | A |
5257988 | L'Esperance, Jr. | Nov 1993 | A |
5258004 | Bales et al. | Nov 1993 | A |
5258006 | Rydell et al. | Nov 1993 | A |
5261922 | Hood | Nov 1993 | A |
5263957 | Davison | Nov 1993 | A |
5264925 | Shipp et al. | Nov 1993 | A |
5269297 | Weng et al. | Dec 1993 | A |
5275166 | Vaitekunas et al. | Jan 1994 | A |
5275607 | Lo et al. | Jan 1994 | A |
5275609 | Pingleton et al. | Jan 1994 | A |
5282800 | Foshee et al. | Feb 1994 | A |
5282817 | Hoogeboom et al. | Feb 1994 | A |
5285795 | Ryan et al. | Feb 1994 | A |
5285945 | Brinkerhoff et al. | Feb 1994 | A |
5290286 | Parins | Mar 1994 | A |
5293863 | Zhu et al. | Mar 1994 | A |
5300068 | Rosar et al. | Apr 1994 | A |
5304115 | Pflueger et al. | Apr 1994 | A |
D347474 | Olson | May 1994 | S |
5307976 | Olson et al. | May 1994 | A |
5309927 | Welch | May 1994 | A |
5312023 | Green et al. | May 1994 | A |
5312425 | Evans et al. | May 1994 | A |
5318525 | West et al. | Jun 1994 | A |
5318563 | Malis et al. | Jun 1994 | A |
5318564 | Eggers | Jun 1994 | A |
5318570 | Hood et al. | Jun 1994 | A |
5318589 | Lichtman | Jun 1994 | A |
5322055 | Davison et al. | Jun 1994 | A |
5324299 | Davison et al. | Jun 1994 | A |
5326013 | Green et al. | Jul 1994 | A |
5326342 | Pflueger et al. | Jul 1994 | A |
5330471 | Eggers | Jul 1994 | A |
5330502 | Hassler et al. | Jul 1994 | A |
5334183 | Wuchinich | Aug 1994 | A |
5339723 | Huitema | Aug 1994 | A |
5342356 | Ellman et al. | Aug 1994 | A |
5342359 | Rydell | Aug 1994 | A |
5344420 | Hilal et al. | Sep 1994 | A |
5345937 | Middleman et al. | Sep 1994 | A |
5346502 | Estabrook et al. | Sep 1994 | A |
5353474 | Good et al. | Oct 1994 | A |
5357164 | Imabayashi et al. | Oct 1994 | A |
5357423 | Weaver et al. | Oct 1994 | A |
5359994 | Krauter et al. | Nov 1994 | A |
5361583 | Huitema | Nov 1994 | A |
5366466 | Christian et al. | Nov 1994 | A |
5368557 | Nita et al. | Nov 1994 | A |
5370645 | Klicek et al. | Dec 1994 | A |
5371429 | Manna | Dec 1994 | A |
5374813 | Shipp | Dec 1994 | A |
D354564 | Medema | Jan 1995 | S |
5381067 | Greenstein et al. | Jan 1995 | A |
5383874 | Jackson et al. | Jan 1995 | A |
5383917 | Desai et al. | Jan 1995 | A |
5387207 | Dyer et al. | Feb 1995 | A |
5387215 | Fisher | Feb 1995 | A |
5389098 | Tsuruta et al. | Feb 1995 | A |
5394187 | Shipp | Feb 1995 | A |
5395033 | Byrne et al. | Mar 1995 | A |
5395312 | Desai | Mar 1995 | A |
5395363 | Billings et al. | Mar 1995 | A |
5395364 | Anderhub et al. | Mar 1995 | A |
5396266 | Brimhall | Mar 1995 | A |
5396900 | Slater et al. | Mar 1995 | A |
5400267 | Denen et al. | Mar 1995 | A |
5403312 | Yates et al. | Apr 1995 | A |
5403334 | Evans et al. | Apr 1995 | A |
5406503 | Williams, Jr. et al. | Apr 1995 | A |
5408268 | Shipp | Apr 1995 | A |
D358887 | Feinberg | May 1995 | S |
5411481 | Allen et al. | May 1995 | A |
5417709 | Slater | May 1995 | A |
5419761 | Narayanan et al. | May 1995 | A |
5421829 | Olichney et al. | Jun 1995 | A |
5423844 | Miller | Jun 1995 | A |
5428504 | Bhatia | Jun 1995 | A |
5429131 | Scheinman et al. | Jul 1995 | A |
5438997 | Sieben et al. | Aug 1995 | A |
5441499 | Fritzsch | Aug 1995 | A |
5443463 | Stern et al. | Aug 1995 | A |
5445638 | Rydell et al. | Aug 1995 | A |
5445639 | Kuslich et al. | Aug 1995 | A |
5447509 | Mills et al. | Sep 1995 | A |
5449370 | Vaitekunas | Sep 1995 | A |
5451053 | Garrido | Sep 1995 | A |
5451161 | Sharp | Sep 1995 | A |
5451220 | Ciervo | Sep 1995 | A |
5451227 | Michaelson | Sep 1995 | A |
5456684 | Schmidt et al. | Oct 1995 | A |
5458598 | Feinberg et al. | Oct 1995 | A |
5462604 | Shibano et al. | Oct 1995 | A |
5465895 | Knodel et al. | Nov 1995 | A |
5471988 | Fujio et al. | Dec 1995 | A |
5472443 | Cordis et al. | Dec 1995 | A |
5476479 | Green et al. | Dec 1995 | A |
5478003 | Green et al. | Dec 1995 | A |
5480409 | Riza | Jan 1996 | A |
5483501 | Park et al. | Jan 1996 | A |
5484436 | Eggers et al. | Jan 1996 | A |
5486162 | Brumbach | Jan 1996 | A |
5486189 | Mudry et al. | Jan 1996 | A |
5490860 | Middle et al. | Feb 1996 | A |
5496317 | Goble et al. | Mar 1996 | A |
5499992 | Meade et al. | Mar 1996 | A |
5500216 | Julian et al. | Mar 1996 | A |
5501654 | Failla et al. | Mar 1996 | A |
5504650 | Katsui et al. | Apr 1996 | A |
5505693 | Mackool | Apr 1996 | A |
5507297 | Slater et al. | Apr 1996 | A |
5507738 | Ciervo | Apr 1996 | A |
5509922 | Aranyi et al. | Apr 1996 | A |
5511556 | DeSantis | Apr 1996 | A |
5520704 | Castro et al. | May 1996 | A |
5522832 | Kugo et al. | Jun 1996 | A |
5522839 | Pilling | Jun 1996 | A |
5527331 | Kresch et al. | Jun 1996 | A |
5531744 | Nardella et al. | Jul 1996 | A |
5540681 | Strul et al. | Jul 1996 | A |
5540693 | Fisher | Jul 1996 | A |
5542916 | Hirsch et al. | Aug 1996 | A |
5548286 | Craven | Aug 1996 | A |
5549637 | Crainich | Aug 1996 | A |
5553675 | Pitzen et al. | Sep 1996 | A |
5558671 | Yates | Sep 1996 | A |
5562609 | Brumbach | Oct 1996 | A |
5562610 | Brumbach | Oct 1996 | A |
5562659 | Morris | Oct 1996 | A |
5562703 | Desai | Oct 1996 | A |
5563179 | Stone et al. | Oct 1996 | A |
5569164 | Lurz | Oct 1996 | A |
5571121 | Heifetz | Nov 1996 | A |
5573424 | Poppe | Nov 1996 | A |
5573533 | Strul | Nov 1996 | A |
5573534 | Stone | Nov 1996 | A |
5577654 | Bishop | Nov 1996 | A |
5584830 | Ladd et al. | Dec 1996 | A |
5591187 | Dekel | Jan 1997 | A |
5593414 | Shipp et al. | Jan 1997 | A |
5599350 | Schulze et al. | Feb 1997 | A |
5600526 | Russell et al. | Feb 1997 | A |
5601601 | Tai et al. | Feb 1997 | A |
5603773 | Campbell | Feb 1997 | A |
5607436 | Pratt et al. | Mar 1997 | A |
5607450 | Zvenyatsky et al. | Mar 1997 | A |
5609573 | Sandock | Mar 1997 | A |
5611813 | Lichtman | Mar 1997 | A |
5618304 | Hart et al. | Apr 1997 | A |
5618307 | Donlon et al. | Apr 1997 | A |
5618492 | Auten et al. | Apr 1997 | A |
5620447 | Smith et al. | Apr 1997 | A |
5624452 | Yates | Apr 1997 | A |
5626587 | Bishop et al. | May 1997 | A |
5626595 | Sklar et al. | May 1997 | A |
5626608 | Cuny et al. | May 1997 | A |
5628760 | Knoepfler | May 1997 | A |
5630420 | Vaitekunas | May 1997 | A |
5632432 | Schulze et al. | May 1997 | A |
5632717 | Yoon | May 1997 | A |
5640741 | Yano | Jun 1997 | A |
D381077 | Hunt | Jul 1997 | S |
5647871 | Levine et al. | Jul 1997 | A |
5649937 | Bito et al. | Jul 1997 | A |
5649955 | Hashimoto et al. | Jul 1997 | A |
5651780 | Jackson et al. | Jul 1997 | A |
5653713 | Michelson | Aug 1997 | A |
5655100 | Ebrahim et al. | Aug 1997 | A |
5658281 | Heard | Aug 1997 | A |
5662662 | Bishop et al. | Sep 1997 | A |
5662667 | Knodel | Sep 1997 | A |
5665085 | Nardella | Sep 1997 | A |
5665100 | Yoon | Sep 1997 | A |
5669922 | Hood | Sep 1997 | A |
5674219 | Monson et al. | Oct 1997 | A |
5674220 | Fox et al. | Oct 1997 | A |
5674235 | Parisi | Oct 1997 | A |
5678568 | Uchikubo et al. | Oct 1997 | A |
5688270 | Yates et al. | Nov 1997 | A |
5690269 | Bolanos et al. | Nov 1997 | A |
5693051 | Schulze et al. | Dec 1997 | A |
5694936 | Fujimoto et al. | Dec 1997 | A |
5695510 | Hood | Dec 1997 | A |
5700261 | Brinkerhoff | Dec 1997 | A |
5704534 | Huitema et al. | Jan 1998 | A |
5704791 | Gillio | Jan 1998 | A |
5707369 | Vaitekunas et al. | Jan 1998 | A |
5709680 | Yates et al. | Jan 1998 | A |
5711472 | Bryan | Jan 1998 | A |
5713896 | Nardella | Feb 1998 | A |
5715817 | Stevens-Wright et al. | Feb 1998 | A |
5716366 | Yates | Feb 1998 | A |
5717306 | Shipp | Feb 1998 | A |
5720742 | Zacharias | Feb 1998 | A |
5720744 | Eggleston et al. | Feb 1998 | A |
5722980 | Schulz et al. | Mar 1998 | A |
5723970 | Bell | Mar 1998 | A |
5728130 | Ishikawa et al. | Mar 1998 | A |
5730752 | Alden et al. | Mar 1998 | A |
5733074 | Stock et al. | Mar 1998 | A |
5735848 | Yates et al. | Apr 1998 | A |
5741226 | Strukel et al. | Apr 1998 | A |
5743906 | Parins et al. | Apr 1998 | A |
5752973 | Kieturakis | May 1998 | A |
5755717 | Yates et al. | May 1998 | A |
5762255 | Chrisman et al. | Jun 1998 | A |
5766164 | Mueller et al. | Jun 1998 | A |
5772659 | Becker et al. | Jun 1998 | A |
5776130 | Buysse et al. | Jul 1998 | A |
5776155 | Beaupre et al. | Jul 1998 | A |
5779130 | Alesi et al. | Jul 1998 | A |
5779701 | McBrayer et al. | Jul 1998 | A |
5782834 | Lucey et al. | Jul 1998 | A |
5792135 | Madhani et al. | Aug 1998 | A |
5792138 | Shipp | Aug 1998 | A |
5792165 | Klieman et al. | Aug 1998 | A |
5796188 | Bays | Aug 1998 | A |
5797941 | Schulze et al. | Aug 1998 | A |
5797958 | Yoon | Aug 1998 | A |
5797959 | Castro et al. | Aug 1998 | A |
5800432 | Swanson | Sep 1998 | A |
5800448 | Banko | Sep 1998 | A |
5800449 | Wales | Sep 1998 | A |
5805140 | Rosenberg et al. | Sep 1998 | A |
5807393 | Williamson, IV et al. | Sep 1998 | A |
5808396 | Boukhny | Sep 1998 | A |
5810811 | Yates et al. | Sep 1998 | A |
5810828 | Lightman et al. | Sep 1998 | A |
5810859 | DiMatteo et al. | Sep 1998 | A |
5817033 | DeSantis et al. | Oct 1998 | A |
5817084 | Jensen | Oct 1998 | A |
5817093 | Williamson, IV et al. | Oct 1998 | A |
5817119 | Klieman et al. | Oct 1998 | A |
5823197 | Edwards | Oct 1998 | A |
5827271 | Buysse et al. | Oct 1998 | A |
5827323 | Klieman et al. | Oct 1998 | A |
5828160 | Sugishita | Oct 1998 | A |
5833696 | Whitfield et al. | Nov 1998 | A |
5836897 | Sakurai et al. | Nov 1998 | A |
5836909 | Cosmescu | Nov 1998 | A |
5836943 | Miller, III | Nov 1998 | A |
5836957 | Schulz et al. | Nov 1998 | A |
5836990 | Li | Nov 1998 | A |
5843109 | Mehta et al. | Dec 1998 | A |
5851212 | Zirps et al. | Dec 1998 | A |
5853412 | Mayenberger | Dec 1998 | A |
5854590 | Dalstein | Dec 1998 | A |
5858018 | Shipp et al. | Jan 1999 | A |
5865361 | Milliman et al. | Feb 1999 | A |
5873873 | Smith et al. | Feb 1999 | A |
5873882 | Straub et al. | Feb 1999 | A |
5876401 | Schulze et al. | Mar 1999 | A |
5878193 | Wang et al. | Mar 1999 | A |
5879364 | Bromfield et al. | Mar 1999 | A |
5880668 | Hall | Mar 1999 | A |
5883615 | Fago et al. | Mar 1999 | A |
5891142 | Eggers et al. | Apr 1999 | A |
5893835 | Witt et al. | Apr 1999 | A |
5897523 | Wright et al. | Apr 1999 | A |
5897569 | Kellogg et al. | Apr 1999 | A |
5903607 | Tailliet | May 1999 | A |
5904681 | West, Jr. | May 1999 | A |
5906625 | Bito et al. | May 1999 | A |
5906627 | Spaulding | May 1999 | A |
5906628 | Miyawaki et al. | May 1999 | A |
5910129 | Koblish et al. | Jun 1999 | A |
5911699 | Anis et al. | Jun 1999 | A |
5913823 | Hedberg et al. | Jun 1999 | A |
5916229 | Evans | Jun 1999 | A |
5921956 | Grinberg et al. | Jul 1999 | A |
5929846 | Rosenberg et al. | Jul 1999 | A |
5935143 | Hood | Aug 1999 | A |
5935144 | Estabrook | Aug 1999 | A |
5938633 | Beaupre | Aug 1999 | A |
5944718 | Austin et al. | Aug 1999 | A |
5944737 | Tsonton et al. | Aug 1999 | A |
5947984 | Whipple | Sep 1999 | A |
5954717 | Behl et al. | Sep 1999 | A |
5954736 | Bishop et al. | Sep 1999 | A |
5954746 | Holthaus et al. | Sep 1999 | A |
5957882 | Nita et al. | Sep 1999 | A |
5957943 | Vaitekunas | Sep 1999 | A |
5968007 | Simon et al. | Oct 1999 | A |
5968060 | Kellogg | Oct 1999 | A |
5974342 | Petrofsky | Oct 1999 | A |
D416089 | Barton et al. | Nov 1999 | S |
5980510 | Tsonton et al. | Nov 1999 | A |
5980546 | Hood | Nov 1999 | A |
5984938 | Yoon | Nov 1999 | A |
5987344 | West | Nov 1999 | A |
5989274 | Davison et al. | Nov 1999 | A |
5989275 | Estabrook et al. | Nov 1999 | A |
5993465 | Shipp et al. | Nov 1999 | A |
5993972 | Reich et al. | Nov 1999 | A |
5994855 | Lundell et al. | Nov 1999 | A |
6003517 | Sheffield et al. | Dec 1999 | A |
6004335 | Vaitekunas et al. | Dec 1999 | A |
6013052 | Durman et al. | Jan 2000 | A |
6024741 | Williamson, IV et al. | Feb 2000 | A |
6024744 | Kese et al. | Feb 2000 | A |
6024750 | Mastri et al. | Feb 2000 | A |
6027515 | Cimino | Feb 2000 | A |
6031526 | Shipp | Feb 2000 | A |
6033375 | Brumbach | Mar 2000 | A |
6033399 | Gines | Mar 2000 | A |
6036667 | Manna et al. | Mar 2000 | A |
6036707 | Spaulding | Mar 2000 | A |
6039734 | Goble | Mar 2000 | A |
6048224 | Kay | Apr 2000 | A |
6050943 | Slayton et al. | Apr 2000 | A |
6050996 | Schmaltz et al. | Apr 2000 | A |
6051010 | DiMatteo et al. | Apr 2000 | A |
6056735 | Okada et al. | May 2000 | A |
6063098 | Houser et al. | May 2000 | A |
6066132 | Chen et al. | May 2000 | A |
6066151 | Miyawaki et al. | May 2000 | A |
6068627 | Orszulak et al. | May 2000 | A |
6068629 | Haissaguerre et al. | May 2000 | A |
6068647 | Witt et al. | May 2000 | A |
6074389 | Levine et al. | Jun 2000 | A |
6077285 | Boukhny | Jun 2000 | A |
6080149 | Huang et al. | Jun 2000 | A |
6083191 | Rose | Jul 2000 | A |
6086584 | Miller | Jul 2000 | A |
6090120 | Wright et al. | Jul 2000 | A |
6091995 | Ingle et al. | Jul 2000 | A |
6096033 | Tu et al. | Aug 2000 | A |
6099483 | Palmer et al. | Aug 2000 | A |
6099542 | Cohn et al. | Aug 2000 | A |
6099550 | Yoon | Aug 2000 | A |
6109500 | Alli et al. | Aug 2000 | A |
6110127 | Suzuki | Aug 2000 | A |
6113594 | Savage | Sep 2000 | A |
6113598 | Baker | Sep 2000 | A |
6117152 | Huitema | Sep 2000 | A |
H1904 | Yates et al. | Oct 2000 | H |
6126629 | Perkins | Oct 2000 | A |
6126658 | Baker | Oct 2000 | A |
6129735 | Okada et al. | Oct 2000 | A |
6129740 | Michelson | Oct 2000 | A |
6132368 | Cooper | Oct 2000 | A |
6132427 | Jones et al. | Oct 2000 | A |
6132429 | Baker | Oct 2000 | A |
6132448 | Perez et al. | Oct 2000 | A |
6139320 | Hahn | Oct 2000 | A |
6139561 | Shibata et al. | Oct 2000 | A |
6142615 | Qiu et al. | Nov 2000 | A |
6142994 | Swanson et al. | Nov 2000 | A |
6144402 | Norsworthy et al. | Nov 2000 | A |
6147560 | Erhage et al. | Nov 2000 | A |
6152902 | Christian et al. | Nov 2000 | A |
6152923 | Ryan | Nov 2000 | A |
6154198 | Rosenberg | Nov 2000 | A |
6156029 | Mueller | Dec 2000 | A |
6159160 | Hsei et al. | Dec 2000 | A |
6159175 | Strukel et al. | Dec 2000 | A |
6162194 | Shipp | Dec 2000 | A |
6162208 | Hipps | Dec 2000 | A |
6165150 | Banko | Dec 2000 | A |
6174309 | Wrublewski et al. | Jan 2001 | B1 |
6174310 | Kirwan, Jr. | Jan 2001 | B1 |
6176857 | Ashley | Jan 2001 | B1 |
6179853 | Sachse et al. | Jan 2001 | B1 |
6183426 | Akisada et al. | Feb 2001 | B1 |
6187003 | Buysse et al. | Feb 2001 | B1 |
6190386 | Rydell | Feb 2001 | B1 |
6193709 | Miyawaki et al. | Feb 2001 | B1 |
6204592 | Hur | Mar 2001 | B1 |
6205383 | Hermann | Mar 2001 | B1 |
6205855 | Pfeiffer | Mar 2001 | B1 |
6206844 | Reichel et al. | Mar 2001 | B1 |
6206876 | Levine et al. | Mar 2001 | B1 |
6210337 | Dunham et al. | Apr 2001 | B1 |
6210402 | Olsen et al. | Apr 2001 | B1 |
6210403 | Klicek | Apr 2001 | B1 |
6214023 | Whipple et al. | Apr 2001 | B1 |
6228080 | Gines | May 2001 | B1 |
6231565 | Tovey et al. | May 2001 | B1 |
6232899 | Craven | May 2001 | B1 |
6233476 | Strommer et al. | May 2001 | B1 |
6238366 | Savage et al. | May 2001 | B1 |
6241724 | Fleischman et al. | Jun 2001 | B1 |
6245065 | Panescu et al. | Jun 2001 | B1 |
6251110 | Wampler | Jun 2001 | B1 |
6252110 | Uemura et al. | Jun 2001 | B1 |
D444365 | Bass et al. | Jul 2001 | S |
D445092 | Lee | Jul 2001 | S |
D445764 | Lee | Jul 2001 | S |
6254623 | Haibel, Jr. et al. | Jul 2001 | B1 |
6257241 | Wampler | Jul 2001 | B1 |
6258034 | Hanafy | Jul 2001 | B1 |
6259230 | Chou | Jul 2001 | B1 |
6267761 | Ryan | Jul 2001 | B1 |
6270831 | Kumar et al. | Aug 2001 | B2 |
6273852 | Lehe et al. | Aug 2001 | B1 |
6274963 | Estabrook et al. | Aug 2001 | B1 |
6277115 | Saadat | Aug 2001 | B1 |
6277117 | Tetzlaff et al. | Aug 2001 | B1 |
6278218 | Madan et al. | Aug 2001 | B1 |
6280407 | Manna et al. | Aug 2001 | B1 |
6283981 | Beaupre | Sep 2001 | B1 |
6287344 | Wampler et al. | Sep 2001 | B1 |
6290575 | Shipp | Sep 2001 | B1 |
6292700 | Morrison et al. | Sep 2001 | B1 |
6299591 | Banko | Oct 2001 | B1 |
6306131 | Hareyama et al. | Oct 2001 | B1 |
6306157 | Shchervinsky | Oct 2001 | B1 |
6309400 | Beaupre | Oct 2001 | B2 |
6311783 | Harpell | Nov 2001 | B1 |
6319221 | Savage et al. | Nov 2001 | B1 |
6325795 | Lindemann et al. | Dec 2001 | B1 |
6325799 | Goble | Dec 2001 | B1 |
6325811 | Messerly | Dec 2001 | B1 |
6328751 | Beaupre | Dec 2001 | B1 |
6332891 | Himes | Dec 2001 | B1 |
6338657 | Harper et al. | Jan 2002 | B1 |
6340352 | Okada et al. | Jan 2002 | B1 |
6340878 | Oglesbee | Jan 2002 | B1 |
6350269 | Shipp et al. | Feb 2002 | B1 |
6352532 | Kramer et al. | Mar 2002 | B1 |
6356224 | Wohlfarth | Mar 2002 | B1 |
6358246 | Behl et al. | Mar 2002 | B1 |
6358264 | Banko | Mar 2002 | B2 |
6364888 | Niemeyer et al. | Apr 2002 | B1 |
6379320 | Lafon et al. | Apr 2002 | B1 |
D457958 | Dycus et al. | May 2002 | S |
6383194 | Pothula | May 2002 | B1 |
6384690 | Wilhelmsson et al. | May 2002 | B1 |
6387094 | Eitenmuller | May 2002 | B1 |
6387109 | Davison et al. | May 2002 | B1 |
6388657 | Natoli | May 2002 | B1 |
6390973 | Ouchi | May 2002 | B1 |
6391026 | Hung et al. | May 2002 | B1 |
6391042 | Cimino | May 2002 | B1 |
6398779 | Buysse et al. | Jun 2002 | B1 |
6402743 | Orszulak et al. | Jun 2002 | B1 |
6402748 | Schoenman et al. | Jun 2002 | B1 |
6405184 | Bohme et al. | Jun 2002 | B1 |
6405733 | Fogarty et al. | Jun 2002 | B1 |
6409722 | Hoey et al. | Jun 2002 | B1 |
H2037 | Yates et al. | Jul 2002 | H |
6416469 | Phung et al. | Jul 2002 | B1 |
6416486 | Wampler | Jul 2002 | B1 |
6419675 | Gallo, Sr. | Jul 2002 | B1 |
6423073 | Bowman | Jul 2002 | B2 |
6423082 | Houser et al. | Jul 2002 | B1 |
6425906 | Young et al. | Jul 2002 | B1 |
6428538 | Blewett et al. | Aug 2002 | B1 |
6428539 | Baxter et al. | Aug 2002 | B1 |
6430446 | Knowlton | Aug 2002 | B1 |
6432118 | Messerly | Aug 2002 | B1 |
6436114 | Novak et al. | Aug 2002 | B1 |
6436115 | Beaupre | Aug 2002 | B1 |
6440062 | Ouchi | Aug 2002 | B1 |
6443968 | Holthaus et al. | Sep 2002 | B1 |
6443969 | Novak et al. | Sep 2002 | B1 |
6449006 | Shipp | Sep 2002 | B1 |
6454781 | Witt et al. | Sep 2002 | B1 |
6454782 | Schwemberger | Sep 2002 | B1 |
6458128 | Schulze | Oct 2002 | B1 |
6458130 | Frazier et al. | Oct 2002 | B1 |
6458142 | Faller et al. | Oct 2002 | B1 |
6459363 | Walker et al. | Oct 2002 | B1 |
6461363 | Gadberry et al. | Oct 2002 | B1 |
6464689 | Qin et al. | Oct 2002 | B1 |
6464702 | Schulze et al. | Oct 2002 | B2 |
6468270 | Hovda et al. | Oct 2002 | B1 |
6475211 | Chess et al. | Nov 2002 | B2 |
6475215 | Tanrisever | Nov 2002 | B1 |
6480796 | Wiener | Nov 2002 | B2 |
6485490 | Wampler et al. | Nov 2002 | B2 |
6491690 | Goble et al. | Dec 2002 | B1 |
6491701 | Tierney et al. | Dec 2002 | B2 |
6491708 | Madan et al. | Dec 2002 | B2 |
6497715 | Satou | Dec 2002 | B2 |
6500112 | Khouri | Dec 2002 | B1 |
6500176 | Truckai et al. | Dec 2002 | B1 |
6500188 | Harper et al. | Dec 2002 | B2 |
6500312 | Wedekamp | Dec 2002 | B2 |
6503248 | Levine | Jan 2003 | B1 |
6506208 | Hunt et al. | Jan 2003 | B2 |
6511478 | Burnside et al. | Jan 2003 | B1 |
6511480 | Tetzlaff et al. | Jan 2003 | B1 |
6511493 | Moutafis et al. | Jan 2003 | B1 |
6514252 | Nezhat et al. | Feb 2003 | B2 |
6514267 | Jewett | Feb 2003 | B2 |
6517565 | Whitman et al. | Feb 2003 | B1 |
6524251 | Rabiner et al. | Feb 2003 | B2 |
6524316 | Nicholson et al. | Feb 2003 | B1 |
6527736 | Attinger et al. | Mar 2003 | B1 |
6531846 | Smith | Mar 2003 | B1 |
6533784 | Truckai et al. | Mar 2003 | B2 |
6537272 | Christopherson et al. | Mar 2003 | B2 |
6537291 | Friedman et al. | Mar 2003 | B2 |
6543452 | Lavigne | Apr 2003 | B1 |
6543456 | Freeman | Apr 2003 | B1 |
6544260 | Markel et al. | Apr 2003 | B1 |
6551309 | LePivert | Apr 2003 | B1 |
6554829 | Schulze et al. | Apr 2003 | B2 |
6558376 | Bishop | May 2003 | B2 |
6561983 | Cronin et al. | May 2003 | B2 |
6562035 | Levin | May 2003 | B1 |
6562037 | Paton et al. | May 2003 | B2 |
6565558 | Lindenmeier et al. | May 2003 | B1 |
6572563 | Ouchi | Jun 2003 | B2 |
6572632 | Zisterer et al. | Jun 2003 | B2 |
6572639 | Ingle et al. | Jun 2003 | B1 |
6575969 | Rittman, III et al. | Jun 2003 | B1 |
6582427 | Goble et al. | Jun 2003 | B1 |
6582451 | Marucci et al. | Jun 2003 | B1 |
6584360 | Francischelli et al. | Jun 2003 | B2 |
D477408 | Bromley | Jul 2003 | S |
6585735 | Frazier et al. | Jul 2003 | B1 |
6588277 | Giordano et al. | Jul 2003 | B2 |
6589200 | Schwemberger et al. | Jul 2003 | B1 |
6589239 | Khandkar et al. | Jul 2003 | B2 |
6590733 | Wilson et al. | Jul 2003 | B1 |
6599288 | Maguire et al. | Jul 2003 | B2 |
6602252 | Mollenauer | Aug 2003 | B2 |
6602262 | Griego et al. | Aug 2003 | B2 |
6607540 | Shipp | Aug 2003 | B1 |
6610059 | West, Jr. | Aug 2003 | B1 |
6610060 | Mulier et al. | Aug 2003 | B2 |
6611793 | Burnside et al. | Aug 2003 | B1 |
6616450 | Mossle et al. | Sep 2003 | B2 |
6619529 | Green et al. | Sep 2003 | B2 |
6620161 | Schulze et al. | Sep 2003 | B2 |
6622731 | Daniel et al. | Sep 2003 | B2 |
6623482 | Pendekanti et al. | Sep 2003 | B2 |
6623500 | Cook et al. | Sep 2003 | B1 |
6623501 | Heller et al. | Sep 2003 | B2 |
6626848 | Neuenfeldt | Sep 2003 | B2 |
6626926 | Friedman et al. | Sep 2003 | B2 |
6629974 | Penny et al. | Oct 2003 | B2 |
6632221 | Edwards et al. | Oct 2003 | B1 |
6633234 | Wiener et al. | Oct 2003 | B2 |
6635057 | Harano et al. | Oct 2003 | B2 |
6644532 | Green et al. | Nov 2003 | B2 |
6651669 | Burnside | Nov 2003 | B1 |
6652513 | Panescu et al. | Nov 2003 | B2 |
6652539 | Shipp et al. | Nov 2003 | B2 |
6652545 | Shipp et al. | Nov 2003 | B2 |
6656132 | Ouchi | Dec 2003 | B1 |
6656177 | Truckai et al. | Dec 2003 | B2 |
6656198 | Tsonton et al. | Dec 2003 | B2 |
6660017 | Beaupre | Dec 2003 | B2 |
6662127 | Wiener et al. | Dec 2003 | B2 |
6663941 | Brown et al. | Dec 2003 | B2 |
6666860 | Takahashi | Dec 2003 | B1 |
6666875 | Sakurai et al. | Dec 2003 | B1 |
6669690 | Okada et al. | Dec 2003 | B1 |
6669710 | Moutafis et al. | Dec 2003 | B2 |
6673248 | Chowdhury | Jan 2004 | B2 |
6676660 | Wampler et al. | Jan 2004 | B2 |
6678621 | Wiener et al. | Jan 2004 | B2 |
6679875 | Honda et al. | Jan 2004 | B2 |
6679882 | Kornerup | Jan 2004 | B1 |
6679899 | Wiener et al. | Jan 2004 | B2 |
6682501 | Nelson et al. | Jan 2004 | B1 |
6682544 | Mastri et al. | Jan 2004 | B2 |
6685700 | Behl et al. | Feb 2004 | B2 |
6685701 | Orszulak et al. | Feb 2004 | B2 |
6685703 | Pearson et al. | Feb 2004 | B2 |
6689145 | Lee et al. | Feb 2004 | B2 |
6689146 | Himes | Feb 2004 | B1 |
6690960 | Chen et al. | Feb 2004 | B2 |
6695840 | Schulze | Feb 2004 | B2 |
6702821 | Bonutti | Mar 2004 | B2 |
6716215 | David et al. | Apr 2004 | B1 |
6719692 | Kleffner et al. | Apr 2004 | B2 |
6719765 | Bonutti | Apr 2004 | B2 |
6719776 | Baxter et al. | Apr 2004 | B2 |
6722552 | Fenton, Jr. | Apr 2004 | B2 |
6723091 | Goble et al. | Apr 2004 | B2 |
D490059 | Conway et al. | May 2004 | S |
6730080 | Harano et al. | May 2004 | B2 |
6731047 | Kauf et al. | May 2004 | B2 |
6733498 | Paton et al. | May 2004 | B2 |
6733506 | McDevitt et al. | May 2004 | B1 |
6736813 | Yamauchi et al. | May 2004 | B2 |
6739872 | Turri | May 2004 | B1 |
6740079 | Eggers et al. | May 2004 | B1 |
D491666 | Kimmell et al. | Jun 2004 | S |
6743245 | Lobdell | Jun 2004 | B2 |
6746284 | Spink, Jr. | Jun 2004 | B1 |
6746443 | Morley et al. | Jun 2004 | B1 |
6752815 | Beaupre | Jun 2004 | B2 |
6755825 | Shoenman et al. | Jun 2004 | B2 |
6761698 | Shibata et al. | Jul 2004 | B2 |
6762535 | Take et al. | Jul 2004 | B2 |
6766202 | Underwood et al. | Jul 2004 | B2 |
6770072 | Truckai et al. | Aug 2004 | B1 |
6773409 | Truckai et al. | Aug 2004 | B2 |
6773434 | Ciarrocca | Aug 2004 | B2 |
6773435 | Schulze et al. | Aug 2004 | B2 |
6773443 | Truwit et al. | Aug 2004 | B2 |
6773444 | Messerly | Aug 2004 | B2 |
6775575 | Bommannan et al. | Aug 2004 | B2 |
6778023 | Christensen | Aug 2004 | B2 |
6783524 | Anderson et al. | Aug 2004 | B2 |
6786382 | Hoffman | Sep 2004 | B1 |
6786383 | Stegelmann | Sep 2004 | B2 |
6789939 | Schrodinger et al. | Sep 2004 | B2 |
6790173 | Saadat et al. | Sep 2004 | B2 |
6790216 | Ishikawa | Sep 2004 | B1 |
6794027 | Araki et al. | Sep 2004 | B1 |
6796981 | Wham et al. | Sep 2004 | B2 |
D496997 | Dycus et al. | Oct 2004 | S |
6800085 | Selmon et al. | Oct 2004 | B2 |
6802843 | Truckai et al. | Oct 2004 | B2 |
6808525 | Latterell et al. | Oct 2004 | B2 |
6809508 | Donofrio | Oct 2004 | B2 |
6810281 | Brock et al. | Oct 2004 | B2 |
6811842 | Ehrnsperger et al. | Nov 2004 | B1 |
6814731 | Swanson | Nov 2004 | B2 |
6819027 | Saraf | Nov 2004 | B2 |
6821273 | Mollenauer | Nov 2004 | B2 |
6827712 | Tovey et al. | Dec 2004 | B2 |
6828712 | Battaglin et al. | Dec 2004 | B2 |
6835082 | Gonnering | Dec 2004 | B2 |
6835199 | McGuckin, Jr. et al. | Dec 2004 | B2 |
6840938 | Morley et al. | Jan 2005 | B1 |
6843789 | Goble | Jan 2005 | B2 |
6849073 | Hoey et al. | Feb 2005 | B2 |
6860878 | Brock | Mar 2005 | B2 |
6860880 | Treat et al. | Mar 2005 | B2 |
6863676 | Lee et al. | Mar 2005 | B2 |
6866671 | Tierney et al. | Mar 2005 | B2 |
6869439 | White et al. | Mar 2005 | B2 |
6875220 | Du et al. | Apr 2005 | B2 |
6877647 | Green et al. | Apr 2005 | B2 |
6882439 | Ishijima | Apr 2005 | B2 |
6887209 | Kadziauskas et al. | May 2005 | B2 |
6887252 | Okada et al. | May 2005 | B1 |
6893435 | Goble | May 2005 | B2 |
6898536 | Wiener et al. | May 2005 | B2 |
6899685 | Kermode et al. | May 2005 | B2 |
6905497 | Truckai et al. | Jun 2005 | B2 |
6908463 | Treat et al. | Jun 2005 | B2 |
6908472 | Wiener et al. | Jun 2005 | B2 |
6913579 | Truckai et al. | Jul 2005 | B2 |
6915623 | Dey et al. | Jul 2005 | B2 |
6923804 | Eggers et al. | Aug 2005 | B2 |
6923806 | Hooven et al. | Aug 2005 | B2 |
6926712 | Phan | Aug 2005 | B2 |
6926716 | Baker et al. | Aug 2005 | B2 |
6926717 | Garito et al. | Aug 2005 | B1 |
6929602 | Hirakui et al. | Aug 2005 | B2 |
6929622 | Chian | Aug 2005 | B2 |
6929632 | Nita et al. | Aug 2005 | B2 |
6929644 | Truckai et al. | Aug 2005 | B2 |
6933656 | Matsushita et al. | Aug 2005 | B2 |
D509589 | Wells | Sep 2005 | S |
6942660 | Pantera et al. | Sep 2005 | B2 |
6942677 | Nita et al. | Sep 2005 | B2 |
6945981 | Donofrio et al. | Sep 2005 | B2 |
6946779 | Birgel | Sep 2005 | B2 |
6948503 | Refior et al. | Sep 2005 | B2 |
6953461 | McClurken et al. | Oct 2005 | B2 |
6958070 | Witt et al. | Oct 2005 | B2 |
D511145 | Donofrio et al. | Nov 2005 | S |
6974450 | Weber et al. | Dec 2005 | B2 |
6976844 | Hickok et al. | Dec 2005 | B2 |
6976969 | Messerly | Dec 2005 | B2 |
6977495 | Donofrio | Dec 2005 | B2 |
6979332 | Adams | Dec 2005 | B2 |
6981628 | Wales | Jan 2006 | B2 |
6984220 | Wuchinich | Jan 2006 | B2 |
6984231 | Goble et al. | Jan 2006 | B2 |
6988295 | Tillim | Jan 2006 | B2 |
6994708 | Manzo | Feb 2006 | B2 |
6994709 | Iida | Feb 2006 | B2 |
7000818 | Shelton, IV et al. | Feb 2006 | B2 |
7001335 | Adachi et al. | Feb 2006 | B2 |
7001379 | Behl et al. | Feb 2006 | B2 |
7001382 | Gallo, Sr. | Feb 2006 | B2 |
7004951 | Gibbens, III | Feb 2006 | B2 |
7011657 | Truckai et al. | Mar 2006 | B2 |
7014638 | Michelson | Mar 2006 | B2 |
7018389 | Camerlengo | Mar 2006 | B2 |
7025732 | Thompson et al. | Apr 2006 | B2 |
7033356 | Latterell et al. | Apr 2006 | B2 |
7033357 | Baxter et al. | Apr 2006 | B2 |
7037306 | Podany et al. | May 2006 | B2 |
7041083 | Chu et al. | May 2006 | B2 |
7041088 | Nawrocki et al. | May 2006 | B2 |
7041102 | Truckai et al. | May 2006 | B2 |
7044949 | Orszulak et al. | May 2006 | B2 |
7052494 | Goble et al. | May 2006 | B2 |
7052496 | Yamauchi | May 2006 | B2 |
7055731 | Shelton, IV et al. | Jun 2006 | B2 |
7063699 | Hess et al. | Jun 2006 | B2 |
7066893 | Hibner et al. | Jun 2006 | B2 |
7066895 | Podany | Jun 2006 | B2 |
7066936 | Ryan | Jun 2006 | B2 |
7070597 | Truckai et al. | Jul 2006 | B2 |
7074218 | Washington et al. | Jul 2006 | B2 |
7074219 | Levine et al. | Jul 2006 | B2 |
7077039 | Gass et al. | Jul 2006 | B2 |
7077845 | Hacker et al. | Jul 2006 | B2 |
7077853 | Kramer et al. | Jul 2006 | B2 |
7083075 | Swayze et al. | Aug 2006 | B2 |
7083613 | Treat | Aug 2006 | B2 |
7083618 | Couture et al. | Aug 2006 | B2 |
7083619 | Truckai et al. | Aug 2006 | B2 |
7087054 | Truckai et al. | Aug 2006 | B2 |
7090637 | Danitz et al. | Aug 2006 | B2 |
7090672 | Underwood et al. | Aug 2006 | B2 |
7094235 | Francischelli | Aug 2006 | B2 |
7101371 | Dycus et al. | Sep 2006 | B2 |
7101372 | Dycus et al. | Sep 2006 | B2 |
7101373 | Dycus et al. | Sep 2006 | B2 |
7101378 | Salameh et al. | Sep 2006 | B2 |
7104834 | Robinson et al. | Sep 2006 | B2 |
7108695 | Witt et al. | Sep 2006 | B2 |
7111769 | Wales et al. | Sep 2006 | B2 |
7112201 | Truckai et al. | Sep 2006 | B2 |
7113831 | Hooven | Sep 2006 | B2 |
D531311 | Guerra et al. | Oct 2006 | S |
7117034 | Kronberg | Oct 2006 | B2 |
7118564 | Ritchie et al. | Oct 2006 | B2 |
7118570 | Tetzlaff et al. | Oct 2006 | B2 |
7118587 | Dycus et al. | Oct 2006 | B2 |
7119516 | Denning | Oct 2006 | B2 |
7124932 | Isaacson et al. | Oct 2006 | B2 |
7125409 | Truckai et al. | Oct 2006 | B2 |
7128720 | Podany | Oct 2006 | B2 |
7131860 | Sartor et al. | Nov 2006 | B2 |
7131970 | Moses et al. | Nov 2006 | B2 |
7135018 | Ryan et al. | Nov 2006 | B2 |
7135030 | Schwemberger et al. | Nov 2006 | B2 |
7137980 | Buysse et al. | Nov 2006 | B2 |
7143925 | Shelton, IV et al. | Dec 2006 | B2 |
7144403 | Booth | Dec 2006 | B2 |
7147138 | Shelton, IV | Dec 2006 | B2 |
7153315 | Miller | Dec 2006 | B2 |
D536093 | Nakajima et al. | Jan 2007 | S |
7156189 | Bar-Cohen et al. | Jan 2007 | B1 |
7156846 | Dycus et al. | Jan 2007 | B2 |
7156853 | Ratsu | Jan 2007 | B2 |
7157058 | Marhasin et al. | Jan 2007 | B2 |
7159750 | Racenet et al. | Jan 2007 | B2 |
7160259 | Tardy et al. | Jan 2007 | B2 |
7160296 | Pearson et al. | Jan 2007 | B2 |
7160298 | Lawes et al. | Jan 2007 | B2 |
7160299 | Baily | Jan 2007 | B2 |
7163548 | Stulen et al. | Jan 2007 | B2 |
7166103 | Carmel et al. | Jan 2007 | B2 |
7169144 | Hoey et al. | Jan 2007 | B2 |
7169146 | Truckai et al. | Jan 2007 | B2 |
7169156 | Hart | Jan 2007 | B2 |
7179254 | Pendekanti et al. | Feb 2007 | B2 |
7179271 | Friedman et al. | Feb 2007 | B2 |
7186253 | Truckai et al. | Mar 2007 | B2 |
7189233 | Truckai et al. | Mar 2007 | B2 |
7195631 | Dumbauld | Mar 2007 | B2 |
D541418 | Schechter et al. | Apr 2007 | S |
7198635 | Danek et al. | Apr 2007 | B2 |
7204820 | Akahoshi | Apr 2007 | B2 |
7207471 | Heinrich et al. | Apr 2007 | B2 |
7207997 | Shipp et al. | Apr 2007 | B2 |
7208005 | Frecker et al. | Apr 2007 | B2 |
7210881 | Greenberg | May 2007 | B2 |
7211079 | Treat | May 2007 | B2 |
7217128 | Atkin et al. | May 2007 | B2 |
7217269 | El-Galley et al. | May 2007 | B2 |
7220951 | Truckai et al. | May 2007 | B2 |
7223229 | Inman et al. | May 2007 | B2 |
7225964 | Mastri et al. | Jun 2007 | B2 |
7226447 | Uchida et al. | Jun 2007 | B2 |
7226448 | Bertolero et al. | Jun 2007 | B2 |
7229455 | Sakurai et al. | Jun 2007 | B2 |
7232440 | Dumbauld et al. | Jun 2007 | B2 |
7235071 | Gonnering | Jun 2007 | B2 |
7235073 | Levine et al. | Jun 2007 | B2 |
7241294 | Reschke | Jul 2007 | B2 |
7244262 | Wiener et al. | Jul 2007 | B2 |
7251531 | Mosher et al. | Jul 2007 | B2 |
7252641 | Thompson et al. | Aug 2007 | B2 |
7252667 | Moses et al. | Aug 2007 | B2 |
7258688 | Shah et al. | Aug 2007 | B1 |
7264618 | Murakami et al. | Sep 2007 | B2 |
7267677 | Johnson et al. | Sep 2007 | B2 |
7267685 | Butaric et al. | Sep 2007 | B2 |
7269873 | Brewer et al. | Sep 2007 | B2 |
7273483 | Wiener et al. | Sep 2007 | B2 |
D552241 | Bromley et al. | Oct 2007 | S |
7282048 | Goble et al. | Oct 2007 | B2 |
7285895 | Beaupre | Oct 2007 | B2 |
7287682 | Ezzat et al. | Oct 2007 | B1 |
7297149 | Vitali et al. | Nov 2007 | B2 |
7300431 | Dubrovsky | Nov 2007 | B2 |
7300435 | Wham et al. | Nov 2007 | B2 |
7300446 | Beaupre | Nov 2007 | B2 |
7300450 | Vleugels et al. | Nov 2007 | B2 |
7303531 | Lee et al. | Dec 2007 | B2 |
7303557 | Wham et al. | Dec 2007 | B2 |
7306597 | Manzo | Dec 2007 | B2 |
7307313 | Ohyanagi et al. | Dec 2007 | B2 |
7309849 | Truckai et al. | Dec 2007 | B2 |
7311706 | Schoenman et al. | Dec 2007 | B2 |
7311709 | Truckai et al. | Dec 2007 | B2 |
7317955 | McGreevy | Jan 2008 | B2 |
7318831 | Alvarez et al. | Jan 2008 | B2 |
7318832 | Young et al. | Jan 2008 | B2 |
7326236 | Andreas et al. | Feb 2008 | B2 |
7329257 | Kanehira et al. | Feb 2008 | B2 |
7331410 | Yong et al. | Feb 2008 | B2 |
7335165 | Truwit et al. | Feb 2008 | B2 |
7335997 | Wiener | Feb 2008 | B2 |
7337010 | Howard et al. | Feb 2008 | B2 |
7353068 | Tanaka et al. | Apr 2008 | B2 |
7354440 | Truckal et al. | Apr 2008 | B2 |
7357287 | Shelton, IV et al. | Apr 2008 | B2 |
7357802 | Palanker et al. | Apr 2008 | B2 |
7361172 | Cimino | Apr 2008 | B2 |
7364577 | Wham et al. | Apr 2008 | B2 |
7367976 | Lawes et al. | May 2008 | B2 |
7371227 | Zeiner | May 2008 | B2 |
RE40388 | Gines | Jun 2008 | E |
7380695 | Doll et al. | Jun 2008 | B2 |
7380696 | Shelton, IV et al. | Jun 2008 | B2 |
7381209 | Truckai et al. | Jun 2008 | B2 |
7384420 | Dycus et al. | Jun 2008 | B2 |
7390317 | Taylor et al. | Jun 2008 | B2 |
7396356 | Mollenauer | Jul 2008 | B2 |
7403224 | Fuller et al. | Jul 2008 | B2 |
7404508 | Smith et al. | Jul 2008 | B2 |
7407077 | Ortiz et al. | Aug 2008 | B2 |
7408288 | Hara | Aug 2008 | B2 |
7412008 | Lliev | Aug 2008 | B2 |
7416101 | Shelton, IV et al. | Aug 2008 | B2 |
7416437 | Sartor et al. | Aug 2008 | B2 |
D576725 | Shumer et al. | Sep 2008 | S |
7419490 | Falkenstein et al. | Sep 2008 | B2 |
7422139 | Shelton, IV et al. | Sep 2008 | B2 |
7422463 | Kuo | Sep 2008 | B2 |
7422582 | Malackowski et al. | Sep 2008 | B2 |
D578643 | Shumer et al. | Oct 2008 | S |
D578644 | Shumer et al. | Oct 2008 | S |
D578645 | Shumer et al. | Oct 2008 | S |
7431694 | Stefanchik et al. | Oct 2008 | B2 |
7431704 | Babaev | Oct 2008 | B2 |
7431720 | Pendekanti et al. | Oct 2008 | B2 |
7435582 | Zimmermann et al. | Oct 2008 | B2 |
7441684 | Shelton, IV et al. | Oct 2008 | B2 |
7442193 | Shields et al. | Oct 2008 | B2 |
7445621 | Dumbauld et al. | Nov 2008 | B2 |
7449004 | Yamada et al. | Nov 2008 | B2 |
7451904 | Shelton, IV | Nov 2008 | B2 |
7455208 | Wales et al. | Nov 2008 | B2 |
7455641 | Yamada et al. | Nov 2008 | B2 |
7462181 | Kraft et al. | Dec 2008 | B2 |
7464846 | Shelton, IV et al. | Dec 2008 | B2 |
7464849 | Shelton, IV et al. | Dec 2008 | B2 |
7472815 | Shelton, IV et al. | Jan 2009 | B2 |
7473145 | Ehr et al. | Jan 2009 | B2 |
7473253 | Dycus et al. | Jan 2009 | B2 |
7473263 | Johnston et al. | Jan 2009 | B2 |
7479148 | Beaupre | Jan 2009 | B2 |
7479160 | Branch et al. | Jan 2009 | B2 |
7481775 | Weikel, Jr. et al. | Jan 2009 | B2 |
7488285 | Honda et al. | Feb 2009 | B2 |
7488319 | Yates | Feb 2009 | B2 |
7491201 | Shields et al. | Feb 2009 | B2 |
7491202 | Odom et al. | Feb 2009 | B2 |
7494468 | Rabiner et al. | Feb 2009 | B2 |
7494501 | Ahlberg et al. | Feb 2009 | B2 |
7498080 | Tung et al. | Mar 2009 | B2 |
7502234 | Goliszek et al. | Mar 2009 | B2 |
7503893 | Kucklick | Mar 2009 | B2 |
7503895 | Rabiner et al. | Mar 2009 | B2 |
7506790 | Shelton, IV | Mar 2009 | B2 |
7506791 | Omaits et al. | Mar 2009 | B2 |
7507239 | Shadduck | Mar 2009 | B2 |
7510107 | Timm et al. | Mar 2009 | B2 |
7510556 | Nguyen et al. | Mar 2009 | B2 |
7513025 | Fischer | Apr 2009 | B2 |
7517349 | Truckai et al. | Apr 2009 | B2 |
7520865 | Radley Young et al. | Apr 2009 | B2 |
7524320 | Tierney et al. | Apr 2009 | B2 |
7530986 | Beaupre et al. | May 2009 | B2 |
7534243 | Chin et al. | May 2009 | B1 |
7535233 | Kojovic et al. | May 2009 | B2 |
D594983 | Price et al. | Jun 2009 | S |
7540871 | Gonnering | Jun 2009 | B2 |
7540872 | Schechter et al. | Jun 2009 | B2 |
7543730 | Marczyk | Jun 2009 | B1 |
7549564 | Boudreaux | Jun 2009 | B2 |
7550216 | Ofer et al. | Jun 2009 | B2 |
7553309 | Buysse et al. | Jun 2009 | B2 |
7554343 | Bromfield | Jun 2009 | B2 |
7559450 | Wales et al. | Jul 2009 | B2 |
7559452 | Wales et al. | Jul 2009 | B2 |
7563259 | Takahashi | Jul 2009 | B2 |
7566318 | Haefner | Jul 2009 | B2 |
7567012 | Namikawa | Jul 2009 | B2 |
7568603 | Shelton, IV et al. | Aug 2009 | B2 |
7569057 | Liu et al. | Aug 2009 | B2 |
7572266 | Young et al. | Aug 2009 | B2 |
7572268 | Babaev | Aug 2009 | B2 |
7578820 | Moore et al. | Aug 2009 | B2 |
7582084 | Swanson et al. | Sep 2009 | B2 |
7582086 | Privitera et al. | Sep 2009 | B2 |
7582087 | Tetzlaff et al. | Sep 2009 | B2 |
7582095 | Shipp et al. | Sep 2009 | B2 |
7585181 | Olsen | Sep 2009 | B2 |
7586289 | Andruk et al. | Sep 2009 | B2 |
7587536 | McLeod | Sep 2009 | B2 |
7588176 | Timm et al. | Sep 2009 | B2 |
7588177 | Racenet | Sep 2009 | B2 |
7594925 | Danek et al. | Sep 2009 | B2 |
7597693 | Garrison | Oct 2009 | B2 |
7601119 | Shahinian | Oct 2009 | B2 |
7601136 | Akahoshi | Oct 2009 | B2 |
7604150 | Boudreaux | Oct 2009 | B2 |
7607557 | Shelton, IV et al. | Oct 2009 | B2 |
7617961 | Viola | Nov 2009 | B2 |
7621930 | Houser | Nov 2009 | B2 |
7625370 | Hart et al. | Dec 2009 | B2 |
7628791 | Garrison et al. | Dec 2009 | B2 |
7628792 | Guerra | Dec 2009 | B2 |
7632267 | Dahla | Dec 2009 | B2 |
7632269 | Truckai et al. | Dec 2009 | B2 |
7637410 | Marczyk | Dec 2009 | B2 |
7641653 | Dalla Betta et al. | Jan 2010 | B2 |
7641671 | Crainich | Jan 2010 | B2 |
7644848 | Swayze et al. | Jan 2010 | B2 |
7645240 | Thompson et al. | Jan 2010 | B2 |
7645277 | McClurken et al. | Jan 2010 | B2 |
7645278 | Ichihashi et al. | Jan 2010 | B2 |
7648499 | Orszulak et al. | Jan 2010 | B2 |
7649410 | Andersen et al. | Jan 2010 | B2 |
7654431 | Hueil et al. | Feb 2010 | B2 |
7655003 | Lorang et al. | Feb 2010 | B2 |
7658311 | Boudreaux | Feb 2010 | B2 |
7659833 | Warner et al. | Feb 2010 | B2 |
7662151 | Crompton, Jr. et al. | Feb 2010 | B2 |
7665647 | Shelton, IV et al. | Feb 2010 | B2 |
7666206 | Taniguchi et al. | Feb 2010 | B2 |
7667592 | Ohyama et al. | Feb 2010 | B2 |
7670334 | Hueil et al. | Mar 2010 | B2 |
7670338 | Albrecht et al. | Mar 2010 | B2 |
7674263 | Ryan | Mar 2010 | B2 |
7678069 | Baker et al. | Mar 2010 | B1 |
7678105 | McGreevy et al. | Mar 2010 | B2 |
7678125 | Shipp | Mar 2010 | B2 |
7682366 | Sakurai et al. | Mar 2010 | B2 |
7686770 | Cohen | Mar 2010 | B2 |
7686826 | Lee et al. | Mar 2010 | B2 |
7688028 | Phillips et al. | Mar 2010 | B2 |
7691095 | Bednarek et al. | Apr 2010 | B2 |
7691098 | Wallace et al. | Apr 2010 | B2 |
7696441 | Kataoka | Apr 2010 | B2 |
7699846 | Ryan | Apr 2010 | B2 |
7703459 | Saadat et al. | Apr 2010 | B2 |
7703653 | Shah et al. | Apr 2010 | B2 |
7708735 | Chapman et al. | May 2010 | B2 |
7708751 | Hughes et al. | May 2010 | B2 |
7708758 | Lee et al. | May 2010 | B2 |
7708768 | Danek et al. | May 2010 | B2 |
7713202 | Boukhny et al. | May 2010 | B2 |
7713267 | Pozzato | May 2010 | B2 |
7714481 | Sakai | May 2010 | B2 |
7717312 | Beetel | May 2010 | B2 |
7717914 | Kimura | May 2010 | B2 |
7717915 | Miyazawa | May 2010 | B2 |
7721935 | Racenet et al. | May 2010 | B2 |
7722527 | Bouchier et al. | May 2010 | B2 |
7722607 | Dumbauld et al. | May 2010 | B2 |
D618797 | Price et al. | Jun 2010 | S |
7726537 | Olson et al. | Jun 2010 | B2 |
7727177 | Bayat | Jun 2010 | B2 |
7731717 | Odom et al. | Jun 2010 | B2 |
7738969 | Bleich | Jun 2010 | B2 |
7740594 | Hibner | Jun 2010 | B2 |
7744615 | Couture | Jun 2010 | B2 |
7749240 | Takahashi et al. | Jul 2010 | B2 |
7751115 | Song | Jul 2010 | B2 |
7753245 | Boudreaux et al. | Jul 2010 | B2 |
7753904 | Shelton, IV et al. | Jul 2010 | B2 |
7753908 | Swanson | Jul 2010 | B2 |
7762445 | Heinrich et al. | Jul 2010 | B2 |
D621503 | Otten et al. | Aug 2010 | S |
7766210 | Shelton, IV et al. | Aug 2010 | B2 |
7766693 | Sartor et al. | Aug 2010 | B2 |
7766910 | Hixson et al. | Aug 2010 | B2 |
7768510 | Tsai et al. | Aug 2010 | B2 |
7770774 | Mastri et al. | Aug 2010 | B2 |
7770775 | Shelton, IV et al. | Aug 2010 | B2 |
7771425 | Dycus et al. | Aug 2010 | B2 |
7771444 | Patel et al. | Aug 2010 | B2 |
7775972 | Brock et al. | Aug 2010 | B2 |
7776036 | Schechter et al. | Aug 2010 | B2 |
7776037 | Odom | Aug 2010 | B2 |
7778733 | Nowlin et al. | Aug 2010 | B2 |
7780054 | Wales | Aug 2010 | B2 |
7780593 | Ueno et al. | Aug 2010 | B2 |
7780651 | Madhani et al. | Aug 2010 | B2 |
7780659 | Okada et al. | Aug 2010 | B2 |
7780663 | Yates et al. | Aug 2010 | B2 |
7784662 | Wales et al. | Aug 2010 | B2 |
7784663 | Shelton, IV | Aug 2010 | B2 |
7789883 | Takashino et al. | Sep 2010 | B2 |
7793814 | Racenet et al. | Sep 2010 | B2 |
7794475 | Hess et al. | Sep 2010 | B2 |
7796969 | Kelly et al. | Sep 2010 | B2 |
7798386 | Schall et al. | Sep 2010 | B2 |
7799020 | Shores et al. | Sep 2010 | B2 |
7799027 | Hafner | Sep 2010 | B2 |
7799045 | Masuda | Sep 2010 | B2 |
7803152 | Honda et al. | Sep 2010 | B2 |
7803156 | Eder et al. | Sep 2010 | B2 |
7803168 | Gifford et al. | Sep 2010 | B2 |
7806891 | Nowlin et al. | Oct 2010 | B2 |
7810693 | Broehl et al. | Oct 2010 | B2 |
7811283 | Moses et al. | Oct 2010 | B2 |
7815238 | Cao | Oct 2010 | B2 |
7815641 | Dodde et al. | Oct 2010 | B2 |
7819298 | Hall et al. | Oct 2010 | B2 |
7819299 | Shelton, IV et al. | Oct 2010 | B2 |
7819819 | Quick et al. | Oct 2010 | B2 |
7819872 | Johnson et al. | Oct 2010 | B2 |
7821143 | Wiener | Oct 2010 | B2 |
D627066 | Romero | Nov 2010 | S |
7824401 | Manzo et al. | Nov 2010 | B2 |
7832408 | Shelton, IV et al. | Nov 2010 | B2 |
7832611 | Boyden et al. | Nov 2010 | B2 |
7832612 | Baxter, III et al. | Nov 2010 | B2 |
7834484 | Sartor | Nov 2010 | B2 |
7837699 | Yamada et al. | Nov 2010 | B2 |
7845537 | Shelton, IV et al. | Dec 2010 | B2 |
7846155 | Houser et al. | Dec 2010 | B2 |
7846159 | Morrison et al. | Dec 2010 | B2 |
7846160 | Payne et al. | Dec 2010 | B2 |
7846161 | Dumbauld et al. | Dec 2010 | B2 |
7854735 | Houser et al. | Dec 2010 | B2 |
D631155 | Peine et al. | Jan 2011 | S |
7861906 | Doll et al. | Jan 2011 | B2 |
7862560 | Marion | Jan 2011 | B2 |
7862561 | Swanson et al. | Jan 2011 | B2 |
7867228 | Nobis et al. | Jan 2011 | B2 |
7871392 | Sartor | Jan 2011 | B2 |
7871423 | Livneh | Jan 2011 | B2 |
7876030 | Taki et al. | Jan 2011 | B2 |
D631965 | Price et al. | Feb 2011 | S |
7877852 | Unger et al. | Feb 2011 | B2 |
7878991 | Babaev | Feb 2011 | B2 |
7879029 | Jimenez | Feb 2011 | B2 |
7879033 | Sartor et al. | Feb 2011 | B2 |
7879035 | Garrison et al. | Feb 2011 | B2 |
7879070 | Ortiz et al. | Feb 2011 | B2 |
7883475 | Dupont et al. | Feb 2011 | B2 |
7892606 | Thies et al. | Feb 2011 | B2 |
7896875 | Heim et al. | Mar 2011 | B2 |
7897792 | Iikura et al. | Mar 2011 | B2 |
7901400 | Wham et al. | Mar 2011 | B2 |
7901423 | Stulen et al. | Mar 2011 | B2 |
7905881 | Masuda et al. | Mar 2011 | B2 |
7909220 | Viola | Mar 2011 | B2 |
7909820 | Lipson et al. | Mar 2011 | B2 |
7909824 | Masuda et al. | Mar 2011 | B2 |
7918848 | Lau et al. | Apr 2011 | B2 |
7919184 | Mohapatra et al. | Apr 2011 | B2 |
7922061 | Shelton, IV et al. | Apr 2011 | B2 |
7922651 | Yamada et al. | Apr 2011 | B2 |
7931611 | Novak et al. | Apr 2011 | B2 |
7931649 | Couture et al. | Apr 2011 | B2 |
D637288 | Houghton | May 2011 | S |
D638540 | Ijiri et al. | May 2011 | S |
7935114 | Takashino et al. | May 2011 | B2 |
7936203 | Zimlich | May 2011 | B2 |
7951095 | Makin et al. | May 2011 | B2 |
7951165 | Golden et al. | May 2011 | B2 |
7955331 | Truckai et al. | Jun 2011 | B2 |
7956620 | Gilbert | Jun 2011 | B2 |
7959050 | Smith et al. | Jun 2011 | B2 |
7959626 | Hong et al. | Jun 2011 | B2 |
7963963 | Francischelli et al. | Jun 2011 | B2 |
7967602 | Lindquist | Jun 2011 | B2 |
7972328 | Wham et al. | Jul 2011 | B2 |
7972329 | Refior et al. | Jul 2011 | B2 |
7975895 | Milliman | Jul 2011 | B2 |
7976544 | McClurken et al. | Jul 2011 | B2 |
7980443 | Scheib et al. | Jul 2011 | B2 |
7981050 | Ritchart et al. | Jul 2011 | B2 |
7981113 | Truckai et al. | Jul 2011 | B2 |
7997278 | Utley et al. | Aug 2011 | B2 |
7998157 | Culp et al. | Aug 2011 | B2 |
8002732 | Visconti | Aug 2011 | B2 |
8002770 | Swanson et al. | Aug 2011 | B2 |
8020743 | Shelton, IV | Sep 2011 | B2 |
8025672 | Novak et al. | Sep 2011 | B2 |
8028885 | Smith et al. | Oct 2011 | B2 |
8033173 | Ehlert et al. | Oct 2011 | B2 |
8034049 | Odom et al. | Oct 2011 | B2 |
8038693 | Allen | Oct 2011 | B2 |
8048070 | O'Brien et al. | Nov 2011 | B2 |
8052672 | Laufer et al. | Nov 2011 | B2 |
8055208 | Lilia et al. | Nov 2011 | B2 |
8056720 | Hawkes | Nov 2011 | B2 |
8056787 | Boudreaux et al. | Nov 2011 | B2 |
8057468 | Konesky | Nov 2011 | B2 |
8057498 | Robertson | Nov 2011 | B2 |
8058771 | Giordano et al. | Nov 2011 | B2 |
8061014 | Smith et al. | Nov 2011 | B2 |
8066167 | Measamer et al. | Nov 2011 | B2 |
8070036 | Knodel | Dec 2011 | B1 |
8070711 | Bassinger et al. | Dec 2011 | B2 |
8070762 | Escudero et al. | Dec 2011 | B2 |
8075555 | Truckai et al. | Dec 2011 | B2 |
8075558 | Truckai et al. | Dec 2011 | B2 |
8089197 | Rinner et al. | Jan 2012 | B2 |
8092475 | Cotter et al. | Jan 2012 | B2 |
8096459 | Ortiz et al. | Jan 2012 | B2 |
8097012 | Kagarise | Jan 2012 | B2 |
8100894 | Mucko et al. | Jan 2012 | B2 |
8105230 | Honda et al. | Jan 2012 | B2 |
8105323 | Buysse et al. | Jan 2012 | B2 |
8105324 | Palanker et al. | Jan 2012 | B2 |
8114104 | Young et al. | Feb 2012 | B2 |
8118276 | Sanders et al. | Feb 2012 | B2 |
8128624 | Couture et al. | Mar 2012 | B2 |
8133218 | Daw et al. | Mar 2012 | B2 |
8136712 | Zingman | Mar 2012 | B2 |
8141762 | Bedi et al. | Mar 2012 | B2 |
8142421 | Cooper et al. | Mar 2012 | B2 |
8142461 | Houser et al. | Mar 2012 | B2 |
8147485 | Wham et al. | Apr 2012 | B2 |
8147488 | Masuda | Apr 2012 | B2 |
8147508 | Madan et al. | Apr 2012 | B2 |
8152801 | Goldberg et al. | Apr 2012 | B2 |
8152825 | Madan et al. | Apr 2012 | B2 |
8157145 | Shelton, IV et al. | Apr 2012 | B2 |
8161977 | Shelton, IV et al. | Apr 2012 | B2 |
8162966 | Connor et al. | Apr 2012 | B2 |
8170717 | Sutherland et al. | May 2012 | B2 |
8172846 | Brunnett et al. | May 2012 | B2 |
8172870 | Shipp | May 2012 | B2 |
8177800 | Spitz et al. | May 2012 | B2 |
8182502 | Stulen et al. | May 2012 | B2 |
8186560 | Hess et al. | May 2012 | B2 |
8186877 | Klimovitch et al. | May 2012 | B2 |
8187267 | Pappone et al. | May 2012 | B2 |
D661801 | Price et al. | Jun 2012 | S |
D661802 | Price et al. | Jun 2012 | S |
D661803 | Price et al. | Jun 2012 | S |
D661804 | Price et al. | Jun 2012 | S |
8197472 | Lau et al. | Jun 2012 | B2 |
8197479 | Olson et al. | Jun 2012 | B2 |
8197502 | Smith et al. | Jun 2012 | B2 |
8207651 | Gilbert | Jun 2012 | B2 |
8210411 | Yates et al. | Jul 2012 | B2 |
8211100 | Podhajsky et al. | Jul 2012 | B2 |
8220688 | Laurent et al. | Jul 2012 | B2 |
8221306 | Okada et al. | Jul 2012 | B2 |
8221415 | Francischelli | Jul 2012 | B2 |
8221418 | Prakash et al. | Jul 2012 | B2 |
8226580 | Govari et al. | Jul 2012 | B2 |
8226665 | Cohen | Jul 2012 | B2 |
8226675 | Houser et al. | Jul 2012 | B2 |
8231607 | Takuma | Jul 2012 | B2 |
8235917 | Joseph et al. | Aug 2012 | B2 |
8236018 | Yoshimine et al. | Aug 2012 | B2 |
8236019 | Houser | Aug 2012 | B2 |
8236020 | Smith et al. | Aug 2012 | B2 |
8241235 | Kahler et al. | Aug 2012 | B2 |
8241271 | Millman et al. | Aug 2012 | B2 |
8241282 | Unger et al. | Aug 2012 | B2 |
8241283 | Guerra et al. | Aug 2012 | B2 |
8241284 | Dycus et al. | Aug 2012 | B2 |
8241312 | Messerly | Aug 2012 | B2 |
8246575 | Viola | Aug 2012 | B2 |
8246615 | Behnke | Aug 2012 | B2 |
8246616 | Amoah et al. | Aug 2012 | B2 |
8246618 | Bucciaglia et al. | Aug 2012 | B2 |
8246642 | Houser et al. | Aug 2012 | B2 |
8251994 | McKenna et al. | Aug 2012 | B2 |
8252012 | Stulen | Aug 2012 | B2 |
8253303 | Giordano et al. | Aug 2012 | B2 |
8257377 | Wiener et al. | Sep 2012 | B2 |
8257387 | Cunningham | Sep 2012 | B2 |
8262563 | Bakos et al. | Sep 2012 | B2 |
8267300 | Boudreaux | Sep 2012 | B2 |
8267935 | Couture et al. | Sep 2012 | B2 |
8273087 | Kimura et al. | Sep 2012 | B2 |
D669992 | Schafer et al. | Oct 2012 | S |
D669993 | Merchant et al. | Oct 2012 | S |
8277446 | Heard | Oct 2012 | B2 |
8277447 | Garrison et al. | Oct 2012 | B2 |
8277471 | Wiener et al. | Oct 2012 | B2 |
8282581 | Zhao et al. | Oct 2012 | B2 |
8282669 | Gerber et al. | Oct 2012 | B2 |
8286846 | Smith et al. | Oct 2012 | B2 |
8287485 | Kimura et al. | Oct 2012 | B2 |
8287528 | Wham et al. | Oct 2012 | B2 |
8287532 | Carroll et al. | Oct 2012 | B2 |
8292886 | Kerr et al. | Oct 2012 | B2 |
8292888 | Whitman | Oct 2012 | B2 |
8292905 | Taylor et al. | Oct 2012 | B2 |
8295902 | Salahieh et al. | Oct 2012 | B2 |
8298223 | Wham et al. | Oct 2012 | B2 |
8298225 | Gilbert | Oct 2012 | B2 |
8298232 | Unger | Oct 2012 | B2 |
8298233 | Mueller | Oct 2012 | B2 |
8303576 | Brock | Nov 2012 | B2 |
8303579 | Shibata | Nov 2012 | B2 |
8303580 | Wham et al. | Nov 2012 | B2 |
8303583 | Hosier et al. | Nov 2012 | B2 |
8303613 | Crandall et al. | Nov 2012 | B2 |
8306629 | Mioduski et al. | Nov 2012 | B2 |
8308040 | Huang et al. | Nov 2012 | B2 |
8319400 | Houser et al. | Nov 2012 | B2 |
8323302 | Robertson et al. | Dec 2012 | B2 |
8323310 | Kingsley | Dec 2012 | B2 |
8328061 | Kasvikis | Dec 2012 | B2 |
8328761 | Widenhouse et al. | Dec 2012 | B2 |
8328802 | Deville et al. | Dec 2012 | B2 |
8328833 | Cuny | Dec 2012 | B2 |
8328834 | Isaacs et al. | Dec 2012 | B2 |
8333764 | Francischelli et al. | Dec 2012 | B2 |
8333778 | Smith et al. | Dec 2012 | B2 |
8333779 | Smith et al. | Dec 2012 | B2 |
8334468 | Palmer et al. | Dec 2012 | B2 |
8334635 | Voegele et al. | Dec 2012 | B2 |
8337407 | Quistgaard et al. | Dec 2012 | B2 |
8338726 | Palmer et al. | Dec 2012 | B2 |
8343146 | Godara et al. | Jan 2013 | B2 |
8344596 | Nield et al. | Jan 2013 | B2 |
8348880 | Messerly et al. | Jan 2013 | B2 |
8348947 | Takashino et al. | Jan 2013 | B2 |
8348967 | Stulen | Jan 2013 | B2 |
8353297 | Dacquay et al. | Jan 2013 | B2 |
8357103 | Mark et al. | Jan 2013 | B2 |
8357144 | Whitman et al. | Jan 2013 | B2 |
8357149 | Govari et al. | Jan 2013 | B2 |
8357158 | McKenna et al. | Jan 2013 | B2 |
8361066 | Long et al. | Jan 2013 | B2 |
8361072 | Dumbauld et al. | Jan 2013 | B2 |
8361569 | Saito et al. | Jan 2013 | B2 |
8366727 | Witt et al. | Feb 2013 | B2 |
8372064 | Douglass et al. | Feb 2013 | B2 |
8372099 | Deville et al. | Feb 2013 | B2 |
8372101 | Smith et al. | Feb 2013 | B2 |
8372102 | Stulen et al. | Feb 2013 | B2 |
8374670 | Selkee | Feb 2013 | B2 |
8377044 | Coe et al. | Feb 2013 | B2 |
8377059 | Deville et al. | Feb 2013 | B2 |
8377085 | Smith et al. | Feb 2013 | B2 |
8382748 | Geisel | Feb 2013 | B2 |
8382775 | Bender et al. | Feb 2013 | B1 |
8382782 | Robertson et al. | Feb 2013 | B2 |
8382792 | Chojin | Feb 2013 | B2 |
8388646 | Chojin | Mar 2013 | B2 |
8388647 | Nau, Jr. et al. | Mar 2013 | B2 |
8393514 | Shelton, IV et al. | Mar 2013 | B2 |
8394115 | Houser et al. | Mar 2013 | B2 |
8397971 | Yates et al. | Mar 2013 | B2 |
8398394 | Sauter et al. | Mar 2013 | B2 |
8403926 | Nobis et al. | Mar 2013 | B2 |
8403945 | Whitfield et al. | Mar 2013 | B2 |
8403948 | Deville et al. | Mar 2013 | B2 |
8403949 | Palmer et al. | Mar 2013 | B2 |
8403950 | Palmer et al. | Mar 2013 | B2 |
8409234 | Stabler et al. | Apr 2013 | B2 |
8414577 | Boudreaux et al. | Apr 2013 | B2 |
8418073 | Mohr et al. | Apr 2013 | B2 |
8418349 | Smith et al. | Apr 2013 | B2 |
8419757 | Smith et al. | Apr 2013 | B2 |
8419758 | Smith et al. | Apr 2013 | B2 |
8419759 | Dietz | Apr 2013 | B2 |
8423182 | Robinson et al. | Apr 2013 | B2 |
8425410 | Murray et al. | Apr 2013 | B2 |
8425545 | Smith et al. | Apr 2013 | B2 |
8430811 | Hess et al. | Apr 2013 | B2 |
8430874 | Newton et al. | Apr 2013 | B2 |
8430876 | Kappus et al. | Apr 2013 | B2 |
8430897 | Novak et al. | Apr 2013 | B2 |
8430898 | Wiener et al. | Apr 2013 | B2 |
8435257 | Smith et al. | May 2013 | B2 |
8437832 | Govari et al. | May 2013 | B2 |
8439912 | Cunningham et al. | May 2013 | B2 |
8439939 | Deville et al. | May 2013 | B2 |
8444637 | Podmore et al. | May 2013 | B2 |
8444662 | Palmer et al. | May 2013 | B2 |
8444663 | Houser et al. | May 2013 | B2 |
8444664 | Balanev et al. | May 2013 | B2 |
8453906 | Huang et al. | Jun 2013 | B2 |
8454599 | Inagaki et al. | Jun 2013 | B2 |
8454639 | Du et al. | Jun 2013 | B2 |
8459525 | Yates et al. | Jun 2013 | B2 |
8460284 | Aronow et al. | Jun 2013 | B2 |
8460288 | Tamai et al. | Jun 2013 | B2 |
8460292 | Truckai et al. | Jun 2013 | B2 |
8461744 | Wiener et al. | Jun 2013 | B2 |
8469981 | Robertson et al. | Jun 2013 | B2 |
8471685 | Shingai | Jun 2013 | B2 |
8479969 | Shelton, IV | Jul 2013 | B2 |
8480703 | Nicholas et al. | Jul 2013 | B2 |
8484833 | Cunningham et al. | Jul 2013 | B2 |
8485413 | Scheib et al. | Jul 2013 | B2 |
8485970 | Widenhouse et al. | Jul 2013 | B2 |
8486057 | Behnke, II | Jul 2013 | B2 |
8486096 | Robertson et al. | Jul 2013 | B2 |
8491578 | Manwaring et al. | Jul 2013 | B2 |
8491625 | Horner | Jul 2013 | B2 |
8496682 | Guerra et al. | Jul 2013 | B2 |
D687549 | Johnson et al. | Aug 2013 | S |
8506555 | Ruiz Morales | Aug 2013 | B2 |
8509318 | Tailliet | Aug 2013 | B2 |
8512336 | Couture | Aug 2013 | B2 |
8512337 | Francischelli et al. | Aug 2013 | B2 |
8512359 | Whitman et al. | Aug 2013 | B2 |
8512364 | Kowalski et al. | Aug 2013 | B2 |
8512365 | Wiener et al. | Aug 2013 | B2 |
8518067 | Masuda et al. | Aug 2013 | B2 |
8521331 | Itkowitz | Aug 2013 | B2 |
8523882 | Huitema et al. | Sep 2013 | B2 |
8523889 | Stulen et al. | Sep 2013 | B2 |
8528563 | Gruber | Sep 2013 | B2 |
8529437 | Taylor et al. | Sep 2013 | B2 |
8529565 | Masuda et al. | Sep 2013 | B2 |
8531064 | Robertson et al. | Sep 2013 | B2 |
8535308 | Govari et al. | Sep 2013 | B2 |
8535311 | Schall | Sep 2013 | B2 |
8535340 | Allen | Sep 2013 | B2 |
8535341 | Allen | Sep 2013 | B2 |
8540128 | Shelton, IV et al. | Sep 2013 | B2 |
8546996 | Messerly et al. | Oct 2013 | B2 |
8546999 | Houser et al. | Oct 2013 | B2 |
8551077 | Main et al. | Oct 2013 | B2 |
8551086 | Kimura et al. | Oct 2013 | B2 |
8556929 | Harper et al. | Oct 2013 | B2 |
8561870 | Baxter, III et al. | Oct 2013 | B2 |
8562592 | Conlon et al. | Oct 2013 | B2 |
8562598 | Falkenstein et al. | Oct 2013 | B2 |
8562600 | Kirkpatrick et al. | Oct 2013 | B2 |
8562604 | Nishimura | Oct 2013 | B2 |
8568390 | Mueller | Oct 2013 | B2 |
8568397 | Horner et al. | Oct 2013 | B2 |
8568400 | Gilbert | Oct 2013 | B2 |
8568412 | Brandt et al. | Oct 2013 | B2 |
8569997 | Lee | Oct 2013 | B2 |
8573461 | Shelton, IV et al. | Nov 2013 | B2 |
8573465 | Shelton, IV | Nov 2013 | B2 |
8574231 | Boudreaux et al. | Nov 2013 | B2 |
8574253 | Gruber et al. | Nov 2013 | B2 |
8579176 | Smith et al. | Nov 2013 | B2 |
8579897 | Vakharia et al. | Nov 2013 | B2 |
8579928 | Robertson et al. | Nov 2013 | B2 |
8579937 | Gresham | Nov 2013 | B2 |
8585727 | Polo | Nov 2013 | B2 |
8588371 | Ogawa et al. | Nov 2013 | B2 |
8591459 | Clymer et al. | Nov 2013 | B2 |
8591506 | Wham et al. | Nov 2013 | B2 |
8591536 | Robertson | Nov 2013 | B2 |
D695407 | Price et al. | Dec 2013 | S |
D696631 | Price et al. | Dec 2013 | S |
8596513 | Olson et al. | Dec 2013 | B2 |
8597193 | Grunwald et al. | Dec 2013 | B2 |
8597287 | Benamou et al. | Dec 2013 | B2 |
8602031 | Reis et al. | Dec 2013 | B2 |
8602288 | Shelton, IV et al. | Dec 2013 | B2 |
8603085 | Jimenez | Dec 2013 | B2 |
8603089 | Viola | Dec 2013 | B2 |
8608044 | Hueil et al. | Dec 2013 | B2 |
8608045 | Smith et al. | Dec 2013 | B2 |
8608745 | Guzman et al. | Dec 2013 | B2 |
8613383 | Beckman et al. | Dec 2013 | B2 |
8616431 | Timm et al. | Dec 2013 | B2 |
8617152 | Werneth et al. | Dec 2013 | B2 |
8617194 | Beaupre | Dec 2013 | B2 |
8622274 | Yates et al. | Jan 2014 | B2 |
8623011 | Spivey | Jan 2014 | B2 |
8623016 | Fischer | Jan 2014 | B2 |
8623044 | Timm et al. | Jan 2014 | B2 |
8628529 | Aldridge et al. | Jan 2014 | B2 |
8628534 | Jones et al. | Jan 2014 | B2 |
8632461 | Glossop | Jan 2014 | B2 |
8636736 | Yates et al. | Jan 2014 | B2 |
8638428 | Brown | Jan 2014 | B2 |
8640788 | Dachs, II et al. | Feb 2014 | B2 |
8641663 | Kirschenman et al. | Feb 2014 | B2 |
8647350 | Mohan et al. | Feb 2014 | B2 |
8650728 | Wan et al. | Feb 2014 | B2 |
8652120 | Giordano et al. | Feb 2014 | B2 |
8652132 | Tsuchiya et al. | Feb 2014 | B2 |
8652155 | Houser et al. | Feb 2014 | B2 |
8657489 | Ladurner et al. | Feb 2014 | B2 |
8659208 | Rose et al. | Feb 2014 | B1 |
8663214 | Weinberg et al. | Mar 2014 | B2 |
8663220 | Wiener et al. | Mar 2014 | B2 |
8663222 | Anderson et al. | Mar 2014 | B2 |
8663223 | Masuda et al. | Mar 2014 | B2 |
8663262 | Smith et al. | Mar 2014 | B2 |
8668691 | Heard | Mar 2014 | B2 |
8668710 | Slipszenko et al. | Mar 2014 | B2 |
8684253 | Giordano et al. | Apr 2014 | B2 |
8685016 | Wham et al. | Apr 2014 | B2 |
8685020 | Weizman et al. | Apr 2014 | B2 |
8690582 | Rohrbach et al. | Apr 2014 | B2 |
8695866 | Leimbach et al. | Apr 2014 | B2 |
8696366 | Chen et al. | Apr 2014 | B2 |
8696665 | Hunt et al. | Apr 2014 | B2 |
8696666 | Sanai et al. | Apr 2014 | B2 |
8696917 | Petisce et al. | Apr 2014 | B2 |
8702609 | Hadjicostis | Apr 2014 | B2 |
8702704 | Shelton, IV et al. | Apr 2014 | B2 |
8704425 | Giordano et al. | Apr 2014 | B2 |
8708213 | Shelton, IV et al. | Apr 2014 | B2 |
8709008 | Willis et al. | Apr 2014 | B2 |
8709031 | Stulen | Apr 2014 | B2 |
8709035 | Johnson et al. | Apr 2014 | B2 |
8715270 | Weitzner et al. | May 2014 | B2 |
8715277 | Weizman | May 2014 | B2 |
8721640 | Taylor et al. | May 2014 | B2 |
8721657 | Kondoh et al. | May 2014 | B2 |
8733613 | Huitema et al. | May 2014 | B2 |
8733614 | Ross et al. | May 2014 | B2 |
8734443 | Hixson et al. | May 2014 | B2 |
8738110 | Tabada et al. | May 2014 | B2 |
8747238 | Shelton, IV et al. | Jun 2014 | B2 |
8747351 | Schultz | Jun 2014 | B2 |
8747404 | Boudreaux et al. | Jun 2014 | B2 |
8749116 | Messerly et al. | Jun 2014 | B2 |
8752264 | Ackley et al. | Jun 2014 | B2 |
8752749 | Moore et al. | Jun 2014 | B2 |
8753338 | Widenhouse et al. | Jun 2014 | B2 |
8754570 | Voegele et al. | Jun 2014 | B2 |
8758342 | Bales et al. | Jun 2014 | B2 |
8758352 | Cooper et al. | Jun 2014 | B2 |
8758391 | Swayze et al. | Jun 2014 | B2 |
8764735 | Coe et al. | Jul 2014 | B2 |
8764747 | Cummings et al. | Jul 2014 | B2 |
8767970 | Eppolito | Jul 2014 | B2 |
8770459 | Racenet et al. | Jul 2014 | B2 |
8771269 | Sherman et al. | Jul 2014 | B2 |
8771270 | Burbank | Jul 2014 | B2 |
8771293 | Surti et al. | Jul 2014 | B2 |
8773001 | Wiener et al. | Jul 2014 | B2 |
8777944 | Frankhouser et al. | Jul 2014 | B2 |
8777945 | Floume et al. | Jul 2014 | B2 |
8779648 | Giordano et al. | Jul 2014 | B2 |
8783541 | Shelton, IV et al. | Jul 2014 | B2 |
8784415 | Malackowski et al. | Jul 2014 | B2 |
8784418 | Romero | Jul 2014 | B2 |
8790342 | Stulen et al. | Jul 2014 | B2 |
8795274 | Hanna | Aug 2014 | B2 |
8795275 | Hafner | Aug 2014 | B2 |
8795276 | Dietz et al. | Aug 2014 | B2 |
8795327 | Dietz et al. | Aug 2014 | B2 |
8800838 | Shelton, IV | Aug 2014 | B2 |
8801710 | Ullrich et al. | Aug 2014 | B2 |
8801752 | Fortier et al. | Aug 2014 | B2 |
8808204 | Irisawa et al. | Aug 2014 | B2 |
8808319 | Houser et al. | Aug 2014 | B2 |
8814856 | Elmouelhi et al. | Aug 2014 | B2 |
8814870 | Paraschiv et al. | Aug 2014 | B2 |
8820605 | Shelton, IV | Sep 2014 | B2 |
8821388 | Naito et al. | Sep 2014 | B2 |
8827992 | Koss et al. | Sep 2014 | B2 |
8827995 | Schaller et al. | Sep 2014 | B2 |
8834466 | Cummings et al. | Sep 2014 | B2 |
8834518 | Faller et al. | Sep 2014 | B2 |
8844789 | Shelton, IV et al. | Sep 2014 | B2 |
8845537 | Tanaka et al. | Sep 2014 | B2 |
8845630 | Mehta et al. | Sep 2014 | B2 |
8848808 | Dress | Sep 2014 | B2 |
8851354 | Swensgard et al. | Oct 2014 | B2 |
8852184 | Kucklick | Oct 2014 | B2 |
8858547 | Brogna | Oct 2014 | B2 |
8862955 | Cesari | Oct 2014 | B2 |
8864749 | Okada | Oct 2014 | B2 |
8864757 | Klimovitch et al. | Oct 2014 | B2 |
8864761 | Johnson et al. | Oct 2014 | B2 |
8870865 | Frankhouser et al. | Oct 2014 | B2 |
8874220 | Draghici et al. | Oct 2014 | B2 |
8876726 | Amit et al. | Nov 2014 | B2 |
8876858 | Braun | Nov 2014 | B2 |
8882766 | Couture et al. | Nov 2014 | B2 |
8882791 | Stulen | Nov 2014 | B2 |
8888776 | Dietz et al. | Nov 2014 | B2 |
8888783 | Young | Nov 2014 | B2 |
8888809 | Davison et al. | Nov 2014 | B2 |
8899462 | Kostrzewski et al. | Dec 2014 | B2 |
8900259 | Houser et al. | Dec 2014 | B2 |
8906016 | Boudreaux et al. | Dec 2014 | B2 |
8906017 | Rioux et al. | Dec 2014 | B2 |
8911438 | Swoyer et al. | Dec 2014 | B2 |
8911460 | Neurohr et al. | Dec 2014 | B2 |
8920412 | Fritz et al. | Dec 2014 | B2 |
8920414 | Stone et al. | Dec 2014 | B2 |
8920421 | Rupp | Dec 2014 | B2 |
8926607 | Norvell et al. | Jan 2015 | B2 |
8926608 | Bacher et al. | Jan 2015 | B2 |
8926620 | Chasmawala et al. | Jan 2015 | B2 |
8931682 | Timm et al. | Jan 2015 | B2 |
8932282 | Gilbert | Jan 2015 | B2 |
8932299 | Bono et al. | Jan 2015 | B2 |
8936614 | Allen, IV | Jan 2015 | B2 |
8939974 | Boudreaux et al. | Jan 2015 | B2 |
8945126 | Garrison et al. | Feb 2015 | B2 |
8951248 | Messerly et al. | Feb 2015 | B2 |
8951272 | Robertson et al. | Feb 2015 | B2 |
8956349 | Aldridge et al. | Feb 2015 | B2 |
8960520 | McCuen | Feb 2015 | B2 |
8961515 | Twomey et al. | Feb 2015 | B2 |
8961547 | Dietz et al. | Feb 2015 | B2 |
8967443 | McCuen | Mar 2015 | B2 |
8968283 | Kharin | Mar 2015 | B2 |
8968294 | Maass et al. | Mar 2015 | B2 |
8968296 | McPherson | Mar 2015 | B2 |
8968355 | Malkowski et al. | Mar 2015 | B2 |
8974447 | Kimball et al. | Mar 2015 | B2 |
8974477 | Yamada | Mar 2015 | B2 |
8974479 | Ross et al. | Mar 2015 | B2 |
8974932 | McGahan et al. | Mar 2015 | B2 |
8979843 | Timm et al. | Mar 2015 | B2 |
8979844 | White et al. | Mar 2015 | B2 |
8979890 | Boudreaux | Mar 2015 | B2 |
8986287 | Park et al. | Mar 2015 | B2 |
8986297 | Daniel et al. | Mar 2015 | B2 |
8986302 | Aldridge et al. | Mar 2015 | B2 |
8989855 | Murphy et al. | Mar 2015 | B2 |
8989903 | Weir et al. | Mar 2015 | B2 |
8991678 | Wellman et al. | Mar 2015 | B2 |
8992422 | Spivey et al. | Mar 2015 | B2 |
8992526 | Brodbeck et al. | Mar 2015 | B2 |
8998891 | Garito et al. | Apr 2015 | B2 |
9005199 | Beckman et al. | Apr 2015 | B2 |
9011437 | Woodruff et al. | Apr 2015 | B2 |
9011471 | Timm et al. | Apr 2015 | B2 |
9017326 | DiNardo et al. | Apr 2015 | B2 |
9017355 | Smith et al. | Apr 2015 | B2 |
9017372 | Artale et al. | Apr 2015 | B2 |
9023070 | Levine et al. | May 2015 | B2 |
9023071 | Miller et al. | May 2015 | B2 |
9028397 | Naito | May 2015 | B2 |
9028476 | Bonn | May 2015 | B2 |
9028478 | Mueller | May 2015 | B2 |
9028481 | Behnke, II | May 2015 | B2 |
9028494 | Shelton, IV et al. | May 2015 | B2 |
9028519 | Yates et al. | May 2015 | B2 |
9031667 | Williams | May 2015 | B2 |
9033973 | Krapohl et al. | May 2015 | B2 |
9035741 | Hamel et al. | May 2015 | B2 |
9037259 | Mathur | May 2015 | B2 |
9039690 | Kersten et al. | May 2015 | B2 |
9039695 | Giordano et al. | May 2015 | B2 |
9039696 | Assmus et al. | May 2015 | B2 |
9039705 | Takashino | May 2015 | B2 |
9039731 | Joseph | May 2015 | B2 |
9043018 | Mohr | May 2015 | B2 |
9044227 | Shelton, IV et al. | Jun 2015 | B2 |
9044238 | Orszulak | Jun 2015 | B2 |
9044243 | Johnson et al. | Jun 2015 | B2 |
9044245 | Condie et al. | Jun 2015 | B2 |
9044256 | Cadeddu et al. | Jun 2015 | B2 |
9044261 | Houser | Jun 2015 | B2 |
9050093 | Aldridge et al. | Jun 2015 | B2 |
9050098 | Deville et al. | Jun 2015 | B2 |
9050123 | Krause et al. | Jun 2015 | B2 |
9050124 | Houser | Jun 2015 | B2 |
9055961 | Manzo et al. | Jun 2015 | B2 |
9059547 | McLawhorn | Jun 2015 | B2 |
9060770 | Shelton, IV et al. | Jun 2015 | B2 |
9060775 | Wiener et al. | Jun 2015 | B2 |
9060776 | Yates et al. | Jun 2015 | B2 |
9060778 | Condie et al. | Jun 2015 | B2 |
9066720 | Ballakur et al. | Jun 2015 | B2 |
9066723 | Beller et al. | Jun 2015 | B2 |
9066747 | Robertson | Jun 2015 | B2 |
9072523 | Houser et al. | Jul 2015 | B2 |
9072535 | Shelton, IV et al. | Jul 2015 | B2 |
9072536 | Shelton, IV et al. | Jul 2015 | B2 |
9072538 | Suzuki et al. | Jul 2015 | B2 |
9072539 | Messerly et al. | Jul 2015 | B2 |
9084624 | Larkin et al. | Jul 2015 | B2 |
9089327 | Worrell et al. | Jul 2015 | B2 |
9089360 | Messerly et al. | Jul 2015 | B2 |
9095362 | Dachs, II et al. | Aug 2015 | B2 |
9095367 | Olson et al. | Aug 2015 | B2 |
9099863 | Smith et al. | Aug 2015 | B2 |
9101358 | Kerr et al. | Aug 2015 | B2 |
9101385 | Shelton, IV et al. | Aug 2015 | B2 |
9107684 | Ma | Aug 2015 | B2 |
9107689 | Robertson et al. | Aug 2015 | B2 |
9107690 | Bales, Jr. et al. | Aug 2015 | B2 |
9113900 | Buysse et al. | Aug 2015 | B2 |
9113907 | Allen, IV et al. | Aug 2015 | B2 |
9113940 | Twomey | Aug 2015 | B2 |
9119657 | Shelton, IV et al. | Sep 2015 | B2 |
9119957 | Gantz et al. | Sep 2015 | B2 |
9125662 | Shelton, IV | Sep 2015 | B2 |
9125667 | Stone et al. | Sep 2015 | B2 |
9144453 | Rencher et al. | Sep 2015 | B2 |
9147965 | Lee | Sep 2015 | B2 |
9149324 | Huang et al. | Oct 2015 | B2 |
9149325 | Worrell et al. | Oct 2015 | B2 |
9161803 | Yates et al. | Oct 2015 | B2 |
9165114 | Jain et al. | Oct 2015 | B2 |
9168054 | Turner et al. | Oct 2015 | B2 |
9168085 | Juzkiw et al. | Oct 2015 | B2 |
9168089 | Buysse et al. | Oct 2015 | B2 |
9173656 | Schurr et al. | Nov 2015 | B2 |
9179912 | Yates et al. | Nov 2015 | B2 |
9186199 | Strauss et al. | Nov 2015 | B2 |
9186204 | Nishimura et al. | Nov 2015 | B2 |
9186796 | Ogawa | Nov 2015 | B2 |
9192380 | (Tarinelli) Racenet et al. | Nov 2015 | B2 |
9192421 | Garrison | Nov 2015 | B2 |
9192428 | Houser et al. | Nov 2015 | B2 |
9192431 | Woodruff et al. | Nov 2015 | B2 |
9198714 | Worrell et al. | Dec 2015 | B2 |
9198715 | Livneh | Dec 2015 | B2 |
9198718 | Marczyk et al. | Dec 2015 | B2 |
9198776 | Young | Dec 2015 | B2 |
9204879 | Shelton, IV | Dec 2015 | B2 |
9204891 | Weitzman | Dec 2015 | B2 |
9204918 | Germain et al. | Dec 2015 | B2 |
9204923 | Manzo et al. | Dec 2015 | B2 |
9216050 | Condie et al. | Dec 2015 | B2 |
9216051 | Fischer et al. | Dec 2015 | B2 |
9216062 | Duque et al. | Dec 2015 | B2 |
9220483 | Frankhouser et al. | Dec 2015 | B2 |
9220527 | Houser et al. | Dec 2015 | B2 |
9220559 | Worrell et al. | Dec 2015 | B2 |
9226750 | Weir et al. | Jan 2016 | B2 |
9226751 | Shelton, IV et al. | Jan 2016 | B2 |
9226766 | Aldridge et al. | Jan 2016 | B2 |
9226767 | Stulen et al. | Jan 2016 | B2 |
9232979 | Parihar et al. | Jan 2016 | B2 |
9237891 | Shelton, IV | Jan 2016 | B2 |
9237921 | Messerly et al. | Jan 2016 | B2 |
9241060 | Fujisaki | Jan 2016 | B1 |
9241692 | Gunday et al. | Jan 2016 | B2 |
9241728 | Price et al. | Jan 2016 | B2 |
9241730 | Babaev | Jan 2016 | B2 |
9241731 | Boudreaux et al. | Jan 2016 | B2 |
9241768 | Sandhu et al. | Jan 2016 | B2 |
9247953 | Palmer et al. | Feb 2016 | B2 |
9254165 | Aronow et al. | Feb 2016 | B2 |
9259234 | Robertson et al. | Feb 2016 | B2 |
9259265 | Harris et al. | Feb 2016 | B2 |
9265567 | Orban, III et al. | Feb 2016 | B2 |
9265926 | Strobl et al. | Feb 2016 | B2 |
9265973 | Akagane | Feb 2016 | B2 |
9277962 | Koss et al. | Mar 2016 | B2 |
9282974 | Shelton, IV | Mar 2016 | B2 |
9283027 | Monson et al. | Mar 2016 | B2 |
9283045 | Rhee et al. | Mar 2016 | B2 |
9289256 | Shelton, IV et al. | Mar 2016 | B2 |
9295514 | Shelton, IV et al. | Mar 2016 | B2 |
9301759 | Spivey et al. | Apr 2016 | B2 |
9305497 | Seo et al. | Apr 2016 | B2 |
9307388 | Liang et al. | Apr 2016 | B2 |
9307986 | Hall et al. | Apr 2016 | B2 |
9308009 | Madan et al. | Apr 2016 | B2 |
9308014 | Fischer | Apr 2016 | B2 |
9314261 | Bales, Jr. et al. | Apr 2016 | B2 |
9314292 | Trees et al. | Apr 2016 | B2 |
9314301 | Ben-Haim et al. | Apr 2016 | B2 |
9326754 | Polster | May 2016 | B2 |
9326787 | Sanai et al. | May 2016 | B2 |
9326788 | Batross et al. | May 2016 | B2 |
9333025 | Monson et al. | May 2016 | B2 |
9333034 | Hancock | May 2016 | B2 |
9339289 | Robertson | May 2016 | B2 |
9339323 | Eder et al. | May 2016 | B2 |
9339326 | McCullagh et al. | May 2016 | B2 |
9345481 | Hall et al. | May 2016 | B2 |
9345534 | Artale et al. | May 2016 | B2 |
9345900 | Wu et al. | May 2016 | B2 |
9351642 | Nadkarni et al. | May 2016 | B2 |
9351726 | Leimbach et al. | May 2016 | B2 |
9351754 | Vakharia et al. | May 2016 | B2 |
9352173 | Yamada et al. | May 2016 | B2 |
9358065 | Ladtkow et al. | Jun 2016 | B2 |
9364171 | Harris et al. | Jun 2016 | B2 |
9364230 | Shelton, IV et al. | Jun 2016 | B2 |
9364279 | Houser et al. | Jun 2016 | B2 |
9370364 | Smith et al. | Jun 2016 | B2 |
9370400 | Parihar | Jun 2016 | B2 |
9370611 | Ross et al. | Jun 2016 | B2 |
9375230 | Ross et al. | Jun 2016 | B2 |
9375232 | Hunt et al. | Jun 2016 | B2 |
9375256 | Cunningham et al. | Jun 2016 | B2 |
9375264 | Horner et al. | Jun 2016 | B2 |
9375267 | Kerr et al. | Jun 2016 | B2 |
9385831 | Marr et al. | Jul 2016 | B2 |
9386983 | Swensgard et al. | Jul 2016 | B2 |
9393037 | Olson et al. | Jul 2016 | B2 |
9393070 | Gelfand et al. | Jul 2016 | B2 |
9398911 | Auld | Jul 2016 | B2 |
9402680 | Ginnebaugh et al. | Aug 2016 | B2 |
9402682 | Worrell et al. | Aug 2016 | B2 |
9408606 | Shelton, IV | Aug 2016 | B2 |
9408622 | Stulen et al. | Aug 2016 | B2 |
9408660 | Strobl et al. | Aug 2016 | B2 |
9414853 | Stulen et al. | Aug 2016 | B2 |
9414880 | Monson et al. | Aug 2016 | B2 |
9421060 | Monson et al. | Aug 2016 | B2 |
9427249 | Robertson et al. | Aug 2016 | B2 |
9427279 | Muniz-Medina et al. | Aug 2016 | B2 |
9439668 | Timm et al. | Sep 2016 | B2 |
9439669 | Wiener et al. | Sep 2016 | B2 |
9439671 | Akagane | Sep 2016 | B2 |
9442288 | Tanimura | Sep 2016 | B2 |
9445784 | O'Keeffe | Sep 2016 | B2 |
9445832 | Wiener et al. | Sep 2016 | B2 |
9451967 | Jordan et al. | Sep 2016 | B2 |
9456863 | Moua | Oct 2016 | B2 |
9456864 | Witt et al. | Oct 2016 | B2 |
9468498 | Sigmon, Jr. | Oct 2016 | B2 |
9474542 | Slipszenko et al. | Oct 2016 | B2 |
9474568 | Akagane | Oct 2016 | B2 |
9486236 | Price et al. | Nov 2016 | B2 |
9492146 | Kostrzewski et al. | Nov 2016 | B2 |
9492224 | Boudreaux et al. | Nov 2016 | B2 |
9498245 | Voegele et al. | Nov 2016 | B2 |
9498275 | Wham et al. | Nov 2016 | B2 |
9504483 | Houser et al. | Nov 2016 | B2 |
9504520 | Worrell et al. | Nov 2016 | B2 |
9504524 | Behnke, II | Nov 2016 | B2 |
9504855 | Messerly et al. | Nov 2016 | B2 |
9510850 | Robertson et al. | Dec 2016 | B2 |
9510906 | Boudreaux et al. | Dec 2016 | B2 |
9522029 | Yates et al. | Dec 2016 | B2 |
9522032 | Behnke | Dec 2016 | B2 |
9526564 | Rusin | Dec 2016 | B2 |
9526565 | Strobl | Dec 2016 | B2 |
9545253 | Worrell et al. | Jan 2017 | B2 |
9545497 | Wenderow et al. | Jan 2017 | B2 |
9554846 | Boudreaux | Jan 2017 | B2 |
9554854 | Yates et al. | Jan 2017 | B2 |
9560995 | Addison et al. | Feb 2017 | B2 |
9561038 | Shelton, IV et al. | Feb 2017 | B2 |
9572592 | Price et al. | Feb 2017 | B2 |
9574644 | Parihar | Feb 2017 | B2 |
9585714 | Livneh | Mar 2017 | B2 |
9592072 | Akagane | Mar 2017 | B2 |
9597143 | Madan et al. | Mar 2017 | B2 |
9603669 | Govari et al. | Mar 2017 | B2 |
9610091 | Johnson et al. | Apr 2017 | B2 |
9610114 | Baxter, III et al. | Apr 2017 | B2 |
9615877 | Tyrrell et al. | Apr 2017 | B2 |
9623237 | Turner et al. | Apr 2017 | B2 |
9636135 | Stulen | May 2017 | B2 |
9636165 | Larson et al. | May 2017 | B2 |
9636167 | Gregg | May 2017 | B2 |
9638770 | Dietz et al. | May 2017 | B2 |
9642644 | Houser et al. | May 2017 | B2 |
9642669 | Takashino et al. | May 2017 | B2 |
9643052 | Tchao et al. | May 2017 | B2 |
9649111 | Shelton, IV et al. | May 2017 | B2 |
9649126 | Robertson et al. | May 2017 | B2 |
9649173 | Choi et al. | May 2017 | B2 |
9655670 | Larson et al. | May 2017 | B2 |
9662131 | Omori et al. | May 2017 | B2 |
9668806 | Unger et al. | Jun 2017 | B2 |
9671860 | Ogawa et al. | Jun 2017 | B2 |
9674949 | Liu et al. | Jun 2017 | B1 |
9675374 | Stulen et al. | Jun 2017 | B2 |
9675375 | Houser et al. | Jun 2017 | B2 |
9681884 | Clem et al. | Jun 2017 | B2 |
9687290 | Keller | Jun 2017 | B2 |
9690362 | Leimbach et al. | Jun 2017 | B2 |
9693817 | Mehta et al. | Jul 2017 | B2 |
9700309 | Jaworek et al. | Jul 2017 | B2 |
9700339 | Nield | Jul 2017 | B2 |
9700343 | Messerly et al. | Jul 2017 | B2 |
9705456 | Gilbert | Jul 2017 | B2 |
9707004 | Houser et al. | Jul 2017 | B2 |
9707027 | Ruddenklau et al. | Jul 2017 | B2 |
9707030 | Davison et al. | Jul 2017 | B2 |
9713507 | Stulen et al. | Jul 2017 | B2 |
9717548 | Couture | Aug 2017 | B2 |
9717552 | Cosman et al. | Aug 2017 | B2 |
9724118 | Schulte et al. | Aug 2017 | B2 |
9724120 | Faller et al. | Aug 2017 | B2 |
9724152 | Horlle et al. | Aug 2017 | B2 |
9730695 | Leimbach et al. | Aug 2017 | B2 |
9737326 | Worrell et al. | Aug 2017 | B2 |
9737355 | Yates et al. | Aug 2017 | B2 |
9737358 | Beckman et al. | Aug 2017 | B2 |
9743929 | Leimbach et al. | Aug 2017 | B2 |
9743946 | Faller et al. | Aug 2017 | B2 |
9743947 | Price et al. | Aug 2017 | B2 |
9757142 | Shimizu | Sep 2017 | B2 |
9757150 | Alexander et al. | Sep 2017 | B2 |
9757186 | Boudreaux et al. | Sep 2017 | B2 |
9764164 | Wiener et al. | Sep 2017 | B2 |
9770285 | Zoran et al. | Sep 2017 | B2 |
9782214 | Houser et al. | Oct 2017 | B2 |
9788851 | Dannaher et al. | Oct 2017 | B2 |
9795405 | Price et al. | Oct 2017 | B2 |
9795436 | Yates et al. | Oct 2017 | B2 |
9795808 | Messerly et al. | Oct 2017 | B2 |
9801648 | Houser et al. | Oct 2017 | B2 |
9802033 | Hibner et al. | Oct 2017 | B2 |
9808246 | Shelton, IV et al. | Nov 2017 | B2 |
9808308 | Faller et al. | Nov 2017 | B2 |
9814514 | Shelton, IV et al. | Nov 2017 | B2 |
9820768 | Gee et al. | Nov 2017 | B2 |
9820771 | Norton et al. | Nov 2017 | B2 |
9820806 | Lee et al. | Nov 2017 | B2 |
9839443 | Brockman et al. | Dec 2017 | B2 |
9848901 | Robertson et al. | Dec 2017 | B2 |
9848902 | Price et al. | Dec 2017 | B2 |
9848937 | Trees et al. | Dec 2017 | B2 |
9861381 | Johnson | Jan 2018 | B2 |
9861428 | Trees et al. | Jan 2018 | B2 |
9867651 | Wham | Jan 2018 | B2 |
9867670 | Brannan et al. | Jan 2018 | B2 |
9872722 | Lech | Jan 2018 | B2 |
9872725 | Worrell et al. | Jan 2018 | B2 |
9872726 | Morisaki | Jan 2018 | B2 |
9877720 | Worrell et al. | Jan 2018 | B2 |
9877776 | Boudreaux | Jan 2018 | B2 |
9878184 | Beaupre | Jan 2018 | B2 |
9883884 | Neurohr et al. | Feb 2018 | B2 |
9888919 | Leimbach et al. | Feb 2018 | B2 |
9888958 | Evans et al. | Feb 2018 | B2 |
9901321 | Harks et al. | Feb 2018 | B2 |
9901383 | Hassler, Jr. | Feb 2018 | B2 |
9901754 | Yamada | Feb 2018 | B2 |
9907563 | Germain et al. | Mar 2018 | B2 |
9913656 | Stulen | Mar 2018 | B2 |
9913680 | Voegele et al. | Mar 2018 | B2 |
9918730 | Trees et al. | Mar 2018 | B2 |
9925003 | Parihar et al. | Mar 2018 | B2 |
9949785 | Price et al. | Apr 2018 | B2 |
9949788 | Boudreaux | Apr 2018 | B2 |
9962182 | Dietz et al. | May 2018 | B2 |
9974539 | Yates et al. | May 2018 | B2 |
9987033 | Neurohr et al. | Jun 2018 | B2 |
10004526 | Dycus et al. | Jun 2018 | B2 |
10004527 | Gee et al. | Jun 2018 | B2 |
10010339 | Witt et al. | Jul 2018 | B2 |
10010341 | Houser et al. | Jul 2018 | B2 |
10016207 | Suzuki et al. | Jul 2018 | B2 |
10022142 | Aranyi et al. | Jul 2018 | B2 |
10022567 | Messerly et al. | Jul 2018 | B2 |
10022568 | Messerly et al. | Jul 2018 | B2 |
10028761 | Leimbach et al. | Jul 2018 | B2 |
10028786 | Mucilli et al. | Jul 2018 | B2 |
10034684 | Weisenburgh, II et al. | Jul 2018 | B2 |
10034704 | Asher et al. | Jul 2018 | B2 |
10039588 | Harper et al. | Aug 2018 | B2 |
10045794 | Witt et al. | Aug 2018 | B2 |
10045810 | Schall et al. | Aug 2018 | B2 |
10045819 | Jensen et al. | Aug 2018 | B2 |
10070916 | Artale | Sep 2018 | B2 |
10080609 | Hancock et al. | Sep 2018 | B2 |
10085762 | Timm et al. | Oct 2018 | B2 |
10085792 | Johnson et al. | Oct 2018 | B2 |
10092310 | Boudreaux et al. | Oct 2018 | B2 |
10092344 | Mohr et al. | Oct 2018 | B2 |
10092348 | Boudreaux | Oct 2018 | B2 |
10092350 | Rothweiler et al. | Oct 2018 | B2 |
10105140 | Malinouskas et al. | Oct 2018 | B2 |
10111699 | Boudreaux | Oct 2018 | B2 |
10111703 | Cosman, Jr. et al. | Oct 2018 | B2 |
10117667 | Robertson et al. | Nov 2018 | B2 |
10117702 | Danziger et al. | Nov 2018 | B2 |
10123835 | Keller et al. | Nov 2018 | B2 |
10130367 | Cappola et al. | Nov 2018 | B2 |
10130410 | Strobl et al. | Nov 2018 | B2 |
10130412 | Wham | Nov 2018 | B2 |
10154848 | Chernov et al. | Dec 2018 | B2 |
10154852 | Conlon et al. | Dec 2018 | B2 |
10159524 | Yates et al. | Dec 2018 | B2 |
10166060 | Johnson et al. | Jan 2019 | B2 |
10172665 | Heckel et al. | Jan 2019 | B2 |
10172669 | Felder et al. | Jan 2019 | B2 |
10179022 | Yates et al. | Jan 2019 | B2 |
10188455 | Hancock et al. | Jan 2019 | B2 |
10194972 | Yates et al. | Feb 2019 | B2 |
10194973 | Wiener et al. | Feb 2019 | B2 |
10194976 | Boudreaux | Feb 2019 | B2 |
10194977 | Yang | Feb 2019 | B2 |
10194999 | Bacher et al. | Feb 2019 | B2 |
10201364 | Leimbach et al. | Feb 2019 | B2 |
10201365 | Boudreaux et al. | Feb 2019 | B2 |
10201382 | Wiener et al. | Feb 2019 | B2 |
10226273 | Messerly et al. | Mar 2019 | B2 |
10231747 | Stulen et al. | Mar 2019 | B2 |
10238385 | Yates et al. | Mar 2019 | B2 |
10238391 | Leimbach et al. | Mar 2019 | B2 |
10245095 | Boudreaux | Apr 2019 | B2 |
10245104 | McKenna et al. | Apr 2019 | B2 |
10251664 | Shelton, IV et al. | Apr 2019 | B2 |
10263171 | Wiener et al. | Apr 2019 | B2 |
10265117 | Wiener et al. | Apr 2019 | B2 |
10265118 | Gerhardt | Apr 2019 | B2 |
10271840 | Sapre | Apr 2019 | B2 |
10278721 | Dietz et al. | May 2019 | B2 |
10285724 | Faller et al. | May 2019 | B2 |
10285750 | Coulson et al. | May 2019 | B2 |
10299810 | Robertson et al. | May 2019 | B2 |
10299821 | Shelton, IV et al. | May 2019 | B2 |
10314579 | Chowaniec et al. | Jun 2019 | B2 |
10314638 | Gee et al. | Jun 2019 | B2 |
10321950 | Yates et al. | Jun 2019 | B2 |
10335182 | Stulen et al. | Jul 2019 | B2 |
10335183 | Worrell et al. | Jul 2019 | B2 |
10335614 | Messerly et al. | Jul 2019 | B2 |
10342602 | Strobl et al. | Jul 2019 | B2 |
10342606 | Cosman et al. | Jul 2019 | B2 |
10349999 | Yates et al. | Jul 2019 | B2 |
10357303 | Conlon et al. | Jul 2019 | B2 |
10363084 | Friedrichs | Jul 2019 | B2 |
10376305 | Yates et al. | Aug 2019 | B2 |
10398466 | Stulen et al. | Sep 2019 | B2 |
10398497 | Batross et al. | Sep 2019 | B2 |
10413352 | Thomas et al. | Sep 2019 | B2 |
10413353 | Kerr et al. | Sep 2019 | B2 |
10420579 | Wiener et al. | Sep 2019 | B2 |
10420607 | Woloszko et al. | Sep 2019 | B2 |
10426507 | Wiener et al. | Oct 2019 | B2 |
10426978 | Akagane | Oct 2019 | B2 |
10433865 | Witt et al. | Oct 2019 | B2 |
10433866 | Witt et al. | Oct 2019 | B2 |
10433900 | Harris et al. | Oct 2019 | B2 |
10441308 | Robertson | Oct 2019 | B2 |
10441310 | Olson et al. | Oct 2019 | B2 |
10441345 | Aldridge et al. | Oct 2019 | B2 |
10448986 | Zikorus et al. | Oct 2019 | B2 |
10456193 | Yates et al. | Oct 2019 | B2 |
10463421 | Boudreaux et al. | Nov 2019 | B2 |
10463887 | Witt et al. | Nov 2019 | B2 |
10485607 | Strobl et al. | Nov 2019 | B2 |
10492849 | Juergens et al. | Dec 2019 | B2 |
10507033 | Dickerson et al. | Dec 2019 | B2 |
10512795 | Voegele et al. | Dec 2019 | B2 |
10517627 | Timm et al. | Dec 2019 | B2 |
10524787 | Shelton, IV et al. | Jan 2020 | B2 |
10524854 | Woodruff et al. | Jan 2020 | B2 |
10524872 | Stewart et al. | Jan 2020 | B2 |
10537351 | Shelton, IV et al. | Jan 2020 | B2 |
10543008 | Vakharia et al. | Jan 2020 | B2 |
10548655 | Scheib et al. | Feb 2020 | B2 |
10555769 | Worrell et al. | Feb 2020 | B2 |
10561560 | Boutoussov et al. | Feb 2020 | B2 |
10575892 | Danziger et al. | Mar 2020 | B2 |
10595929 | Boudreaux et al. | Mar 2020 | B2 |
10595930 | Scheib et al. | Mar 2020 | B2 |
10610286 | Wiener et al. | Apr 2020 | B2 |
10617420 | Shelton, IV et al. | Apr 2020 | B2 |
10617464 | Duppuis | Apr 2020 | B2 |
10624691 | Wiener et al. | Apr 2020 | B2 |
RE47996 | Turner et al. | May 2020 | E |
10639092 | Corbett et al. | May 2020 | B2 |
10639098 | Cosman et al. | May 2020 | B2 |
10646269 | Worrell et al. | May 2020 | B2 |
10677764 | Ross et al. | Jun 2020 | B2 |
10687884 | Wiener et al. | Jun 2020 | B2 |
10688321 | Wiener et al. | Jun 2020 | B2 |
10695119 | Smith | Jun 2020 | B2 |
10702329 | Strobl et al. | Jul 2020 | B2 |
10709469 | Shelton, IV et al. | Jul 2020 | B2 |
10709906 | Nield | Jul 2020 | B2 |
10716615 | Shelton, IV et al. | Jul 2020 | B2 |
10729458 | Stoddard et al. | Aug 2020 | B2 |
10729494 | Parihar et al. | Aug 2020 | B2 |
10736685 | Wiener et al. | Aug 2020 | B2 |
10751108 | Yates et al. | Aug 2020 | B2 |
10758294 | Jones | Sep 2020 | B2 |
10765470 | Yates et al. | Sep 2020 | B2 |
10779845 | Timm et al. | Sep 2020 | B2 |
10779849 | Shelton, IV et al. | Sep 2020 | B2 |
10779879 | Yates et al. | Sep 2020 | B2 |
10820938 | Fischer et al. | Nov 2020 | B2 |
10828058 | Shelton, IV et al. | Nov 2020 | B2 |
10835307 | Shelton, IV et al. | Nov 2020 | B2 |
10842523 | Shelton, IV et al. | Nov 2020 | B2 |
10842563 | Gilbert et al. | Nov 2020 | B2 |
10856896 | Eichmann et al. | Dec 2020 | B2 |
10856929 | Yates et al. | Dec 2020 | B2 |
10856934 | Trees et al. | Dec 2020 | B2 |
10874465 | Weir et al. | Dec 2020 | B2 |
10881449 | Boudreaux et al. | Jan 2021 | B2 |
10888347 | Witt et al. | Jan 2021 | B2 |
10898256 | Yates et al. | Jan 2021 | B2 |
10912580 | Green et al. | Feb 2021 | B2 |
10912603 | Boudreaux et al. | Feb 2021 | B2 |
10925659 | Shelton, IV et al. | Feb 2021 | B2 |
10932847 | Yates et al. | Mar 2021 | B2 |
10952788 | Asher et al. | Mar 2021 | B2 |
10966741 | Illizaliturri-Sanchez et al. | Apr 2021 | B2 |
10966747 | Worrell et al. | Apr 2021 | B2 |
10987123 | Weir et al. | Apr 2021 | B2 |
10987156 | Trees et al. | Apr 2021 | B2 |
10993763 | Batross et al. | May 2021 | B2 |
11020140 | Gee et al. | Jun 2021 | B2 |
11033322 | Wiener et al. | Jun 2021 | B2 |
11051840 | Shelton, IV et al. | Jul 2021 | B2 |
11051873 | Wiener et al. | Jul 2021 | B2 |
11058447 | Houser | Jul 2021 | B2 |
11058448 | Shelton, IV et al. | Jul 2021 | B2 |
11058475 | Wiener et al. | Jul 2021 | B2 |
11090104 | Wiener et al. | Aug 2021 | B2 |
11096752 | Stulen et al. | Aug 2021 | B2 |
11129669 | Stulen et al. | Sep 2021 | B2 |
11129670 | Shelton, IV et al. | Sep 2021 | B2 |
11134978 | Shelton, IV et al. | Oct 2021 | B2 |
11141213 | Yates et al. | Oct 2021 | B2 |
11202670 | Worrell et al. | Dec 2021 | B2 |
11229450 | Shelton, IV et al. | Jan 2022 | B2 |
11229471 | Shelton, IV et al. | Jan 2022 | B2 |
11229472 | Shelton, IV et al. | Jan 2022 | B2 |
20010025173 | Ritchie et al. | Sep 2001 | A1 |
20010025183 | Shahidi | Sep 2001 | A1 |
20010025184 | Messerly | Sep 2001 | A1 |
20010031950 | Ryan | Oct 2001 | A1 |
20010039419 | Francischelli et al. | Nov 2001 | A1 |
20020002377 | Cimino | Jan 2002 | A1 |
20020002380 | Bishop | Jan 2002 | A1 |
20020019649 | Sikora et al. | Feb 2002 | A1 |
20020022836 | Goble et al. | Feb 2002 | A1 |
20020029036 | Goble et al. | Mar 2002 | A1 |
20020029055 | Bonutti | Mar 2002 | A1 |
20020049551 | Friedman et al. | Apr 2002 | A1 |
20020052617 | Anis et al. | May 2002 | A1 |
20020077550 | Rabiner et al. | Jun 2002 | A1 |
20020107517 | Witt et al. | Aug 2002 | A1 |
20020156466 | Sakurai et al. | Oct 2002 | A1 |
20020156493 | Houser et al. | Oct 2002 | A1 |
20020165577 | Witt et al. | Nov 2002 | A1 |
20020177862 | Aranyi et al. | Nov 2002 | A1 |
20030014053 | Nguyen et al. | Jan 2003 | A1 |
20030014087 | Fang et al. | Jan 2003 | A1 |
20030036705 | Hare et al. | Feb 2003 | A1 |
20030040758 | Wang et al. | Feb 2003 | A1 |
20030050572 | Brautigam et al. | Mar 2003 | A1 |
20030055443 | Spotnitz | Mar 2003 | A1 |
20030109778 | Rashidi | Jun 2003 | A1 |
20030109875 | Tetzlaff et al. | Jun 2003 | A1 |
20030114851 | Truckai et al. | Jun 2003 | A1 |
20030130693 | Levin et al. | Jul 2003 | A1 |
20030139741 | Goble et al. | Jul 2003 | A1 |
20030144680 | Kellogg et al. | Jul 2003 | A1 |
20030158548 | Phan et al. | Aug 2003 | A1 |
20030171747 | Kanehira et al. | Sep 2003 | A1 |
20030181898 | Bowers | Sep 2003 | A1 |
20030199794 | Sakurai et al. | Oct 2003 | A1 |
20030204199 | Novak et al. | Oct 2003 | A1 |
20030208186 | Moreyra | Nov 2003 | A1 |
20030212332 | Fenton et al. | Nov 2003 | A1 |
20030212363 | Shipp | Nov 2003 | A1 |
20030212392 | Fenton et al. | Nov 2003 | A1 |
20030212422 | Fenton et al. | Nov 2003 | A1 |
20030225332 | Okada et al. | Dec 2003 | A1 |
20030229344 | Dycus et al. | Dec 2003 | A1 |
20040030254 | Babaev | Feb 2004 | A1 |
20040030330 | Brassell et al. | Feb 2004 | A1 |
20040047485 | Sherrit et al. | Mar 2004 | A1 |
20040054364 | Aranyi et al. | Mar 2004 | A1 |
20040064151 | Mollenauer | Apr 2004 | A1 |
20040087943 | Dycus et al. | May 2004 | A1 |
20040092921 | Kadziauskas et al. | May 2004 | A1 |
20040092992 | Adams et al. | May 2004 | A1 |
20040097911 | Murakami et al. | May 2004 | A1 |
20040097912 | Gonnering | May 2004 | A1 |
20040097919 | Wellman et al. | May 2004 | A1 |
20040097996 | Rabiner et al. | May 2004 | A1 |
20040116952 | Sakurai et al. | Jun 2004 | A1 |
20040122423 | Dycus et al. | Jun 2004 | A1 |
20040132383 | Langford et al. | Jul 2004 | A1 |
20040138621 | Jahns et al. | Jul 2004 | A1 |
20040142667 | Lochhead et al. | Jul 2004 | A1 |
20040147934 | Kiester | Jul 2004 | A1 |
20040147945 | Fritzsch | Jul 2004 | A1 |
20040158237 | Abboud et al. | Aug 2004 | A1 |
20040167508 | Wham et al. | Aug 2004 | A1 |
20040176686 | Hare et al. | Sep 2004 | A1 |
20040176751 | Weitzner et al. | Sep 2004 | A1 |
20040193150 | Sharkey et al. | Sep 2004 | A1 |
20040193153 | Sartor et al. | Sep 2004 | A1 |
20040199193 | Hayashi et al. | Oct 2004 | A1 |
20040215132 | Yoon | Oct 2004 | A1 |
20040243147 | Lipow | Dec 2004 | A1 |
20040249374 | Tetzlaff et al. | Dec 2004 | A1 |
20040260273 | Wan | Dec 2004 | A1 |
20040260300 | Gorensek et al. | Dec 2004 | A1 |
20040267311 | Viola et al. | Dec 2004 | A1 |
20050015125 | Mioduski et al. | Jan 2005 | A1 |
20050020967 | Ono | Jan 2005 | A1 |
20050021018 | Anderson et al. | Jan 2005 | A1 |
20050021065 | Yamada et al. | Jan 2005 | A1 |
20050021078 | Vleugels et al. | Jan 2005 | A1 |
20050033278 | McClurken et al. | Feb 2005 | A1 |
20050033337 | Muir et al. | Feb 2005 | A1 |
20050070800 | Takahashi | Mar 2005 | A1 |
20050080427 | Govari et al. | Apr 2005 | A1 |
20050088285 | Jei | Apr 2005 | A1 |
20050090817 | Phan | Apr 2005 | A1 |
20050096683 | Ellins et al. | May 2005 | A1 |
20050099824 | Dowling et al. | May 2005 | A1 |
20050107777 | West et al. | May 2005 | A1 |
20050131390 | Heinrich et al. | Jun 2005 | A1 |
20050143769 | White et al. | Jun 2005 | A1 |
20050149108 | Cox | Jul 2005 | A1 |
20050165429 | Douglas et al. | Jul 2005 | A1 |
20050171522 | Christopherson | Aug 2005 | A1 |
20050177184 | Easley | Aug 2005 | A1 |
20050182339 | Lee et al. | Aug 2005 | A1 |
20050188743 | Land | Sep 2005 | A1 |
20050192610 | Houser et al. | Sep 2005 | A1 |
20050192611 | Houser | Sep 2005 | A1 |
20050206583 | Lemelson et al. | Sep 2005 | A1 |
20050222598 | Ho et al. | Oct 2005 | A1 |
20050234484 | Houser et al. | Oct 2005 | A1 |
20050249667 | Tuszynski et al. | Nov 2005 | A1 |
20050256405 | Makin et al. | Nov 2005 | A1 |
20050261588 | Makin et al. | Nov 2005 | A1 |
20050262175 | Iino et al. | Nov 2005 | A1 |
20050267464 | Truckai et al. | Dec 2005 | A1 |
20050271807 | Iijima et al. | Dec 2005 | A1 |
20050273090 | Nieman et al. | Dec 2005 | A1 |
20050288659 | Kimura et al. | Dec 2005 | A1 |
20060025757 | Heim | Feb 2006 | A1 |
20060030797 | Zhou et al. | Feb 2006 | A1 |
20060030848 | Craig et al. | Feb 2006 | A1 |
20060058825 | Ogura et al. | Mar 2006 | A1 |
20060063130 | Hayman et al. | Mar 2006 | A1 |
20060064086 | Odom | Mar 2006 | A1 |
20060066181 | Bromfield et al. | Mar 2006 | A1 |
20060074442 | Noriega et al. | Apr 2006 | A1 |
20060079874 | Faller et al. | Apr 2006 | A1 |
20060079878 | Houser | Apr 2006 | A1 |
20060079879 | Faller | Apr 2006 | A1 |
20060095046 | Trieu et al. | May 2006 | A1 |
20060109061 | Dobson et al. | May 2006 | A1 |
20060159731 | Shoshan | Jul 2006 | A1 |
20060190034 | Nishizawa et al. | Aug 2006 | A1 |
20060206100 | Eskridge et al. | Sep 2006 | A1 |
20060206115 | Schomer et al. | Sep 2006 | A1 |
20060211943 | Beaupre | Sep 2006 | A1 |
20060217729 | Eskridge et al. | Sep 2006 | A1 |
20060224160 | Trieu et al. | Oct 2006 | A1 |
20060247558 | Yamada | Nov 2006 | A1 |
20060253050 | Yoshimine et al. | Nov 2006 | A1 |
20060259026 | Godara et al. | Nov 2006 | A1 |
20060264809 | Hansmann et al. | Nov 2006 | A1 |
20060264995 | Fanton et al. | Nov 2006 | A1 |
20060265035 | Yachi et al. | Nov 2006 | A1 |
20060270916 | Skwarek et al. | Nov 2006 | A1 |
20060271030 | Francis et al. | Nov 2006 | A1 |
20060293656 | Shadduck et al. | Dec 2006 | A1 |
20070016235 | Tanaka et al. | Jan 2007 | A1 |
20070016236 | Beaupre | Jan 2007 | A1 |
20070021738 | Hasser et al. | Jan 2007 | A1 |
20070027468 | Wales et al. | Feb 2007 | A1 |
20070032704 | Gandini et al. | Feb 2007 | A1 |
20070055228 | Berg | Mar 2007 | A1 |
20070056596 | Fanney et al. | Mar 2007 | A1 |
20070060935 | Schwardt et al. | Mar 2007 | A1 |
20070063618 | Bromfield | Mar 2007 | A1 |
20070066971 | Podhajsky | Mar 2007 | A1 |
20070067123 | Jungerman | Mar 2007 | A1 |
20070073185 | Nakao | Mar 2007 | A1 |
20070073341 | Smith et al. | Mar 2007 | A1 |
20070074584 | Talarico et al. | Apr 2007 | A1 |
20070106317 | Shelton et al. | May 2007 | A1 |
20070118115 | Artale et al. | May 2007 | A1 |
20070130771 | Ehlert et al. | Jun 2007 | A1 |
20070135803 | Belson | Jun 2007 | A1 |
20070149881 | Rabin | Jun 2007 | A1 |
20070156163 | Davison et al. | Jul 2007 | A1 |
20070166663 | Telles et al. | Jul 2007 | A1 |
20070173803 | Wham et al. | Jul 2007 | A1 |
20070173813 | Odom | Jul 2007 | A1 |
20070173872 | Neuenfeldt | Jul 2007 | A1 |
20070175955 | Shelton et al. | Aug 2007 | A1 |
20070185474 | Nahen | Aug 2007 | A1 |
20070191712 | Messerly et al. | Aug 2007 | A1 |
20070191713 | Eichmann et al. | Aug 2007 | A1 |
20070203483 | Kim et al. | Aug 2007 | A1 |
20070208336 | Kim et al. | Sep 2007 | A1 |
20070208340 | Ganz et al. | Sep 2007 | A1 |
20070219481 | Babaev | Sep 2007 | A1 |
20070232926 | Stulen et al. | Oct 2007 | A1 |
20070232928 | Wiener et al. | Oct 2007 | A1 |
20070236213 | Paden et al. | Oct 2007 | A1 |
20070239101 | Kellogg | Oct 2007 | A1 |
20070249941 | Salehi et al. | Oct 2007 | A1 |
20070260242 | Dycus et al. | Nov 2007 | A1 |
20070265560 | Soltani et al. | Nov 2007 | A1 |
20070265613 | Edelstein et al. | Nov 2007 | A1 |
20070265616 | Couture et al. | Nov 2007 | A1 |
20070265620 | Kraas et al. | Nov 2007 | A1 |
20070275348 | Lemon | Nov 2007 | A1 |
20070287933 | Phan et al. | Dec 2007 | A1 |
20070288055 | Lee | Dec 2007 | A1 |
20070299895 | Johnson et al. | Dec 2007 | A1 |
20080005213 | Holtzman | Jan 2008 | A1 |
20080013809 | Zhu et al. | Jan 2008 | A1 |
20080015575 | Odom et al. | Jan 2008 | A1 |
20080033465 | Schmitz et al. | Feb 2008 | A1 |
20080039746 | Hissong et al. | Feb 2008 | A1 |
20080051812 | Schmitz et al. | Feb 2008 | A1 |
20080058775 | Darian et al. | Mar 2008 | A1 |
20080058845 | Shimizu et al. | Mar 2008 | A1 |
20080071269 | Hilario et al. | Mar 2008 | A1 |
20080077145 | Boyden et al. | Mar 2008 | A1 |
20080082039 | Babaev | Apr 2008 | A1 |
20080082098 | Tanaka et al. | Apr 2008 | A1 |
20080097501 | Blier | Apr 2008 | A1 |
20080114355 | Whayne et al. | May 2008 | A1 |
20080114364 | Goldin et al. | May 2008 | A1 |
20080122496 | Wagner | May 2008 | A1 |
20080125768 | Tahara et al. | May 2008 | A1 |
20080147058 | Horrell et al. | Jun 2008 | A1 |
20080147062 | Truckai et al. | Jun 2008 | A1 |
20080147092 | Rogge et al. | Jun 2008 | A1 |
20080171938 | Masuda et al. | Jul 2008 | A1 |
20080177268 | Daum et al. | Jul 2008 | A1 |
20080188755 | Hart | Aug 2008 | A1 |
20080200940 | Eichmann et al. | Aug 2008 | A1 |
20080208108 | Kimura | Aug 2008 | A1 |
20080208231 | Ota et al. | Aug 2008 | A1 |
20080214967 | Aranyi et al. | Sep 2008 | A1 |
20080234709 | Houser | Sep 2008 | A1 |
20080243162 | Shibata et al. | Oct 2008 | A1 |
20080255413 | Zemlok et al. | Oct 2008 | A1 |
20080275440 | Kratoska et al. | Nov 2008 | A1 |
20080281200 | Voic et al. | Nov 2008 | A1 |
20080281315 | Gines | Nov 2008 | A1 |
20080287944 | Pearson et al. | Nov 2008 | A1 |
20080287948 | Newton et al. | Nov 2008 | A1 |
20080296346 | Shelton, IV et al. | Dec 2008 | A1 |
20080300588 | Groth et al. | Dec 2008 | A1 |
20090012516 | Curtis et al. | Jan 2009 | A1 |
20090023985 | Ewers | Jan 2009 | A1 |
20090043293 | Pankratov et al. | Feb 2009 | A1 |
20090048537 | Lydon et al. | Feb 2009 | A1 |
20090048589 | Takashino et al. | Feb 2009 | A1 |
20090054886 | Yachi et al. | Feb 2009 | A1 |
20090054889 | Newton et al. | Feb 2009 | A1 |
20090054894 | Yachi | Feb 2009 | A1 |
20090065565 | Cao | Mar 2009 | A1 |
20090076506 | Baker | Mar 2009 | A1 |
20090082716 | Akahoshi | Mar 2009 | A1 |
20090082766 | Unger et al. | Mar 2009 | A1 |
20090088785 | Masuda | Apr 2009 | A1 |
20090090763 | Zemlok et al. | Apr 2009 | A1 |
20090101692 | Whitman et al. | Apr 2009 | A1 |
20090105750 | Price | Apr 2009 | A1 |
20090118751 | Wiener et al. | May 2009 | A1 |
20090143678 | Keast et al. | Jun 2009 | A1 |
20090143799 | Smith et al. | Jun 2009 | A1 |
20090143800 | Deville et al. | Jun 2009 | A1 |
20090157064 | Hodel | Jun 2009 | A1 |
20090163807 | Sliwa | Jun 2009 | A1 |
20090177119 | Heidner et al. | Jul 2009 | A1 |
20090179923 | Amundson et al. | Jul 2009 | A1 |
20090182322 | D'Amelio et al. | Jul 2009 | A1 |
20090182331 | D'Amelio et al. | Jul 2009 | A1 |
20090182332 | Long et al. | Jul 2009 | A1 |
20090192441 | Gelbart et al. | Jul 2009 | A1 |
20090198272 | Kerver et al. | Aug 2009 | A1 |
20090204114 | Odom | Aug 2009 | A1 |
20090216157 | Yamada | Aug 2009 | A1 |
20090223033 | Houser | Sep 2009 | A1 |
20090240244 | Malis et al. | Sep 2009 | A1 |
20090248021 | McKenna | Oct 2009 | A1 |
20090254077 | Craig | Oct 2009 | A1 |
20090254080 | Honda | Oct 2009 | A1 |
20090259149 | Tahara et al. | Oct 2009 | A1 |
20090264909 | Beaupre | Oct 2009 | A1 |
20090270771 | Takahashi | Oct 2009 | A1 |
20090270812 | Litscher et al. | Oct 2009 | A1 |
20090270853 | Yachi et al. | Oct 2009 | A1 |
20090270891 | Beaupre | Oct 2009 | A1 |
20090270899 | Carusillo et al. | Oct 2009 | A1 |
20090287205 | Ingle | Nov 2009 | A1 |
20090292283 | Odom | Nov 2009 | A1 |
20090299141 | Downey et al. | Dec 2009 | A1 |
20090306639 | Nevo et al. | Dec 2009 | A1 |
20090327715 | Smith et al. | Dec 2009 | A1 |
20100004508 | Naito et al. | Jan 2010 | A1 |
20100022825 | Yoshie | Jan 2010 | A1 |
20100030233 | Whitman et al. | Feb 2010 | A1 |
20100034605 | Huckins et al. | Feb 2010 | A1 |
20100036370 | Mirel et al. | Feb 2010 | A1 |
20100042093 | Wham et al. | Feb 2010 | A9 |
20100049180 | Wells et al. | Feb 2010 | A1 |
20100057118 | Dietz et al. | Mar 2010 | A1 |
20100063437 | Nelson et al. | Mar 2010 | A1 |
20100063525 | Beaupre et al. | Mar 2010 | A1 |
20100063528 | Beaupre | Mar 2010 | A1 |
20100081863 | Hess et al. | Apr 2010 | A1 |
20100081864 | Hess et al. | Apr 2010 | A1 |
20100081883 | Murray et al. | Apr 2010 | A1 |
20100094323 | Isaacs et al. | Apr 2010 | A1 |
20100106173 | Yoshimine | Apr 2010 | A1 |
20100109480 | Forslund et al. | May 2010 | A1 |
20100158307 | Kubota et al. | Jun 2010 | A1 |
20100168741 | Sanai et al. | Jul 2010 | A1 |
20100181966 | Sakakibara | Jul 2010 | A1 |
20100187283 | Crainich et al. | Jul 2010 | A1 |
20100204721 | Young et al. | Aug 2010 | A1 |
20100222714 | Muir et al. | Sep 2010 | A1 |
20100222752 | Collins, Jr. et al. | Sep 2010 | A1 |
20100228250 | Brogna | Sep 2010 | A1 |
20100234906 | Koh | Sep 2010 | A1 |
20100274160 | Yachi et al. | Oct 2010 | A1 |
20100274278 | Fleenor et al. | Oct 2010 | A1 |
20100280368 | Can et al. | Nov 2010 | A1 |
20100298743 | Nield et al. | Nov 2010 | A1 |
20100331742 | Masuda | Dec 2010 | A1 |
20110004233 | Muir et al. | Jan 2011 | A1 |
20110015650 | Choi et al. | Jan 2011 | A1 |
20110028964 | Edwards | Feb 2011 | A1 |
20110071523 | Dickhans | Mar 2011 | A1 |
20110106141 | Nakamura | May 2011 | A1 |
20110112400 | Emery et al. | May 2011 | A1 |
20110125149 | El-Galley et al. | May 2011 | A1 |
20110125151 | Strauss et al. | May 2011 | A1 |
20110144640 | Heinrich et al. | Jun 2011 | A1 |
20110160725 | Kabaya et al. | Jun 2011 | A1 |
20110238010 | Kirschenman et al. | Sep 2011 | A1 |
20110273465 | Konishi et al. | Nov 2011 | A1 |
20110278343 | Knodel et al. | Nov 2011 | A1 |
20110279268 | Konishi et al. | Nov 2011 | A1 |
20110284014 | Cadeddu et al. | Nov 2011 | A1 |
20110290856 | Shelton, IV et al. | Dec 2011 | A1 |
20110295295 | Shelton, IV et al. | Dec 2011 | A1 |
20110306967 | Payne et al. | Dec 2011 | A1 |
20110313415 | Fernandez et al. | Dec 2011 | A1 |
20120004655 | Kim et al. | Jan 2012 | A1 |
20120016413 | Timm et al. | Jan 2012 | A1 |
20120022519 | Huang et al. | Jan 2012 | A1 |
20120022526 | Aldridge et al. | Jan 2012 | A1 |
20120022583 | Sugalski et al. | Jan 2012 | A1 |
20120041358 | Mann et al. | Feb 2012 | A1 |
20120053597 | Anvari et al. | Mar 2012 | A1 |
20120059286 | Hastings et al. | Mar 2012 | A1 |
20120059289 | Nield et al. | Mar 2012 | A1 |
20120071863 | Lee et al. | Mar 2012 | A1 |
20120078244 | Worrell et al. | Mar 2012 | A1 |
20120080344 | Shelton, IV | Apr 2012 | A1 |
20120101495 | Young et al. | Apr 2012 | A1 |
20120109186 | Parrott et al. | May 2012 | A1 |
20120116222 | Sawada et al. | May 2012 | A1 |
20120116265 | Houser et al. | May 2012 | A1 |
20120116266 | Houser et al. | May 2012 | A1 |
20120116381 | Houser et al. | May 2012 | A1 |
20120136279 | Tanaka et al. | May 2012 | A1 |
20120136386 | Kishida et al. | May 2012 | A1 |
20120143211 | Kishi | Jun 2012 | A1 |
20120150049 | Zielinski et al. | Jun 2012 | A1 |
20120150169 | Zielinksi et al. | Jun 2012 | A1 |
20120172904 | Muir et al. | Jul 2012 | A1 |
20120191091 | Allen | Jul 2012 | A1 |
20120211542 | Racenet | Aug 2012 | A1 |
20120253328 | Cunningham et al. | Oct 2012 | A1 |
20120265241 | Hart et al. | Oct 2012 | A1 |
20120296325 | Takashino | Nov 2012 | A1 |
20120296371 | Kappus et al. | Nov 2012 | A1 |
20130023925 | Mueller | Jan 2013 | A1 |
20130085510 | Stefanchik et al. | Apr 2013 | A1 |
20130123776 | Monson et al. | May 2013 | A1 |
20130158659 | Bergs et al. | Jun 2013 | A1 |
20130158660 | Bergs et al. | Jun 2013 | A1 |
20130165929 | Muir et al. | Jun 2013 | A1 |
20130214025 | Zemlok et al. | Aug 2013 | A1 |
20130253256 | Griffith et al. | Sep 2013 | A1 |
20130253480 | Kimball et al. | Sep 2013 | A1 |
20130277410 | Fernandez et al. | Oct 2013 | A1 |
20130296843 | Boudreaux et al. | Nov 2013 | A1 |
20130334989 | Kataoka | Dec 2013 | A1 |
20140001231 | Shelton, IV et al. | Jan 2014 | A1 |
20140001234 | Shelton, IV et al. | Jan 2014 | A1 |
20140005640 | Shelton, IV et al. | Jan 2014 | A1 |
20140005678 | Shelton, IV et al. | Jan 2014 | A1 |
20140005702 | Timm et al. | Jan 2014 | A1 |
20140005705 | Weir et al. | Jan 2014 | A1 |
20140005718 | Shelton, IV et al. | Jan 2014 | A1 |
20140014544 | Bugnard et al. | Jan 2014 | A1 |
20140121569 | Schafer et al. | May 2014 | A1 |
20140135804 | Weisenburgh, II et al. | May 2014 | A1 |
20140180274 | Kabaya et al. | Jun 2014 | A1 |
20140194868 | Sanai et al. | Jul 2014 | A1 |
20140194874 | Dietz et al. | Jul 2014 | A1 |
20140194875 | Reschke et al. | Jul 2014 | A1 |
20140207135 | Winter | Jul 2014 | A1 |
20140246475 | Hall et al. | Sep 2014 | A1 |
20140263541 | Leimbach et al. | Sep 2014 | A1 |
20140263552 | Hall et al. | Sep 2014 | A1 |
20140276797 | Batchelor et al. | Sep 2014 | A1 |
20150032150 | Ishida et al. | Jan 2015 | A1 |
20150080876 | Worrell et al. | Mar 2015 | A1 |
20150080887 | Sobajima et al. | Mar 2015 | A1 |
20150088122 | Jensen | Mar 2015 | A1 |
20150112335 | Boudreaux et al. | Apr 2015 | A1 |
20150157356 | Gee | Jun 2015 | A1 |
20150164533 | Felder et al. | Jun 2015 | A1 |
20150164534 | Felder et al. | Jun 2015 | A1 |
20150164535 | Felder et al. | Jun 2015 | A1 |
20150164536 | Czarnecki et al. | Jun 2015 | A1 |
20150164537 | Cagle et al. | Jun 2015 | A1 |
20150164538 | Aldridge et al. | Jun 2015 | A1 |
20150238260 | Nau, Jr. | Aug 2015 | A1 |
20150272581 | Leimbach et al. | Oct 2015 | A1 |
20150272659 | Boudreaux et al. | Oct 2015 | A1 |
20150282879 | Ruelas | Oct 2015 | A1 |
20150289364 | Ilkko et al. | Oct 2015 | A1 |
20150313667 | Allen, IV | Nov 2015 | A1 |
20160045248 | Unger et al. | Feb 2016 | A1 |
20160051316 | Boudreaux | Feb 2016 | A1 |
20160175029 | Witt et al. | Jun 2016 | A1 |
20160206342 | Robertson et al. | Jul 2016 | A1 |
20160262786 | Madan et al. | Sep 2016 | A1 |
20160270842 | Strobl et al. | Sep 2016 | A1 |
20160296251 | Olson et al. | Oct 2016 | A1 |
20160296252 | Olson et al. | Oct 2016 | A1 |
20160296270 | Strobl et al. | Oct 2016 | A1 |
20160358849 | Jur et al. | Dec 2016 | A1 |
20170086909 | Yates et al. | Mar 2017 | A1 |
20170119426 | Akagane | May 2017 | A1 |
20170135751 | Rothweiler et al. | May 2017 | A1 |
20170164997 | Johnson et al. | Jun 2017 | A1 |
20170189095 | Danziger et al. | Jul 2017 | A1 |
20170202595 | Shelton, IV | Jul 2017 | A1 |
20170312018 | Trees et al. | Nov 2017 | A1 |
20170325874 | Noack et al. | Nov 2017 | A1 |
20180014872 | Dickerson | Jan 2018 | A1 |
20180098785 | Price et al. | Apr 2018 | A1 |
20180146976 | Clauda et al. | May 2018 | A1 |
20180235691 | Voegele et al. | Aug 2018 | A1 |
20190105067 | Boudreaux et al. | Apr 2019 | A1 |
20190201048 | Stulen et al. | Jul 2019 | A1 |
20190209201 | Boudreaux et al. | Jul 2019 | A1 |
20190262030 | Faller et al. | Aug 2019 | A1 |
20190274700 | Robertson et al. | Sep 2019 | A1 |
20190282288 | Boudreaux | Sep 2019 | A1 |
20190388091 | Eschbach et al. | Dec 2019 | A1 |
20200030021 | Yates et al. | Jan 2020 | A1 |
20200054382 | Yates et al. | Feb 2020 | A1 |
20200078085 | Yates et al. | Mar 2020 | A1 |
20200078609 | Messerly et al. | Mar 2020 | A1 |
20200129261 | Eschbach | Apr 2020 | A1 |
20200138473 | Shelton, IV et al. | May 2020 | A1 |
20200229833 | Vakharia et al. | Jul 2020 | A1 |
20200229834 | Olson et al. | Jul 2020 | A1 |
20200237434 | Scheib et al. | Jul 2020 | A1 |
20200261141 | Wiener et al. | Aug 2020 | A1 |
20200268433 | Wiener et al. | Aug 2020 | A1 |
20210052313 | Shelton, IV et al. | Feb 2021 | A1 |
20210100578 | Weir et al. | Apr 2021 | A1 |
20210100579 | Shelton, IV et al. | Apr 2021 | A1 |
20210177481 | Shelton, IV et al. | Jun 2021 | A1 |
20210177496 | Shelton, IV et al. | Jun 2021 | A1 |
20210186553 | Green et al. | Jun 2021 | A1 |
20210186554 | Green et al. | Jun 2021 | A1 |
20210196263 | Shelton, IV et al. | Jul 2021 | A1 |
20210196265 | Shelton, IV et al. | Jul 2021 | A1 |
20210196266 | Shelton, IV et al. | Jul 2021 | A1 |
20210196267 | Shelton, IV et al. | Jul 2021 | A1 |
20210196268 | Shelton, IV et al. | Jul 2021 | A1 |
20210196269 | Shelton, IV et al. | Jul 2021 | A1 |
20210196270 | Shelton, IV et al. | Jul 2021 | A1 |
20210196271 | Shelton, IV et al. | Jul 2021 | A1 |
20210196301 | Shelton, IV et al. | Jul 2021 | A1 |
20210196302 | Shelton, IV et al. | Jul 2021 | A1 |
20210196305 | Strobl | Jul 2021 | A1 |
20210196306 | Estera et al. | Jul 2021 | A1 |
20210196307 | Shelton, IV | Jul 2021 | A1 |
20210196334 | Sarley et al. | Jul 2021 | A1 |
20210196335 | Messerly et al. | Jul 2021 | A1 |
20210196336 | Faller et al. | Jul 2021 | A1 |
20210196343 | Shelton, IV et al. | Jul 2021 | A1 |
20210196344 | Shelton, IV et al. | Jul 2021 | A1 |
20210196345 | Messerly et al. | Jul 2021 | A1 |
20210196346 | Leuck et al. | Jul 2021 | A1 |
20210196349 | Fiebig et al. | Jul 2021 | A1 |
20210196350 | Fiebig et al. | Jul 2021 | A1 |
20210196351 | Sarley et al. | Jul 2021 | A1 |
20210196352 | Messerly et al. | Jul 2021 | A1 |
20210196353 | Gee et al. | Jul 2021 | A1 |
20210196354 | Shelton, IV et al. | Jul 2021 | A1 |
20210196355 | Shelton, IV et al. | Jul 2021 | A1 |
20210196356 | Shelton, IV et al. | Jul 2021 | A1 |
20210196357 | Shelton, IV et al. | Jul 2021 | A1 |
20210196358 | Shelton, IV et al. | Jul 2021 | A1 |
20210196359 | Shelton, IV et al. | Jul 2021 | A1 |
20210196360 | Shelton, IV et al. | Jul 2021 | A1 |
20210196361 | Shelton, IV et al. | Jul 2021 | A1 |
20210196362 | Shelton, IV et al. | Jul 2021 | A1 |
20210196363 | Shelton, IV et al. | Jul 2021 | A1 |
20210196364 | Shelton, IV et al. | Jul 2021 | A1 |
20210196365 | Shelton, IV et al. | Jul 2021 | A1 |
20210196366 | Shelton, IV et al. | Jul 2021 | A1 |
20210196367 | Salguero et al. | Jul 2021 | A1 |
20210212744 | Shelton, IV et al. | Jul 2021 | A1 |
20210220036 | Shelton, IV et al. | Jul 2021 | A1 |
20210236195 | Asher et al. | Aug 2021 | A1 |
20210282804 | Worrell et al. | Sep 2021 | A1 |
20210393288 | Shelton, IV et al. | Dec 2021 | A1 |
20210393314 | Wiener et al. | Dec 2021 | A1 |
20210393319 | Shelton, IV et al. | Dec 2021 | A1 |
Number | Date | Country |
---|---|---|
2535467 | Apr 1993 | CA |
2460047 | Nov 2001 | CN |
1634601 | Jul 2005 | CN |
1775323 | May 2006 | CN |
1922563 | Feb 2007 | CN |
2868227 | Feb 2007 | CN |
101474081 | Jul 2009 | CN |
101516285 | Aug 2009 | CN |
101522112 | Sep 2009 | CN |
102100582 | Jun 2011 | CN |
102149312 | Aug 2011 | CN |
202027624 | Nov 2011 | CN |
102792181 | Nov 2012 | CN |
103281982 | Sep 2013 | CN |
103379853 | Oct 2013 | CN |
203468630 | Mar 2014 | CN |
104001276 | Aug 2014 | CN |
104013444 | Sep 2014 | CN |
104434298 | Mar 2015 | CN |
3904558 | Aug 1990 | DE |
9210327 | Nov 1992 | DE |
4300307 | Jul 1994 | DE |
29623113 | Oct 1997 | DE |
20004812 | Sep 2000 | DE |
20021619 | Mar 2001 | DE |
10042606 | Aug 2001 | DE |
10201569 | Jul 2003 | DE |
102012109037 | Apr 2014 | DE |
0171967 | Feb 1986 | EP |
0336742 | Oct 1989 | EP |
0136855 | Nov 1989 | EP |
0705571 | Apr 1996 | EP |
1698289 | Sep 2006 | EP |
1862133 | Dec 2007 | EP |
1972264 | Sep 2008 | EP |
2060238 | May 2009 | EP |
1747761 | Oct 2009 | EP |
2131760 | Dec 2009 | EP |
1214913 | Jul 2010 | EP |
1946708 | Jun 2011 | EP |
1767164 | Jan 2013 | EP |
2578172 | Apr 2013 | EP |
2668922 | Dec 2013 | EP |
2076195 | Dec 2015 | EP |
2510891 | Jun 2016 | EP |
2032221 | Apr 1980 | GB |
2317566 | Apr 1998 | GB |
S50100891 | Aug 1975 | JP |
S5968513 | May 1984 | JP |
S59141938 | Aug 1984 | JP |
S62221343 | Sep 1987 | JP |
S62227343 | Oct 1987 | JP |
S62292153 | Dec 1987 | JP |
S62292154 | Dec 1987 | JP |
S63109386 | May 1988 | JP |
S63315049 | Dec 1988 | JP |
H01151452 | Jun 1989 | JP |
H01198540 | Aug 1989 | JP |
H0271510 | May 1990 | JP |
H02286149 | Nov 1990 | JP |
H02292193 | Dec 1990 | JP |
H0337061 | Feb 1991 | JP |
H0425707 | Feb 1992 | JP |
H0464351 | Feb 1992 | JP |
H0430508 | Mar 1992 | JP |
H04152942 | May 1992 | JP |
H 0541716 | Feb 1993 | JP |
H0595955 | Apr 1993 | JP |
H05115490 | May 1993 | JP |
H0670938 | Mar 1994 | JP |
H06104503 | Apr 1994 | JP |
H0824266 | Jan 1996 | JP |
H08229050 | Sep 1996 | JP |
H08275951 | Oct 1996 | JP |
H08299351 | Nov 1996 | JP |
H08336545 | Dec 1996 | JP |
H09130655 | May 1997 | JP |
H09135553 | May 1997 | JP |
H09140722 | Jun 1997 | JP |
H105237 | Jan 1998 | JP |
10127654 | May 1998 | JP |
H10295700 | Nov 1998 | JP |
H11128238 | May 1999 | JP |
2000210299 | Aug 2000 | JP |
2000271142 | Oct 2000 | JP |
2000271145 | Oct 2000 | JP |
2000287987 | Oct 2000 | JP |
2001029353 | Feb 2001 | JP |
2002059380 | Feb 2002 | JP |
2002186901 | Jul 2002 | JP |
2002263579 | Sep 2002 | JP |
2002330977 | Nov 2002 | JP |
2003000612 | Jan 2003 | JP |
2003010201 | Jan 2003 | JP |
2003116870 | Apr 2003 | JP |
2003126104 | May 2003 | JP |
2003126110 | May 2003 | JP |
2003153919 | May 2003 | JP |
2003339730 | Dec 2003 | JP |
2004129871 | Apr 2004 | JP |
2004147701 | May 2004 | JP |
2005003496 | Jan 2005 | JP |
2005027026 | Jan 2005 | JP |
2005074088 | Mar 2005 | JP |
2005337119 | Dec 2005 | JP |
2006068396 | Mar 2006 | JP |
2006081664 | Mar 2006 | JP |
2006114072 | Apr 2006 | JP |
2006217716 | Aug 2006 | JP |
2006288431 | Oct 2006 | JP |
2007037568 | Feb 2007 | JP |
200801876 | Jan 2008 | JP |
200833644 | Feb 2008 | JP |
2008188160 | Aug 2008 | JP |
D1339835 | Aug 2008 | JP |
2010009686 | Jan 2010 | JP |
2010121865 | Jun 2010 | JP |
2012071186 | Apr 2012 | JP |
2012235658 | Nov 2012 | JP |
100789356 | Dec 2007 | KR |
2154437 | Aug 2000 | RU |
22035 | Mar 2002 | RU |
2201169 | Mar 2003 | RU |
2405603 | Dec 2010 | RU |
2013119977 | Nov 2014 | RU |
850068 | Jul 1981 | SU |
WO-8103272 | Nov 1981 | WO |
WO-9308757 | May 1993 | WO |
WO-9314708 | Aug 1993 | WO |
WO-9421183 | Sep 1994 | WO |
WO-9424949 | Nov 1994 | WO |
WO-9639086 | Dec 1996 | WO |
WO-9800069 | Jan 1998 | WO |
WO-9840015 | Sep 1998 | WO |
WO-9920213 | Apr 1999 | WO |
WO-9923960 | May 1999 | WO |
WO-0024330 | May 2000 | WO |
WO-0064358 | Nov 2000 | WO |
WO-0128444 | Apr 2001 | WO |
WO-0167970 | Sep 2001 | WO |
WO-0172251 | Oct 2001 | WO |
WO-0195810 | Dec 2001 | WO |
WO-03095028 | Nov 2003 | WO |
WO-2004037095 | May 2004 | WO |
WO-2004078051 | Sep 2004 | WO |
WO-2004098426 | Nov 2004 | WO |
WO-2007008710 | Jan 2007 | WO |
WO-2008118709 | Oct 2008 | WO |
WO-2008130793 | Oct 2008 | WO |
WO-2010027109 | Mar 2010 | WO |
WO-2010104755 | Sep 2010 | WO |
WO-2011008672 | Jan 2011 | WO |
WO-2011044343 | Apr 2011 | WO |
WO-2011052939 | May 2011 | WO |
WO-2011060031 | May 2011 | WO |
WO-2012044606 | Apr 2012 | WO |
WO-2012088535 | Jun 2012 | WO |
WO-2012150567 | Nov 2012 | WO |
Entry |
---|
Arnoczky et al., “Thermal Modification of Conective Tissues: Basic Science Considerations and Clinical Implications,” J. Am Acad Orthop Surg, vol. 8, No. 5, pp. 305-313 (Sep./Oct. 2000). |
Hörmann et al., “Reversible and irreversible denaturation of collagen fibers.” Biochemistry, 10, pp. 932-937 (1971). |
Technology Overview, printed from www.harmonicscalpel.com, Internet site, website accessed on Jun. 13, 2007, (3 pages). |
Sherrit et al., “Novel Horn Designs for Ultrasonic/Sonic Cleaning Welding, Soldering, Cutting and Drilling,” Proc. SPIE Smart Structures Conference, vol. 4701, Paper No. 34, San Diego, CA, pp. 353-360, Mar. 2002. |
Lim et al., “A Review of Mechanism Used in Laparoscopic Surgical Instruments,” Mechanism and Machine Theory, vol. 38, pp. 1133-1147, (2003). |
Gooch et al., “Recommended Infection-Control Practices for Dentistry, 1993,” Published: May 28, 1993; [retrieved on Aug. 23, 2008], Retrieved from the internet: URL: http//wonder.cdc.gov/wonder/prevguid/p0000191/p0000191.asp (15 pages). |
Dean, D.A., “Electrical Impedance Spectroscopy Study of Biological Tissues,” J. Electrostat, 66(3-4), Mar. 2008, pp. 165-177. Accessed Apr. 10, 2018: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597841/. |
Covidien Brochure, The LigaSure Precise™ Instrument, dated Mar. 2011 (2 pages). |
AST Products, Inc., “Principles of Video Contact Angle Analysis,” 20 pages, (2006). |
Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal Free Shrinkage,” Transactions of the ASME, vol. 119, pp. 372-378 (Nov. 1997). |
Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal, Isotonic Shrinkage,” Transactions ofthe ASME, vol. 120, pp. 382-388 (Jun. 1998). |
Chen et al., “Heat-induced changes in the mechanics of a collagenous tissue: pseudoelastic behavior at 37° C.,” Journal of Biomechanics, 31, pp. 211-216 (1998). |
Chen et al., “Phenomenological Evolution Equations for Heat-Induced Shrinkage of a Collagenous Tissue,” IEEE Transactions on Biomedical Engineering, vol. 45, No. 10, pp. 1234-1240 (Oct. 1998). |
Moraleda et al., A Temperature Sensor Based on a Polymer Optical Fiber Macro-Bend, Sensors 2013, 13, 13076-13089, doi: 10.3390/s131013076, ISSN 1424-8220. |
Leonard I. Malis, M.D., “The Value of Irrigation During Bipolar Coagulation,” 1989. |
http:/www.ethicon.com/gb-en/healthcare-professionals/products/energy-devices/capital//ge . . . . |
Huston et al., “Magnetic and Magnetostrictive Properties of Cube Textured Nickel for Magnetostrictive Transducer Applications,” IEEE Transactions on Magnetics, vol. 9(4), pp. 636-640 (Dec. 1973). |
Orr et al., “Overview of Bioheat Transfer,” pp. 367-384 in Optical-Thermal Response of Laser-Irradiated Tissue, A. J. Welch and M. J. C. van Gemert, eds., Plenum, New York (1995). |
Incropera et al., Fundamentals of Heat and Mass Transfer, Wiley, New York (1990). |
F. A. Duck, “Optical Properties of Tissue Including Ultraviolet and Infrared Radiation,” pp. 43-71 in Physical Properties of Tissue (1990). |
Campbell et al., “Thermal Imaging in Surgery,” p. 19-3, in Medical Infrared Imaging, N. A. Diakides and J. D. Bronzino, Eds. (2008). |
http://www.dotmed.com/listing/electrosurical-unit/ethicon/ultracision-g110-/1466724. |
http://www.4-traders.com/JOHNSON-JOHNSON-4832/news/Johnson-Johnson-Ethicon-E . . . . |
Gerhard, Glen C., “Surgical Electrotechnology: Quo Vadis?,” IEEE Transactions on Biomedical Engineering, vol. BME-31, No. 12, pp. 787-792, Dec. 1984. |
Fowler, K.R., “A Programmable, Arbitrary Waveform Electrosurgical Device,” IEEE Engineering in Medicine and Biology Society 10th Annual International Conference, pp. 1324, 1325 (1988). |
Sullivan, “Cost-Constrained Selection of Strand Diameter and No. in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 16, No. 2, Mar. 2001, pp. 281-288. |
Graff, K.F., “Elastic Wave Propagation in a Curved Sonic Transmission Line,” IEEE Transactions on Sonics and Ultrasonics, SU-17(1), 1-6 (1970). |
Makarov, S. N., Ochmann, M., Desinger, K., “The longitudinal vibration response of a curved fiber used for laser ultrasound surgical therapy,” Journal of the Acoustical Society of America 102, 1191-1199 (1997). |
Morley, L. S. D., “Elastic Waves in a Naturally Curved Rod,” Quarterly Journal of Mechanics and Applied Mathematics, 14: 155-172 (1961). |
Walsh, S. J., White, R. G., “Vibrational Power Transmission in Curved Beams,” Journal of Sound and Vibration, 233(3), 455-488 (2000). |
Covidien Brochure, [Value Analysis Brief], LigaSure Advance™ Pistol Grip, dated Rev. Apr. 2010 (7 pages). |
Wright, et al., “Time-Temperature Equivalence of Heat-Induced Changes in Cells and Proteins,” Feb. 1998. ASME Journal of Biomechanical Engineering, vol. 120, pp. 22-26. |
Covidien Brochure, LigaSure Impact™ Instrument LF4318, dated Feb. 2013 (3 pages). |
Covidien Brochure, LigaSure Atlas™ Hand Switching Instruments, dated Dec. 2008 (2 pages). |
Covidien Brochure, The LigaSure™ 5 mm Blunt Tip Sealer/Divider Family, dated Apr. 2013 (2 pages). |
Erbe Electrosurgery VIO® 200 S, (2012), p. 7, 12 pages, accessed Mar. 31, 2014 at http://www. erbe-med. com/erbe/media/Marketing materialien/85140170 ERBE EN VIO 200 S D027541. |
Jang, J. et al. “Neuro-fuzzy and Soft Computing.” Prentice Hall, 1997, pp. 13-89, 199-293, 335-393, 453-496, 535-549. |
Sullivan, “Optimal Choice for Number of Strands in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 14, No. 2, Mar. 1999, pp. 283-291. |
Weir, C.E., “Rate of shrinkage of tendon collagen—heat, entropy and free energy of activation of the shrinkage of untreated tendon. Effect of acid salt, pickle, and tannage on the activation of tendon collagen.” Journal of the American Leather Chemists Association, 44, pp. 108-140 (1949). |
Henriques. F.C., “Studies in thermal injury V. The predictability and the significance of thermally induced rate processes leading to irreversible epidermal injury.” Archives of Pathology, 434, pp. 489-502 (1947). |
Wall et al., “Thermal modification of collagen,” J Shoulder Elbow Surg, No. 8, pp. 339-344 (Jul./Aug. 1999). |
Harris et al., “Kinetics of Thermal Damage to a Collagenous Membrane Under Biaxial Isotonic Loading,” IEEE Transactions on Biomedical Engineering, vol. 51, No. 2, pp. 371-379 (Feb. 2004). |
Harris et al., “Altered Mechanical Behavior of Epicardium Due to Isothermal Heating Under Biaxial Isotonic Loads,” Journal of Biomechanical Engineering, vol. 125, pp. 381-388 (Jun. 2003). |
Lee et al., “A multi-sample denaturation temperature tester for collagenous biomaterials,” Med. Eng. Phy., vol. 17, No. 2, pp. 115-121 (Mar. 1995). |
Moran et al., “Thermally Induced Shrinkage of Joint Capsule,” Clinical Orthopaedics and Related Research, No. 281, pp. 248-255 (Dec. 2000). |
Wells et al., “Altered Mechanical Behavior of Epicardium Under Isothermal Biaxial Loading,” Transactions of the ASME, Journal of Biomedical Engineering, vol. 126, pp. 492-497 (Aug. 2004). |
Gibson, “Magnetic Refrigerator Successfully Tested,” U.S. Department of Energy Research News, accessed online on Aug. 6, 2010 at http://www.eurekalert.org/features/doe/2001-11/dl-mrs062802.php (Nov. 1, 2001). |
Humphrey, J.D., “Continuum Thermomechanics and the Clinical Treatment of Disease and Injury,” Appl. Mech. Rev., vol. 56, No. 2 pp. 231-260 (Mar. 2003). |
National Semiconductors Temperature Sensor Handbook—http://www.national.com/appinfo/tempsensors/files/temphb.pdf; accessed online: Apr. 1, 2011. |
Hayashi et al., “The Effect of Thermal Heating on the Length and Histologic Properties of the Glenohumeral Joint Capsule,” American Journal of Sports Medicine, vol. 25, Issue 1, 11 pages (Jan. 1997), URL: http://www.mdconsult.com/das/article/body/156183648-2/jorg=journal&source=MI&sp=1 . . . , accessed Aug. 25, 2009. |
Douglas, S.C. “Introduction to Adaptive Filter”. Digital Signal Processing Handbook. Ed. Vijay K. Madisetti and Douglas B. Williams. Boca Raton: CRC Press LLC, 1999. |
Kurt Gieck & Reiner Gieck, Engineering Formulas § Z.7 (7th ed. 1997). |
Glaser and Subak-Sharpe,Integrated Circuit Engineering, Addison-Wesley Publishing, Reading, MA (1979). |
Covidien 501 (k) Summary Sonicision, dated Feb. 24, 2011 (7 pages). |
http://www.megadyne.com/es_generator.php. |
LaCourse, J.R.; Vogt, M.C.; Miller, W.T., III; Selikowitz, S.M., “Spectral Analysis Interpretation of Electrosurgical Generator Nerve and Muscle Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, pp. 505-509, Jul. 1988. |
https://www.kjmagnetics.com/fieldcalculator.asp, retrieved Jul. 11, 2016, backdated to Nov. 11, 2011 via https://web.archive.org/web/20111116164447/http://www.kjmagnetics.com/fieldcalculator.asp. |
http://www.apicalinstr.com/generators.htm. |
http://www.medicalexpo.com/medical-manufacturer/electrosurgical-generator-6951.html. |
http://www.valleylab.com/product/es/generators/index.html. |
Number | Date | Country | |
---|---|---|---|
20200085465 A1 | Mar 2020 | US |
Number | Date | Country | |
---|---|---|---|
61621876 | Apr 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15260882 | Sep 2016 | US |
Child | 16693807 | US | |
Parent | 13839093 | Mar 2013 | US |
Child | 15260882 | US |